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CHAPTER 0 
 
UNDERSTANDING THE ‘GRAMMAR’ FOR THE SCRIPT OF LIFE: 
‘DNA’ and basic concepts 
 
THE GENOME versus EPIGENOME 
‘Life’ is one of the most enigmatic phenomenon on the planet Earth and a deeply personal 
one for humans. Over the last century, the human race has taken early, but significant steps 
to understand the language of the genome, which directs every facet of ‘life’ here on Earth. 
But what is the genome? The genome is a heritable and relatively stable set of instructions 
needed for the growth, development and propagation of life (Gregory, 2005). From its 
simplest forms, like viruses to the most complex mammalian organisms, life is governed by a 
set of genomic instructions written in the 4-letter code of DNA, or in certain cases RNA. DNA 
is the blue print of an organism capable of programming the organism using 4 molecules; 
Adenosine (A), Guanine (G), Thymine (T) and Cytosine (C).  Adenine binds to thymine (A-T) 
and cytosine binds to guanine (C-G) to form the double stranded double helix structure 
resembling the winding stairs formation (Alberts et al., 2014). This long ATGC thread like 
structure is bundled up and organized into tertiary structure called chromatin and 
condensed into chromosomes in Eukaryotes (Tsompana and Buck, 2014). To better 
understand this language of life and specifically of humans, the international research 
project called the Human Genome Project (HGP) was launched in 1990 and partially 
completed in 2003 (Consortium, 2001).  The Human Genome Project originally aimed to 
map the nucleotides contained in a human haploid reference genome (more than three 
billion). Similar endeavors were launched to understand the genomes of other organisms 
such as mouse, drosophila, yeast, E.coli etc. Only around 2-5% of the eukaryotic genome 
was regarded to be functional with the rest being termed ‘non-functional junk’ DNA 
(Tsompana and Buck, 2014). It was also understood that DNA forms only the coding 
component of the genome, but to understand ‘the language of life’ understanding the 
epigenome or grammar of the language was necessary. Epigenome has been defined in 
Merriam-Webster dictionary as ‘The complement of chemical compounds that modify the 
expression and function of the genome.’ 
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A human, like other higher eukaryotic organisms consists of billions of cells, each containing 
the same DNA and thus the same set of instructions. Even while containing the same 
genome, different cells from different organs can be completely distinct phenotypically and 
functionally. This difference in phenotype without change in genotype is brought about by 
controlling the functional part of the genome, using a higher order of regulation, called the 
epigenome or epigenetic regulation.  
The meters of DNA from a single eukaryotic cell fit into a small diameter structure called the 
nucleus (Alberts et al., 2014). The DNA is not disorganized in the nucleus but is packed 
efficiently around protein molecules called histones, forming the basic unit of chromatin 
packaging called ‘nucleosome’ (Kritikou and Editor, 2005).  A nucleosome is 147bp of DNA 
wrapped around an octamer of histones (H3, H4, H2A, H2B) forming an efficient unit of 
packaging called beads on string model (Kornberg, 1974). The nucleosome does not only 
serve as a passive packing unit, but also can be chemically modified to form active signaling 
unit of the epigenome, regulating access to the genome. These chemical modifications of 
the histone along with DNA modifications, non-coding RNA and transcription factors (TFs) 
and chromatin remodelers form the core of epigenetic mechanisms for regulated expression 
of the genome, resulting in phenotypic variation in cells. 
EPIGENETIC FEATURES OF CHROMATIN 
CHROMATIN ACCESSIBILITY 
DNA encodes RNA and RNA encodes protein is the ‘central dogma of molecular biology’ 
(Crick, 1970). However, it is also true that the entire DNA in the genome does not code for 
protein, and all protein coding DNA is not expressed as RNA or protein in any given cell, or 
at a given time. The first level of regulation for control of DNA expression is spatial 
accessibility. The eukaryotic genome is divided into transcriptionally silenced densely 
packed heterochromatin and active open euchromatin (Allis and Jenuwein, 2016). While 
heterochromatin is tightly packed with repressively labelled nucleosome, euchromatin 
made up of relatively ‘free’ nucleosomes and is susceptible to digestion by endonuclease 
enzymes such DNase1 in artificial experimental conditions. The openness of the 
euchromatin allows access to pro-transcriptional TFs and DNA-dependent RNA polymerases 
to translate the DNA into RNA for further processing. Hence, using techniques such as 
DNase1 digestion and Assay for Transposase Accessible Chromatin with high-throughput 
sequencing  (ATAC-seq), scientists have been able to investigate the regulatory fraction of 
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the genome (Buenrostro et al., 2013; Song and Crawford, 2010). The regions of the genome 
susceptible to DNase1 digestion, called DNase1 hyper sensitive sites (DHSs), are known to 
contain regulatory features of the epigenome called the promoter, enhancer, repressor, 
insulator etc. Recent developments in molecular biology have shown these features to 
contain DNA motifs to recruit regulatory protein such as transcription factors.   
DNA METHYLATION 
Transcription of DNA is not only controlled by chromatin accessibility, but also by chemical 
modification of the DNA macromolecule itself. In eukaryotes, DNA methylation modification 
occurs only on one of the 4 nucleotide bases: the cytosine nucleotide (Suzuki and Bird, 
2008). Almost all of the methylated cytosines form a part of the palindromic CpG 
dinucleotide sequence where usually both/or none of the CpGs are methylated, and form 
the basic pattern for heredity of DNA methylation during replication (Lister et al., 2009; 
Suzuki and Bird, 2008; Zemach et al., 2010; Zilberman et al., 2007). DNMT3A and DNMT3B 
are enzymes responsible for de novo methylation of DNA, whereas DNMT1 is responsible 
for maintenance (Okano et al., 1999). Early observations suggested a negative correlation 
between CpG methylation and DNA transcription; hence DNA methylation is called a 
repressive epigenetic mark (Miranda and Jones, 2007). Interestingly, this repressive 
property of methylated DNA was observed in selective repression of only one allele of the 
gene during imprinting for gene dosage compensation (Li et al., 1993). Later studies also 
associated promoter methylation with repression of a given gene, while methylated gene 
body was observed to be a feature of transcriptionally active gene. Studies have also shown 
the importance of differential methylation on enhancers for maintenance of cell specific 
activity (Miranda and Jones, 2007; Suzuki and Bird, 2008; Wiench et al., 2011). 
HISTONE MODIFICATIONS 
In parallel to discovery of DNA methylation and its role in epigenetic regulation, it was 
observed that the packaging proteins of the nucleosomes (the histone) are also chemically 
modified and play a regulatory role (ALLFREY et al., 1964). Histone modifications are the 
covalently linked post-translational modifications (PTMs) to histone proteins which include 
amongst others methylation, phosphorylation, acetylation, ubiquitination, and sumoylation 
(Bannister and Kouzarides, 2011). The PTMs on histones have been shown regulate gene 
expression by recruiting TFs, other histone modifiers or by directly altering the chromatin 
structure. Hence, histone modifications perform diverse biological functions such as 
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transcriptional activation and repression, DNA repair signaling and chromatin packaging 
(Grant, 2001; Swygert and Peterson, 2014; Tessarz and Kouzarides, 2014; Zhang et al., 
2015). Some of the most important and widely studied histone modifications are: histone 
acetylation and deacetylation carried out by enzymes called the histone acetyltransferases 
(HATs) and histone deacetylases (HDACs) respectively (Bannister and Kouzarides, 2011; Roth 
et al., 2001; Zhang et al., 2015). Interestingly, H3K27 histone acetylation has been linked to 
activation of gene expression. Histones can be methylated at various positions on the 
histone tails resulting in distinct biological outcomes. H3K4 tri-methylation mark has been 
associated with gene activation in euchromatin (Santos-Rosa et al., 2002). Interestingly, the 
number of methyl groups on the same histone position can label distinct epigenetic features 
(Martin and Zhang, 2005). H3K27 and H3K9 methylation both play a role in repression of 
gene transcription and mediate formation of heterochromatin (Vakoc et al., 2006). Studies 
have shown that histone modifications can act as a docking site for binding of specific TFs 
and transcription co-factors depending on the context of the chromatin, for example, the 
chromodomain of Cbx protein can bind specifically to H3K27me3 repressive mark, thereby 
facilitating the recruitment of the repressive PRC1 complex (Eissenberg, 2012; Min et al., 
2003; Wang et al., 2012). 
READERS, WRITERS AND ERASERS OF CHROMATIN MODIFICATIONS: TRANSCRIPTION 
FACTORS 
The presence of the first histone modifications were identified in the 1960, but their origin 
and meaning was deciphered much later (ALLFREY et al., 1964; Grant, 2001). With 
identification of proteins and enzymes responsible for the deposition of these marks, first 
steps were taken to understand the complex script of epigenetic modifications. The proteins 
that interact with the chromatin were broadly placed in three categories; Readers of 
chromatin modifications called Transcription Factors (TFs), Writers and Erasers are 
classically called co-factors(Chi et al., 2010; Jenuwein and Allis, 2001). ‘Writer’ class of TFs is 
mainly responsible of marking the chromatin with a plethora of covalent modifications, as 
well as remodeling the chromatin into various structures. In later years, it was discovered 
that these modifications are deposited assigning context to the chromatin, and are 
functional in nature. The functional nature of chromatin was deciphered by identification of 
TFs called ‘Readers’ responsible for recognizing and responding to the modifications 
deposited by ‘Writer’ TFs. Transcriptional context of chromatin of any fragment of the 
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genome can be highly dynamic and hence the ‘Eraser’ class of TFs play an important role. 
The writing, reading and erasing role of TFs can be appreciated by the following example; 
Histone tail methylation is carried out by a class of writers called histone 
methyltransferases. Methylated lysine on histone tails in turn is recognized by Reader TFs, 
such as Cbx class of proteins (Morey et al., 2013). Recruitment of Cbx7, a cofactor from Cbx 
class of protein can recruit PRC1 complex, capable of transcriptionally silencing chromatin. 
Various lysine-specific demethylases can erase histone modifications, such as H3K4 
demethylation by LSD1 (Mosammaparast et al., 2013; Nicholson and Chen, 2009; Shi et al., 
2005). Finally some TFs are responsible for simply modifying the structure of the chromatin, 
by folding the chromatin or by shifting histone to form complex structures (Chen and Dent, 
2014; de Dieuleveult et al., 2016; Ho and Crabtree, 2010).  
Figure  
1. Transcription Factors play diverse roles as chromatin modifiers.   
  
Schematic representation of histone acetyltransferase (HAT) as epigenetic WRITER TF, TAF1 
as a READER TF and histone deacetylase enzyme (HDAC) acts as an ERASER TF on the 
dynamic ‘beads on a string’ chromatin.  
PROMOTERS AND ENHANCERS 
Researchers have found that certain histone modifications and their combinations label 
specific epigenetic feature of the genome. Active chromatin is known to associate with 
H3K4me1/2/3, H3K27ac, H3K9ac, and H3K36me3 histone marks (Bonn et al., 2012; Rada-
Iglesias et al., 2011), while repressed chromatin is associated with H3K9me3 and H3K27me3 
histone marks (Bannister and Kouzarides, 2011; Zhang et al., 2015). Furthermore, 
combinations of histone marks have been used to define distinct epigenetic feature of the 
chromatin. Promoters are specific DNA sequences situated at the transcription start site 
(TSS). RNA polymerase and other TFs bind to the promoter region of a gene to assemble the 
transcriptional machinery and initiate production of mRNA transcripts (Butler and 
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Kadonaga, 2002; Smale and Kadonaga, 2003). In mammals, the promoters of genes have 
been shown to carry specific histone marks such as H3K27ac, H3K4me1,2,3 and in certain 
conditions H3K27me3 (Bernstein et al., 2006; Corden et al., 1980; Harrow et al., 2009; Lee 
and Young, 2000). Another fascinating feature of the epigenome is the stretch of DNA called 
the Enhancer. Enhancers are cis-acting regulatory DNA sequences, upstream or downstream 
of the gene promoters which have the capacity to alter the rate of transcription of a gene. 
These enhancer sequences typically have motifs for recruitment/binding of specific protein 
called Transcription factors (TFs) capable of enhancing transcription at a nearby gene 
promoter (Schaffner, 2015). Enhancers can be identified by their distinct histone 
modification pattern of H3K27ac, H3K4me1 and low amounts of H3K4me3 marks.  
3D CHROMATIN STRUCTURE, FOLDING and ORDERS of CHROMATIN ARCHTECHTURE 
How promoters and enhancers interact has been a topic of debate for many years. One 
mechanism which has gained wide acceptance is that the enhancers and promoters form 
physical interaction loops to bring the two elements in physical proximity, as well as 
providing selectivity. This mechanism has been given further credence by experiments to 
decipher the 3D structure of the genome, such as 3C, 4C, Hi-C and microscopy experiments.  
The 3D structure of the genome shows signs of multiple orders of organization (Bonev 
Boyan and Cavalli Giacomo, 2016; Gibcus and Dekker, 2013). Primarily the chromatin fiber 
can exist in a dense repressed state or in a relaxed open state, depending on the epigenetic 
context. It has been shown to a certain extent, that the chromatin is organized by chromatin 
remodelers to facilitate recruitment of regulatory proteins to specific sequences in the 
genome to enable specific local architecture ensuring contact between cis-regulatory 
elements (Bonev Boyan and Cavalli Giacomo, 2016; Dekker et al., 2013; Gibcus and Dekker, 
2013). The responsible proteins are recruited to these focal structures via a combination of 
chemical signaling by the histone tail modification profiles, DNA sequence and DNA 
modifications. A fascinating question that arises is ‘How these focal structures, responsible 
for transcription, repression, isolation and compartmentalization, are initiated and 
maintained or in certain cases altered in response to stimuli?’   
Hypothetically, if one was able to zoom-out from the finest structure of the chromatin to 
higher order structure of the genome, one could perceive the architecture as following; the 
lowest order starts with local chromatin interactome, consisting of contacts between 
neighboring genes and their regulatory elements. Next order of chromatin architecture is 
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commonly accepted as topologically associated domains or TADs (Dixon et al., 2012a). TADs 
are simply put, sub-domains or fragments of linear genome which show statistically higher 
probability of interaction with each other compared to a neighboring genomic fragment, 
which constitutes the neighboring TAD. As per the definition of a TAD, the fragment of the 
genome inside a TAD is relatively isolated from rest of the genome and forms the basis for 
local chromatin and spatial regulation of genes. TADs can range in size from a few hundred 
kilo bases to mega bases long, depending on the resolution of the technique used to 
decipher the structure. TADs are called the building blocks of higher order conformation of 
the genome maintained by insulator proteins such as CTCF and cohesin (Merkenschlager 
and Nora, 2016, 2016; Ong and Corces, 2014; Seitan et al., 2013; Wendt et al., 2008; Zuin et 
al., 2014, 2014). TADs are extremely stable structures, seldom changing even between cell 
types (Ciabrelli and Cavalli, 2015; Dekker and Heard, 2015; Dixon et al., 2012a; Pope et al., 
2014; Wang et al., 2015). The structure inside the TAD is also called fine structure of 
chromatin and is responsible for fine-tuning the probability of expression of genes. Most of 
the interaction between cis-regulatory elements and promoters of genes are observed 
inside a TAD, and are insulated from the neighboring TADs. Hence, the interaction inside a 
TAD from the local chromatin structure which directly control expression of genes in any 
given domain.   
TADs form the basic structure for dividing the genome into higher order structure made up 
of several TADs, called A/B compartments  (Bonev Boyan and Cavalli Giacomo, 2016; Dekker 
et al., 2013; Dixon et al., 2012a; Gibcus and Dekker, 2013) . The active domains are called 
the A compartment domains and are more open to facilitate transcription, whereas inactive 
domains form the part of B compartment which is spatially restricted. Even higher order of 
chromatin architecture is maintained by restriction of chromosomes into a spatially 
confined region called chromosome territories (Cremer et al., 1982; Lakadamyali and 
Cosma, 2015; Visser et al., 2000). 
Structure and organization of chromatin is highly hierarchical especially in the metazoan 
genome. As discussed earlier, the chromatin condensed into a chromosome structure is 
restricted in the so called spatial ‘chromosome territories’. Secondarily, the chromatin in a 
chromosome is subdivided into a number of relatively isolated structures called the 
topologically associated domains (TADs). A TAD represents a linear fragment of DNA within 
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which physical interactions occur relatively frequently, whereas interactions across a TAD 
boundary occur at a relatively lower frequency (Dixon et al., 2012b).  
 
CHROMATIN DYNAMICS IN TWO STATES OF PLURIPOTENCY 
Embryonic stem cells (ES cells) are pluripotent stem cells derived from an early-stage 
preimplantation embryo, specifically from the inner cell mass of a blastocyst. The ability of 
ESCs to differentiate into any cell type from the body and their property of infinite self-
renewal has fascinated researchers for decades (Evans and Kaufman, 1981; Hackett and 
Surani, 2014). The pluripotent properties of mouse embryonic stem cells (mESCs) makes 
them an invaluable model for fundamental research into the regulatory mechanisms in early 
development. mESCs are classically cultured in growth-media supplemented with fetal calf 
serum and leukemia Inhibitory Factor (LIF) or, more recently, in serum-free 2i medium that 
contains LIF plus 2 small-molecule kinase inhibitors: PD0325901 targeting mitogen-activated 
protein kinase (MEK) pathway and CHIR99021 targeting glycogen synthase kinase-3 (GSK3) 
pathway (Ying et al., 2008). It is well accepted that 2i mESCs represent a ground-state 
pluripotency, whereas the classical serum-derived mESCs are reminiscent of post-
implantation pluripotent stem cells  (Evans and Kaufman, 1981; Habibi et al., 2013; Leitch et 
al., 2013; Marks and Stunnenberg, 2014; Marks et al., 2012; Nichols and Smith, 2009; 
Odsworth et al., 2015; Plusa and Hadjantonakis, 2014; Ying et al., 2008). mESCs grown in 
serum+LIF (“serum mESCs”) and 2i+LIF media (“2i mESCs”) are both pluripotent; however, 
they show distinct epigenetic landscapes and RNA expression profiles (Bernstein et al., 
2006; Habibi et al., 2013; Marks et al., 2012). 2i mESCs have higher expression of metabolic 
genes and diminished expression of lineage priming genes compared to serum mESCs 
(Marks et al., 2012). Another striking feature is that serum mESCs have much higher levels 
of H3K27me3 along with PRC2 localization on the so-called bivalent loci than 2i mESCs 
(Azuara et al., 2006; Bernstein et al., 2006; Marks et al., 2012). In serum mESCs, around 
3000 genes have a bivalent chromatin state (co-occurrence of H3K27me3 and H3K4me3 
marks), and are said to be poised for activation. It is well established that bivalent loci 
coincide with promoters of genes involved in cell-fate determination, development and 
lineage specification (Azuara et al., 2006; Bernstein et al., 2006). In 2i mESCs, the number of 
bivalent genes reduces drastically, however, release from the repressive H3K27me3 does 
not result in transcriptional activation. Polycomb Repressive Complex 2 (PRC2) is responsible 
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for tri-methylation of H3K27 (Pasini et al., 2008). The localization of the PRC2 components, 
Ezh2 and Suz12, is diminished but not abolished at these bivalent gene promoters in 2i 
(Marks et al., 2012). Polycomb Repressive Complex 1 (PRC1) works in a coordinated fashion 
with PRC2 on bivalent loci (Ku et al., 2008). H3K27me3 marks deposited by PRC2 recruits 
canonical PRC1 (Sauvageau and Sauvageau, 2010). Notably, 2i mESCs have a hypo-
methylated DNA similar to pre-implantation embryos whereas serum mESCs are hyper-
methylated reminiscent of post-implantation (Habibi et al., 2013; Leitch et al., 2013; 
Seisenberger et al., 2012). Together, this suggests that serum mESCs are epigenetically more 
restricted and developmentally primed as compared to ground-state 2i mESCs. The 3D 
organization of chromatin may well play a role in initiation and/or maintenance of the 
distinct epigenetic landscapes and RNA-expression profiles in the two states of pluripotency. 
 
IN THIS THESIS 
In this chapter, Chapter 0, I discuss briefly some basic concepts related to the thesis, 
including the relationship between genome and epigenome, transcriptional regulation and 
the importance of 3D chromatin structure. In Chapter 1, named ‘Development of next 
generation tools to deciphering complex chromatin architecture’, I introduce the study of 
3D chromatin conformation. I discuss various techniques developed to study higher order of 
chromatin structure and tools developed to map the interactome of a given cell-type. I 
compare techniques, discussing their uses in solving different biological problems, as well as 
looking at each technique’s advantages and disadvantages. I discuss the future direction the 
study of the interactome is likely to take, and which biological questions the new developing 
technology can be applied to. In Chapter 2, we discuss the need for new technology to 
comprehensively map the interactome of the functional genome. I introduce the new 
technique developed in the lab to study 3D chromatin conformation at high resolution and 
at lower cost, called Capture Hi-C. We discuss the advantages of Capture Hi-C over other 
high-throughput techniques. We discuss in detail the protocol developed for Capture Hi-C in 
collaboration with Roche-NimbleGen. We also discuss the current applications and future 
applications of Capture Hi- C. In Chapter 3, we investigate the dynamics of 3D genomic 
organization during the transition of mESCs between two states of pluripotency, namely 
‘Naïve’ 2i state to a relatively ‘primed’ Serum state of pluripotency. We briefly discuss the 
newly developed Capture Hi-C with target-sequence enrichment of all open chromatin. We 
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detected extremely long-range intra- and inter-chromosomal interactions between a small 
subset of H3K27me3 marked bivalent promoters involving the Hox clusters. Markedly, these 
promoter-confined interactions are not present in 2i ground-state pluripotent mESCs but 
appear upon further development into primed like serum mESCs. Reversing serum mESCs to 
ground-state 2i mESCs reverses the promoter-promoter interaction in a spatiotemporal 
manner. H3K27me3, that is largely absent at bivalent promoters in ground-state 2i mESCs is 
necessary but not sufficient to establish these interactions, which is confirmed by Capture 
Hi-C on Eed-/- serum mESCs.  In Chapter 4, we discuss the role of Cbx7 and DNA methylation 
on initiation and maintenance of Extremely Long-Range Hox-related Interactions or ELRIs. In 
this Chapter we assess possible recruitment of PRC1 and PRC2 to the ELRI loci via the 
canonical or non-canonical pathways. Concentrating on Cbx7, we investigate the effect of 
Cbx7 knock-out on recruitment of PRC1 and PRC2 components to the ELRI and other 
bivalent loci. We also look into the effect of Cbx7 KO on ELRI formation and maintenance. 
Finally, we perform 4C experiment on DNMT triple KO cells grown in serum condition to 
investigate role of DNA methylation on ELRIs.     
Chapter 5 summarizes the findings and insights gained in the thesis. We discuss the main 
messages from each chapter to understand the direction future research should take. 
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CHAPTER 1 
 
DEVELOPMENT OF NEXT GENERATION TOOLS TO DECIPHER 
COMPLEX CHROMATIN ARCHITECTURE 
 
INTRODUCTION 
For Biologists, it has been a mystery for many decades to the very basic question in chromatin 
biology, “How do meters of DNA fit into a nucleus only ~5 µm in diameter”.  Not only are the 
meters of DNA and proteins to be packed into a small space, but also to be efficiently arranged 
for decomposition during replication and transcription. Scientists have come a long way in 
explaining this complex architecture. Many theories dictating the chromatin architecture have 
been proposed, but the ones which have stood the test of scientific critique and time range 
from the basic “beads on a string” fine structure to a “fractal globule” higher structure of the 
chromatin (Grosberg et al., 1993, 1988; Mirny, 2011).  
ROLE OF IMAGING IN DECIPHERING CHROMATIN ARCHITECTURE  
Although we expect certain variability in the fine and higher order architecture of chromatin in 
different cells, logic also dictates that there must be similar architectural features common to 
certain loci in all cells. For example, under a microscope, chromosomes of different cells seem 
to be randomly placed with high variability. With advancement of microscope technology and 
development of FISH (fluorescence in situ hybridization) it was clear that chromosomes, 
interestingly also in interphase nuclei, occupy distinct regions called chromosome territories 
(Branco and Pombo, 2006). This type of research would not have been possible without 
development of advanced FISH techniques such as chromosome painting, 3D FISH and cryo-
FISH. FISH research has shown that though chromosomes maintain their territories, there is 
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certain amount of intermingling between chromosomes, in particular, pertaining to open 
transcribed regions. Intermingling frequency has been observed to increase with de-
condensation of chromatin(Branco and Pombo, 2006; Cremer et al., 2006).  This suggests open, 
transcriptionally active regions interact at higher frequency providing evidence for the concept 
of transcription factories. In contrast to the open regions, compact/closed chromatin is 
localized to the lamin at the periphery of the nucleus (Dechat et al., 2010; Misteli, 2007). Super-
resolution 3D microscopy allows detection of interaction between two loci located hundreds to 
thousands of kilobase-pairs apart from each other. Although there has been an immense 
improvement in the usage of imaging tools to study chromatin architecture, resolution and lack 
of high-throughput properties are known to be its Achilles’ heel. 
ADVENT OF ‘3C’ AND VARIANT TECHNOLOGIES 
Due to afore mentioned limitations of imaging technology, a high resolution next-generation 
sequencing (NGS) based technology was needed to study the high-order to fine architecture of 
chromatin. 3C or Chromosome Capture Conformation technique when coupled with NGS 
technology allows us to study interaction profiles of genes or other genomic elements at a 
genome-wide scale. As the name of the technique suggests, the tool entails ligating genomic 
loci in spatial proximity to detect interaction profile of one genomic locus of interest to all of 
the genome. The two ends of the 3C ligation product typically entail two distinct genomic 
fragments separated by a linear distance, but in spatial proximity due to 3D folding of the 
chromatin, generally dictated by the crosslinking of DNA-protein complexes. These crosslinked 
protein-DNA complexes are generally visualized as a hair-ball like structure with thousands of 
DNA loops sticking out of the center of the protein complex. By cutting off the excess DNA 
chains from these complexes, followed by ligating the digested DNA end in physical proximity, 
3C libraries are constructed. The strength of the interaction of such digested fragments can be 
calculated by taking into account the frequency of such interactions from a pool of cells over 
background and distance between potentially interacting fragments. This proximity ligation 
principle of 3C technology have been used and modified for solving a variety of biological 
problems. Some of the most popularly used 3C based approaches are: 4C, 4C-seq, 5C, ChIA-PET 
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and Hi-C. Most popular 3C based technologies have been graphically represented and 
compared in Figure 1. The 3C-based approaches can be divided essentially into 3 categories, 
each having their own advantages and limitations. The 1st category includes the 3C and 4C 
approaches. This category can be defined as having one-to-one or one-to-many type 
configuration. This means that these techniques can detect interaction pattern/profile of one 
known ‘genomic locus of interest’ to ‘another locus’ (3C) or to ‘many other loci’ (4C-qPCR) or to 
‘all other loci’ (genome-wide 4C-seq). Compared to imaging based tools, this approach provides 
a much superior resolution of potentially less than 1Kb. The limitation of this category of 3C-
based approaches is that only one known locus of interest can be investigated at a time. The 
technique is also limited due to the use of restriction enzymes. In most NGS techniques coupled 
with sonication, PCR-duplicates can easily be discarded; unfortunately, in 4C-seq there is no 
way to distinguish between real interaction di-tag and a PCR duplicate due to an amplification 
step. One way to get around the problem is to convert the data into binary (yes or no reads at 
each restriction digested fragment) or by incorporating random unique barcodes (van de 
Werken et al., 2012; Van De Werken et al., 2012). The 2nd category of tools includes 5C and 
ChIA-PET approaches. 5C technique is an adaption of 4C where instead of ‘one-to-all’ ‘many-to-
all’ interactions can be investigated using a set of universal primers. As 5C is based on 4C, all the 
limitation of 4C are carried on to the 5C technique, although 5C provides for a more genome-
wide view compared to 4C. ChIA-PET is an antibody based ‘some-to-all’ approach. Limitations of 
all NGS techniques using antibodies also apply to ChiA-PET. The success of ChiA-PET 
experiments also largely depends on the quality and availability of the antibody. The 3rd 
category includes the Hi-C technique, which is a true ‘All-to-All’ genome wide technique. The 
technique uses biotin incorporation at the interaction/ligation site to select via streptavidin for 
true interaction events only (Lieberman-Aiden and Berkum, 2009).  
HI-C: ‘A GENOME WIDE’ 4C APPROACH 
On paper, Hi-C seems to be an ideal solution for a ‘All-to-All’ genome wide interaction profiling 
tool. Hi-C has been successfully used to decipher higher-order chromatin architecture of cells 
(Lieberman-Aiden and Berkum, 2009).  Application of Hi-C technology on mammalian cells 
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revealed that the genome is divided into two types of compartments: A and B, with type A 
being an active compartment and type B being more densely compacted and inactive 
(Lieberman-Aiden and Berkum, 2009). Further research showed the presence of a fundamental 
organizational feature of the metazoan genome called the Topologically Associated Domain 
(TAD)(Sexton et al., 2012). TADs are approximately 1Mb wide sections of genome relatively 
isolated from the rest by insulating factors such as CTCF (Dixon et al., 2012). Research showed 
that frequency of interaction inside a TAD exceeded interactions between TADs. Rao et al., 
2014 showed the presence of 6 sub-compartments inside the A-B type compartments, with 
each having their own histone mark profiles, transcriptional activity and replication time (Rao et 
al., 2014). Pope et al., 2014 showed in great detail the direct 1:1 corelation between  replication 
timing / Timing Transition Regions (TTRs) and TADs, and discounted its association with LADs 
(Lamin Associated Domains). The results showed conclusive evidence for TADs as the unit of 
replication timing (Pope et al., 2014). 
LIMITATIONS OF HI-C AND RECENT ADVANCEMENTS 
Although Hi-C could be used for deciphering the higher order structure of chromatin, the 
resolution of genome-wide fine architecture was limited. Hi-C resolution is dictated by the 
frequency of cutting by the restriction enzyme used. Practically, given the complexity of the ‘All-
to-All’ interactions Hi-C library it requires massive parallel high thorough-put sequencing to 
generate enough depth to have enough power to detect interactions at high resolution with 
statistical confidence. All early Hi-C experiments were carried out using a 6 base cutter 
restriction enzyme, essentially limiting the theoretical resolution to > 10 kb. With the use of 4 
base cutter such as Dpn2 or other frequent cutting enzymes like DNase1, the theoretical 
resolution was brought down to < 1 kb (Ma et al., 2015). Another limitation of standard Hi-C 
was that, although the tool is useful for deciphering the general properties of folding and 
architecture of the chromatin, the fine structure of loci of interest are not decipherable due to 
lack of depth. Recently, Hi-C experiment was carried out at 1 kb resolution resulting in an 
unveiling the fine structure of chromatin (Rao et al., 2014). Sub-domains of median length 185 
kb were detected inside TADs using the 1 kb resolution Hi-C. The study entailed sequencing to a 
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depth of gigantic ~25 billion reads (5Tb of data) to generate ~15 billion distinct contacts. In the 
densest library, the study was able to detect 9448 loops, with promoter-enhancer contacts 
correlating with histone marks and gene activation. Although ‘only’ at 1kb resolution, Hi-C is a 
breakthrough in chromatin architecture biology.  The need for the massive depth of sequencing 
and lengthy experiments means, the cost and time associated with it, means the method is not 
available to an average laboratory. These limitations in Hi-C called for the development of a 
more economic tool with a power to enrich for thousands or millions of loci of interest to 
decipher specific biological questions. 
ADVENT OF NEXT-GEN C-TOOLS: CAPTURE-C APPROACH 
Scientists have made significant strides into development of tools for studying chromatin 
architecture from higher order to fine structure. Current research established a need for 
development of a technique that provided a Hi-C like coverage combined with a 4C like 
resolution. This need was answered by the advent of Capture-C. Hughes et al.,2014 introduced 
the concept of an enrichment technique to pull-down and analyze hundreds of genomic loci of 
interest from a pool of all interaction. Capture-C combined the oligonucleotide capture 
technology (OCT) with 3C and NGS to study hundreds of distinct regions of interest in an single 
experiment (Hughes et al., 2014). In the said experiment, the researchers used hundreds of 120 
nucleotides long single stranded RNA oligos to pulldown interactions of interest with 
enrichment of 1000 to 10000 fold over background. Each targeted probe was able to generate 
thousands of interactions using Capture-C instead of tens achieved by other All-to-All 
approaches such as Hi-C and ChIA-PET.   Capture-C was limited by the fact that the approach 
was based on a 3C library source. Although 3C library is a good All-to-All interaction pool, unlike 
Hi-C library, 3C library is not enriched for ligation event using biotin integration at ligation sites. 
This results in contamination of the library with fragments of DNA without ligation junctions. 
Sequencing of non-ligation events consumes sequencing depth without providing informative 
read results. Hence, the next logical advancement of Capture-C was performing the oligo 
pulldown on a Biotin-streptavidin enriched Hi-C library –named Capture Hi-C or CHi-C. 
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The year 2015 saw multiple studies successfully using the Capture Hi-C approach. Jäger et al., 
2015 used CHi-C technology to examine colorectal cancer rick loci by targeting GWAS 
associated SNP loci (Jäger et al., 2015). The use of HindIII (6 bp cutter) restricted the close cis 
interaction resolution to 3Kb while interactions further away (> 5 Mb) the resolution was 
restricted to 9 kb. Like Capture-C, biotinylated-RNA baits of length 120 bp were used for 
capture of 4.6 Mb total region with 43,380 loci. Although much higher number of baits were 
used as compared to Capture-C, a significant enrichment factor of 130-fold was achieved. 
Mifsud et al., 2015 used CHI-C tool to study chromatin architecture in two type of blood cells: 
GM12878 and CD34+.  The pulldown was performed on probes designed against all active and 
inactive promoters (~22000) (Mifsud et al., 2015). Using this promoter capture Hi-C approach 
the authors were able to compare genomic interactions between two distinct blood cell types. 
Interestingly 90% of the interactions detected were between targeted promoters and non-
targeted fragments. Also, 90% of the interacting fragments were within 700kb of each other.  
In a similar approach, Sahlén et al., 2015 used a promoter targeted CHi-C approach to identify 
promoter-enhancer interactions in mouse embryonic stem cells (mESCs). This study used a 4 bp 
cutter instead of a 6 bp cutter as the restriction enzyme, effectively increasing the resolution 
from >3 kb to <1kb (Sahlén et al., 2015). Apart from promoter-promoter interactions, 64% of 
promoter-baited interactions overlapped enhancer associated histone features and DNase 
hypersensitivity, providing evidence of the ability of CHi-C in capturing the fine architecture of 
chromatin. Interestingly, the study showed higher levels of enhancer-RNA expression levels for 
active promoter when compared to inactive promoters. Schoenfelder et al, 2015 used a 
promoter capture approach similar to the aforementioned study to provide further insight into 
pluripotency network in mESCs (Schoenfelder et al., 2015). The study found that 59% of 
promoter-genome contacts were specific for only ESCs showing tissue specific configuration of 
promoters. In contrast to Hi-C, CHi-C did not yield a coarse view of chromosome conformation, 
but a highly tissue specific configuration of promoter and enhancers in TADS.  In contrast to 
active genes, repressed genes were seen to interact with other genomic loci with the 
H3K27me3 repressive histone mark. 
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Although the promoter-capture approach provides a good insight into promoter-promoter and 
promoter-enhancer interactions, enhancer-enhancer interactions cannot be deciphered. DNase 
1 hypersensitive sites (DHS) in a genome are known to be the most important functional 
fraction of the genome. DNase 1 hypersensitive sites encompass all the open regions, which are 
responsible for dictating the transcriptional profile and thus the identity of a cell type. Targeted 
capture of the open regions (DHS) from a Hi-C library can potentially reveal the whole 
architecture of the functional fraction of the genome. To this effect, we performed a CHi-C 
experiment to  investigate dynamics of chromatin architecture during transition of mESCs from 
a ground pluripotent (2i mESCs) to a primed pluripotent (Serum mESCs) state (Joshi et al., 
2015). To interrogate the whole functional genome, we designed capture probes against the 
union of all open genomic regions in 2i and Serum mESCs. We targeted ~100,000 loci using 
~250,000 individual tiled single stranded biotinylated DNA probes. A median of 75bp for the 
probe pool resulted in a 41.9 Mb probe library.   The fold enrichment for the probe-targeted 
open chromatin regions was 20-fold with a capturing efficiency of 58.4% on average. 
Use of 3C Based Technology in Biomedical Diagnostic and Mechanistic  
With advent of next generation sequencing (NGS) technology, we are now capable of 
investigating various cancers and other genetically anomalous genomes epigenetically. With 
miniaturization of 3C based technology we could start applying these technologies to gain 
fundamental insights into disease models from a 3D chromatin conformation point of view to 
design new treatments. Studies have used 4C technology to gain mechanistic understanding for 
acute myeloid leukemia caused due to recurrent translocations and inversions of genomic loci 
on chromosome 3.  The study showed relocation of GATA2 enhancer can ectopically activate 
EVI1 contributing towards cause of sporadic familial AML/MDS and MonoMac/Emberger 
syndromes (Gröschel et al., 2014). 
Recently, Capture Hi-C together with 4C were used to show that genomic rearrangement and 
duplication in patient tissue and mouse disease models can result in formation of new faulty 
domains (neo-TADs) resulting in in molecular pathology (Franke et al., 2016). They showed that 
duplication of a non-coding region inside the Sox9TAD caused the genomic region to behave as 
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an extra enhancer resulting in sex-reversal in humans, although no large-scale changes in TAD 
structure were observed. Inversely, duplication of genomic region, overlapping and extending 
beyond the TAD boundary, resulted in creation of a neo-TAD isolated from rest of the genome. 
Inclusion of the gene Kcnj2 from the neighboring TAD into the neo-TAD caused aberrant 
chromatin contacts and abnormal expression leading to a limb malformation phenotype in 
mice.   
Hence, with the examples of recent studies using 3C based technologies to explain mechanistic 
role 3D chromatin structure plays in disease models, we can in future, use similar approaches to 
understand cause and effect of flawed chromatin structure in other disease models and patient 
materials. With new and developing technologies such as gene therapy and CRISPR-cas we can 
imagine a future of gene editing to correct flawed chromatin structures as a therapy for 
diseases.     
CONCLUSIONS AND FUTURE PERSPECTIVES 
Technology for study of chromatin architecture has developed at an incredible speed especially 
in the last decade. This rapid rate of tool development and their implementation has enabled us 
to interrogate the nature of chromatin folding and general architecture like never before. While 
imaging technologies helped us visually perceive chromatin dynamics, chromosome 
conformation capture technology along with NGS and oligo capture enrichment technology has 
enabled us to study chromatin architecture to a sub-kb resolution. At present, we investigate 
chromatin folding from the higher-order state to the fine architecture in a single experiment at 
a reasonable cost. 
The challenges faced by current generation of 3D chromatin conformation investigative tools 
are twofold. Firstly, live imaging of living cell at high resolution to detect chromatin dynamics is 
not developed. Real-time detection of chromatin contacts in living cells in a high throughput 
fashion would provide new insight into the dynamics and plasticity of chromosome 
conformation. Secondly, most of the current generation 3C based genome-wide approaches are 
limited by the need to use millions of cells. Although there have been strides to perform single 
cell Hi-C, only a coarse view of chromatin architecture could be deciphered using the approach. 
34 
 
Capture Hi-C could become feasible on thousands instead of millions of cells and at the same 
time provide a high-resolution map of chromatin conformation. CHi-C with only thousands of 
cells would enable us to investigate chromatin conformation distortions in systems with limited 
source material such as early embryos, patient material such as from tumors, and rare blood 
cells. Marriage between newly developed techniques such as single cell ChIP-seq, RNA-seq and 
limited cell Capture Hi-C could potentially provide brand new insight into biology which has yet 
been elusive.  
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ABSTRACT 
Over the past decade, tools to study 3D chromatin structure have been developed at a rapid 
rate, from ‘simple’ to advanced super-resolution microscopy and from gel based 3C 
techniques to high throughput based Next-Generation Sequencing (NGS) technologies. These 
techniques have dramatically advanced our knowledge about chromatin structure and 
function. A tool that interrogates chromatin interactions for large fractions of the genome at 
high-resolution, while substantially reducing the high sequencing cost could further advance 
the study of chromatin. Here, we describe capture Hi-C, which is capable of investigating large 
fragments of the genome at 1kb resolution with high efficiency targeting interactions 
involving open chromatin regions, largely enhancers and promoters. We discuss in detail the 
protocol and analysis for capture Hi-C. 
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INTRODUCTION 
Deciphering the role of transcription factors, histones and their modifications has provided 
insight to define epigenetic features such as promoters, enhancers and repressors, capable 
of controlling the expression of all genes in the genome. Enhancers and other regulatory 
elements are often found far from their target gene promoters. Detailed studies of chromatin 
conformation have shown that looping of the chromatin brings cis-regulatory elements in 
spatial proximity to the gene promoters (Dekker et al., 2002; Henikoff and Grosveld, 2013; 
Osborne et al., 2007).  Early studies of the 3D structure of chromatin started with microscopy, 
and is now a large palette of highly refined and increasingly complex approaches to 
investigate the 3D structure of chromatin (Branco and Pombo, 2006; Cremer et al., 2006; 
Dekker et al., 2002). 
3C (Chromosome Conformation Capture) and its high-throughput successors rely on the 
molecular principle of proximity ligation; each variant (4C, 5C, TLA, Hi-C) has its specific 
advantages and disadvantages (Bonev and Cavalli, 2016). 4C allows detection of ‘one to all’ 
interaction events respectively, whereas Hi-C has the capacity to investigate the structural 
interactions throughout the entire genome (Dekker et al., 2002; Denker and De Laat, 2016; 
Lieberman-Aiden et al., 2009; Simonis et al., 2006; Wit and Laat, 2012). The major drawback 
of Hi-C is the high cost associated with sequencing, which scales quadratically with the desired 
resolution (Dixon et al., 2016a). Hence, Hi-C is well capable of investigating 
compartmentalization of the genome, but detailed investigation of the interactome at high 
resolution and at a genome-wide scale is cost prohibitive (Dixon et al., 2016b; Lieberman-
Aiden et al., 2009). The ChIA-PET technique, which uses an antibody to enrich for protein-
mediated interactions, is capable of detecting specific interactions at the genome-scale and 
at considerably lower sequencing depth. However, captured interactions are limited to those 
mediated by antibody targeted proteins. Moreover, its dependence on highly specific 
antibodies combined with a laborious protocol makes CHIA-PET a less attractive alternative 
(Fullwood et al., 2009; Wit and Laat, 2012). 
We have recently developed a new approach to study the 3D conformation of chromatin at 
genome wide scale, at high resolution and at substantially lower sequencing costs. This 
technique, called capture Hi-C (Joshi et al., 2015), maximizes the resolution at which 
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chromatin interactions are revealed, by focusing on interactions where at least one genomic 
locus is targeted by a specifically designed DNA capture bait. We used this technology to 
target chromatin interactions between DNA accessible (open) regions (DHS) in embryonic 
stem cells. This allowed us to study 3D chromatin dynamics between serum and 2i cultured 
pluripotent embryonic stem cells in vitro (Joshi et al., 2015).   
DHS CAPTURE Hi-C:  A METHOD OVERVIEW 
Capture Hi-C is a protocol developed by modifying and amalgamating a standard Hi-C protocol 
and combining this with methods developed to pull-down specific DNA fragments using 
complementary DNA oligonucleotides conjugated with biotin. A schematic overview of the 
capture Hi-C experiment is represented in Figure 1A, 1B. The Hi-C protocol used is a modified 
version of the in-nucleus Hi-C protocol developed by Nagano et al., 2015, for its efficiency, 
performance and accurate representation of in-vivo structure. Like most 3C-based methods, 
the starting material is first fixed with formaldehyde to preserve the protein-DNA and protein-
protein structure. The cells are lysed and the nuclei permeabilized using a detergent 
containing buffer. The cross-linked chromatin is then digested using a restriction enzyme in 
its appropriate restriction buffer. In the experiments performed here, a DpnII restriction 
enzyme (4bp recognition site) was used to maximize the theoretical resolution of the 
interactome to 256 bp. The DpnII fragment ends were then filled-in to generate blunt-ends 
using the Klenow fragment of DNA Polymerase 1 with dATP, dGTP, dTTP and biotin-14-dCTP. 
The biotin labelled chromatin was then subjected to proximity ligation in in-nuclei conditions, 
to preserve the evidence of looping via ligation of biotinylated DNA fragments in spatial 
proximity. The overnight ligation step was followed by de-crosslinking, DNA precipitation, 
removal of biotin from non-ligation events and mechanical shearing by sonication. After 
shearing, the DNA was converted to a NGS library by end repair, A-tailing and sequencing 
adapter ligation. Next, ligation events were selected using streptavidin-coated beads which 
mediate the pull-down of biotinylated DNA ligation junctions.  The Hi-C library was then 
amplified using on-bead PCR to generate ~1µg of material. DNA capture from this Hi-C library 
was carried out to generate a focalized capture Hi-C library. To this end, single-stranded (ss) 
biotinylated DNA oligonucleotides, called Sequence Capture probes (custom developed by 
Roche Sequencing Solutions) were specifically designed to be complimentary to the desired 
fraction of the genome. The Hi-C library was denatured and hybridized with the capture 
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probes (Figure 1B). The desired ‘Hi-C library DNA + capture probe’ hybrids were then isolated 
using streptavidin beads to pull down the hybrids. The enriched Hi-C library was subsequently 
amplified using on-bead PCR, and the library was paired-end sequenced on a NGS platform. 
Reads were mapped, sorted and processed using the HiCUP pipeline (Wingett et al., 2015). 
Finally, significant interactions for which at least one end was sequence-captured were 
identified using the CHiCAGO pipeline (Cairns et al., 2015) and visualized using the WashU 
Epigenome Browser (Zhou et al., 2013). Three examples of data generated and visualized 
using capture Hi-C are represented in Figures 2 G and 3 A/B. 
 Advantages of capture Hi-C 
The practical resolution of Hi-C is limited by the depth of sequencing and the restriction 
enzyme used. Recently, DpnII based Hi-C enabled reconstruction of the human interactome 
at a 1Kb resolution, although this required billions of sequencing reads (Ma et al., 2015; Rao 
et al., 2014). In general, the fact that sequencing depth scales quadratically with the desired 
resolution makes it prohibitive to acquire a satisfactory read count per bin at the genome-
scale. Capture Hi-C is a method that takes advantage of genome-wide scale Hi-C and selective 
enrichment from whole exome sequencing (WES) (Albert et al., 2007; Teer and Mullikin, 
2010). 
Careful design of sequence capture probes allows specific enrichment of Hi-C interactions, 
with and between chromatin regions of interest. We used capture Hi-C to enrich for putative 
regulatory interactions (e.g. between promoters and enhancers), where at least one end of 
the interaction is anchored in an open chromatin region. However, capture Hi-C is not 
restricted to open chromatin and can map genome-wide pairwise interactions at any genomic 
region of interest. To achieve the focalization needed, we used an enrichment strategy similar 
to the one used for Whole Exome Sequencing (WES) called Direct Genomic Selection (DGE) 
(Albert et al., 2007; Bashiardes et al., 2005; Teer and Mullikin, 2010). This strategy entails the 
use of biotinylated ssDNA oligonucleotide capture probes which are complementary to the 
desired fraction of the genome. To this end, capture probes were designed against all of the 
open chromatin in mouse Embryonic Stem cells (determined by a DNAse1 hypersensitivity 
assay) for open chromatin capture Hi-C (Joshi et al., 2015, S1Fig 1A, 1B). Hence with the use 
of DpnII based Hi-C and focalization of the interactome, capture Hi-C is able to generate a 
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high-resolution map of the 3D conformation of chromatin (Joshi et al., 2015). The probe-
targeted open chromatin regions were captured with an average efficiency of 58.4%, resulting 
in a 22-fold enrichment of captured interactions compared to non-captured interactions 
(Figure 2A , Joshi et al., 2015). 
In recent years, other technologies similar to capture Hi-C, such as Capture-C, HiCap and T2C, 
have been developed (Hughes et al., 2014; Kolovos et al., 2014). Capture-C was the first 
method to show the power of focalization of 3C based libraries for greater efficiency and cost 
effectiveness (Hughes et al., 2014). It describes a focused method to study the interactome 
of ~450 promoters in the α/β-globin gene cluster in blood cells. Although the pioneer in 
capture based techniques, Capture-C is a 3C based technique and hence suffers from 
limitations inherent to 3C-seq; i.e. the inefficient enrichment of bona fide interaction/ligation 
events. Unlike 3C-seq, Hi-C and hence capture Hi-C technologies are able to enrich for ligation-
events by incorporating and enriching for biotin in the ligation junction between two 
interaction fragments of DNA (Jäger et al., 2015; Joshi et al., 2015; Mifsud et al., 2015; Sahlén 
et al., 2015). Thus, the capture Hi-C library is theoretically void of contamination by non-
ligation events, preserving the NGS capacity for bona fide interaction.     
APPLICATIONS OF CAPTURE Hi-C, FUTURE PROSPECTS AND LIMITATIONS 
Capture Hi-C is a highly efficient and cost-effective method to investigate and compare high-
resolution 3D chromatin conformation maps of the genome. In a study between serum and 
2i cultured mESC, we captured interactions between putative regulatory elements (identified 
by DNAse1 hypersensitivity) with an average efficiency of ~58%; a 20-fold increase compared 
to non-captured interactions (Fig 2A).   
The higher-order structure of the interactome closely resembles that of a regular Hi-C. For 
instance, previously defined topologically associated domains (TADs) are readily visible in the 
raw capture Hi-C matrix (Fig 2E). After normalizing the capture Hi-C derived interactions in a 
Hi-C fashion, we derived TADs from our capture Hi-C data in the same fashion as previously 
described (Dixon et al., 2012). As expected, TADs derived from the capture Hi-C data are highly 
similar to those previously described (Dixon et al., 2012). We discovered 2,488 TADs in our 
DpnII based capture Hi-C data, compared to 2,200 in the HindIII based Hi-C defined TADs. The 
Jaccard Index -the ratio between the total length of intersecting TADs and the total length of 
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the union of all TADs- was 0.86, indicating that indeed most TADs have a high degree of 
overlap. The majority of the TADs overlapped by more than 90% of their length (Fig. 2B). 
The true advantage of Capture HiC however lies in the genome-wide mapping of putative 
regulatory elements at a resolution that is far beyond the 40kb binning, applied in most Hi-C 
methods. This mapping of pairwise promoter-promoter, promoter-enhancer and enhancer-
enhancer interactions enables the reconstruction of a genome wide interaction network of 
putative regulatory elements. By mapping gene expression (RNA-seq) and histone 
modifications to the “nodes” of this interaction network, the 3D structure of the regulatory 
network can be related to the epigenetic modification at each of interacting loci. Analysis of 
how the nodes (epigenetic make-up) or edges (the strength or frequency of interactions) 
change between two conditions can reveal important regulatory principles in space and time. 
In our paper, we focussed on the changes between two pluripotent states (Joshi et al., Cell 
Stem Cell, 2015), but similar principles apply to other cell types or a comparison between a 
“healthy” and “disease” condition. 
Figure 2G shows and example of regulatory interactions derived from our capture Hi-C data 
between the Klf4 promoter and its distal enhancer. The Klf4 gene is highly expressed (RNAseq 
track) and its promoter is covered with the active H3K4me3 mark. The main distal element is 
shows enrichment of H3K27ac; the mark of an active enhancer. Furthermore, CHiPseq data 
(Galonka et al. CSC 2016) shows binding of the core pluripotency factors at this locus, 
reinforcing the confidence that the distal interacting element is indeed an enhancer. 
The capture Hi-C protocol can be applied to any fraction of the genome, apart from the 
repetitive elements. Depending on the scope and direction of the investigation, capture Hi-C 
can be limited to sub-fractions of the genome. It is important to note that the extent/depth 
of sequencing needed for capture Hi-C is directly proportional to the degree/fraction of the 
genome targeted for capture.     
Other designs of capture Hi-C, targeting different fractions of the genome, have been used 
and successfully applied (Jäger et al., 2015; Joshi et al., 2015; Mifsud et al., 2015; Schoenfelder 
et al., 2015). Capture Hi-C is a significant technological advancement to study 3D 
conformation, but challenges remain. The foremost limitation is that capture Hi-C still 
requires millions of cells, which renders the technique unsuitable for samples with a low 
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amount of starting materials, such as the early stage embryo and biopsies. The single cell Hi-
C holds the promise of capture Hi-C on only a few thousand cells (Hughes et al., 2014).  
CAPTURE PROBE OLIGONUCLEOTIDE DESIGN 
ssDNA probes were custom designed by Roche Sequencing Solutions, using an algorithm that 
considers temperature parameters for melting and hybridization and for GC content. For DHS 
capture Hi-C, ~250,000 individual tiled probes were generated targeting the union of DNAse 
I hotspots in serum and 2i mESCs (~100,000), providing coverage for all of the open chromatin 
(Joshi et al., 2015). The length of probe was on an average 75 nucleotides. The probes were 
biotinylated for easy capture with streptavidin beads. The primary criteria for selection of 
capture Hi-C probes is that they should be as unique as possible, mapping to only one locus 
in the genome, and should be located near but not overlapping the restriction sites for the 
enzyme used in the experiment.  
EXPERIMENTAL DESIGN 
STARTING MATERIAL, FIXATION 
Capture Hi-C has been successfully carried out using 20-40 million adherent cells grown in cell 
culture. The cells are fixed with 2% final concentration of formaldehyde and incubated for 10 
minutes before neutralization with glycine. Standardization of the duration of 
fixing/crosslinking of samples is crucial for reproducibility between biological replicates.        
CELL LYSIS AND DIGESTION  
Cell lysis was carried out as previously described in Nagano et al., 2015 for in-nucleus ligation. 
In-nucleus ligation captures chromatin interactions in an in vivo context, with high consistency 
and significantly reduces both experimental noise and bias (Nagano et al., 2015). Digestion of 
the chromatin was carried out using the restriction enzyme DpnII, which has a 4bp recognition 
site, providing a theoretical resolution of 256bp. Apart from DpnII, any other unbiased and 
frequent-cutting restriction enzyme (such as NlaIII) can be used to obtain a high-resolution 
interactome map. It is important, however, to consider the sequence of the single-stranded 
over-hang generated by the restriction enzyme, as the appropriate complementary biotin-
labelled dNTP must be included in the subsequent fill-in process.  
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BIOTINYLATION, LIGATION AND DNA PURIFICATION 
Biotinylation is the process of filling in the over-hang of the DNA fragments with appropriate 
dNTPs and one biotinylated dNTP to produce blunt ends using DNA polymerase I large Klenow 
enzyme that is devoid of exonuclease activity. During the subsequent proximity ligation step, 
biotinylated blunt ends are ligated, creating a biotin containing ligation-product (junction). 
After the ligation step, the chromatin is de-crosslinked, DNA is precipitated and re-solubilized 
in Tris-Low-EDTA buffer. 
BIOTIN REMOVAL FROM UNLIGATED ENDS  
A critical step is to remove unincorporated biotinylated dNTPs and well as from unligated free 
DNA ends using an exonuclease (T4 DNA polymerase).  The small fraction of free but 
biotinylated DNA ends and the free biotinylated nucleotide present after DNA precipitation 
prevent an efficient ‘pull-down’.  
SONICATION, END REPAIR AND dATP TAILING 
Sonication is performed to mechanically shear the DNA to fragments between 300bps and 
600bps. These DNA fragment ends are subsequently end-repaired and dATP tailed to facilitate 
the addition of sequencing adapters.    
BIOTIN PULL-DOWN, WASH AND ADAPTER LIGATION 
To select for ligation events and avoid contamination with un-ligated DNA fragments, DNA 
fragments with biotinylated ligation-junctions are enriched using streptavidin beads. The 
beads are then washed to remove non-biotinylated DNA contaminants and stray DNA. On-
bead ligation of sequencing adapters is performed. Excess adapter and enzyme is 
subsequently washed off.   
FINAL PCR AND ON-GEL SIZE SELECTION  
Now the DpnII Hi-C library is ready, but still linked to the streptavidin beads via the 
incorporated biotinylated-NTP. A copy of the library is generated using on-bead PCR to 
achieve 1.5 to 2µg of amplified product. This amplified capture Hi-C library is then run on a 
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gel and DNA fragments between 300bp and 800bp in size are excised and gel-extracted. 1µg 
of Hi-C library is carried forward for capture using ssDNA oligonucleotide probes.     
HYBRIDIZATION WITH PROBES AND INCUBATION 
1µg of Hi-C library is mixed with the biotinylated ssDNA capture probes (Roche Sequencing 
Solutions). To avoid undesirable cross-hybridization of library fragments mediated by 
sequencing adapters, a molar excess of complementary blocking oligos (SeqCap HE Universal 
and SeqCap HE Index Oligos) is added. These oligos are critical to achieve high enrichment 
specificity. Mouse COT-1 DNA is also added to the mixture to block hybridisation of highly 
repetitive endogenous genomic DNA elements from participating in non-targeted 
interactions. Hybridization buffer and hybridization component-A are added to the mixture. 
The solution is briefly heated to 95°C to denature the components, and transferred to a 
thermocycler to maintain a hybridization temperature of 47°C for 64 to 72 hours.       
DNA RECOVERY WITH CAPTURE BEADS AND WASHING 
The biotin-linked ‘Hi-C library DNA + capture probe’ hybrids are recovered by incubation with 
streptavidin beads (SeqCap Capture Beads) for 45min. Subsequently, the beads are 
consecutively washed with 4 wash-buffers of differing stringencies to remove non-specifically 
bound library fragments and blocking components before resuspension in 50ul nuclease-free 
water. 
AMPLIFY CAPTURED DNA VIA ON-BEAD PCR 
While the captured Hi-C library remains attached to the streptavidin beads via the 
biotinylated probes, a copy of the library is generated using on-bead PCR amplification. 
MATERIALS NEEDED 
CHEMICALS and APPARATUS are deposited in the attached excel table. 
CAPTURE Hi-C PROTOCOL FOR DPNII 
The following protocol is based on Hi-C protocols described previously (Lieberman-Aiden and 
Berkum, 2009; Lieberman-Aiden et al., 2009; Nagano et al., 2015; Sahlén et al., 2015) and the 
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Roche NimbleGen (Roche Sequencing Solutions) SeqCap Target Enrichment based SeqCap EZ 
System protocol. 
STEP 1: HARVESTING CELLS AND CELL FIXATION  
Prepare before start: 
• DMEM media at room temperature 
• 16% formaldehyde R1026, Agar Scientifics 
• 100 ml 1X PBS 4°C, 1X PBS 37°C 
• Large centrifuge at 4°C 
• 2.5M glycine at room temperature 
1. Capture Hi-C requires 20-30 million cells per experiment. The following steps are 
described for adherent cells, but can be adapted for suspension cells and tissue 
samples. 
2. Discard old media and wash adherent cells with 1X PBS 37°C. Discard and replace 1X 
PBS with 15ml of fixing media (2% final concentration of formaldehyde in DMEM 
media) and incubate for 10 minutes at room temperature with gentle mixing. 
CRITICAL: Fixation time should be evenly maintained across samples as variable degrees 
of crosslinking can introduce bias to the final result. 
3. Neutralize formaldehyde by adding 800µl 2.5M glycine and incubating for 5 minutes 
at room temperature, followed by 10 minutes on ice. 
4. Wash cells with 20ml 1X cold PBS. Add 15ml of 1X cold PBS and scrape to dissociate 
cells from the plate. Collect scraped cells in a 50ml falcon tube on ice. 
5. Centrifuge the tube at 1200 RPM for 5 minutes at 4°C. Gently remove the supernatant 
using a vacuum apparatus to preserve the cell pellet. 
6. The cell pellet can now be preserved by flash freezing and storage at -80°C. 
 
CELL LYSIS AND DIGESTION 
Prepare before starting: 
• Thermomixer at 37°C 
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• NEB3 buffer 
• Lysis buffer at 4°C, 50ml (47.9ml H2O + 1ml 10% NP-40 + 500µl 1M Tris-HCl pH8 
+100µl 5M NaCl + 1 tablet of Protease inhibitor cocktail tablet) 
7. Suspend the cell pellet in 50ml of cold lysis buffer and incubate on ice for 20 minutes, 
inverting every 5 minutes. 
CRITICAL: Lysis buffer should be fresh and cold for every experiment. 
8. Centrifuge for 5 minutes at 2000 rpm at 4°C. Remove the supernatant, preserving the 
nuclei pellet. 
9. Resuspend the nuclei pellet in 1.2X NEB3 buffer to achieve ‘6 to 8 million cells’ per 
358µl of volume. Aliquot 358µl aliquots of the cell suspension into individual 1.5 ml 
Eppendorf tubes. 
10. To each Eppendorf tube, add 11µl 10% SDS and mix by inverting, followed by 
incubation at 37°C for 1 hour while shaking on a thermocycler at 950 RPM. Pause every 
10 minutes to disrupt clumps by pipetting with a 200µl pipette. 
CRITICAL: It is essential to effectively disrupt the clumps to avoid false interactions 
produced due to non-specific protein-protein interactions. 
11. Add 75µl of 10% Triton X-100 to each tube to quench the SDS. Incubate the samples 
at 37°C for 1 hour while shaking on a thermocycler at 950 RPM. Pause every 10 
minutes to disrupt clumps by pipetting with a 200µl pipette. 
CONTROL: Collect 5µl of chromatin from each tube primary tube of 358µl and transfer to 
a single new tube labelled UNDIGESTED CONTROL. Add 5µl of Proteinase K (10mg/ml) to 
the UNDIGESTED CONTROL tube and decrosslink at 65°C over-night. On the next day, 
perform DNA extraction using the QIAquick PCR Purification Kit according to the suggested 
protocol. Store the UNDIGESTED CONTROL eluate at -20°C. 
12. Initiate restriction digestion of the chromatin by adding 6µl of DpnII per tube and 
incubating for 4 hours at 37°C at 950 RPM on a thermomixer. 
13. Add another 6µl of DpnII per tube and continue incubating overnight at 37°C at 950 
RPM on a thermomixer. 
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CONTROL: Next day, collect 5µl of chromatin from each tube and label it DIGESTED. 
CONTROL. Add 5µl of Proteinase K (10mg/ml) to the DIGESTED. CONTROL tube and 
decrosslink at 65°C over-night. Next day, perform DNA extraction using the QIAquick PCR 
Purification Kit (Cat No./ID: 28104) according to the suggested protocol. Store the 
DIGESTED CONTROL eluate at -20°C. The quality of the DpnII restriction digestion can be 
checked by running DIGESTED and UNDIGESTED CONTROL aliquots on a 0.8% agarose gel 
along with a 1 kb ladder (NEB #N3232S). The expected result is illustrated in Figure 2C. 
 
STEP 2: BIOTINYLATION OF DIGESTED CHROMATIN FRAGMENTS AND LIGATION 
Prepare before start: 
• Set a water bath, thermomixer or incubator at 16°C 
• Set a thermomixer at 37°C 
• Set a thermomixer at 65°C 
• Make TLE buffer (10mM Tris, 0.1mM EDTA) pH 8.0 
 
14. De-activate the DpnII by incubating the sample tubes at 65°C for 15 minutes in a 
thermomixer at 900 RPM.  Immediately place tubes on ice for 10 minutes. 
15. To perform biotinylation, the 5’ overhangs generated by DpnII digestion must be filled-
in by adding to each sample tube:  1.5 µl 10 mM dATP, 1.5 µl 10 mM dGTP, 1.5 µl 10 
mM dTTP, 37.5 µl 0.4 mM biotin-14-dCTP, by volume (Invitrogen 19524-016), 6µl 10x 
NEB3 buffer, 2µl H2O and 10 μl 5U/μl Klenow (DNA polymerase I Klenow fragment, 
NEB M0210L). 
16. Mix by gentle pipetting followed by incubation at 37°C for 90 minutes. After the 
incubation, place the sample tube on ice.  
17. Prepare a ligation reaction buffer mix including: 100µl 10x ligation buffer (NEB 
B0202S), 10μl 10mg/ml BSA, and 346ml MQ water. 
18. To each sample tube, add 471µl of ligation reaction buffer mix. Add 25µl of T4 DNA 
ligase (1U/μl Invitrogen 15224-025) and mix by gentle pipetting. Incubate all sample 
tubes at 16°C for 8 to 12 hours without rocking.   
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19. Perform decrosslinking by adding 85µl of Proteinase K (10mg/ml Roche 03115879001) 
to each tube and incubating overnight at 65°C in a thermomixer at 900 RPM. 
20. Cool tubes on ice. After a quick spin, add 10µl of RNase A (10mg/ml) and incubate at 
37°C for one hour. 
21. Immediately proceed to the next step.  
 
STEP 3: DNA PURIFICATION BY PRECIPITATION 
Prepare before start: 
• Cool large centrifuge to 4°C 
• Cool 100ml absolute ethanol on ice 
22. Pool the ligated chromatin samples from each Eppendorf tube into a single 15ml 
falcon tube, and add 1:1 volume (generally 4ml to 6ml) of phenol:chloroform:isoamyl 
alcohol (25:24:1). Mix vigorously.  
 
CRITICAL: Phenol/chloroform/isoamyl alcohol (25:24:1) should be equilibrated to pH 
8.0 for DNA extraction; acidic pH may result in significant loss of DNA. 
Phenol/chloroform/isoamyl alcohol is toxic; steps should be carried out inside a fume 
hood. 
 
23. Centrifuge the 15 ml falcon tubes at 4000 RPM for 5 minutes. Collect the upper 
aqueous layer containing DNA in a new 50ml falcon tube. Add 5ml water to bring the 
total volume to 10ml. 
24. For DNA precipitation, add 2.5 volumes of ice-cold ethanol and 0.1 volumes of Sodium 
Acetate (pH 5.2) to the 50ml falcon. Incubate the tube at -80°C for 2 hours to 
overnight. 
25. Centrifuge the falcon tube at 4000 RPM for 45 minutes at 4°C to pellet the DNA. 
26. Discard the supernatant. Add 30ml of 70% ethanol and mix by briefly vortexing (5 sec). 
Centrifuge the tube at 4000 RPM for 45 minutes at 4°C. Resuspend the DNA pellet in 
100µl of TLE buffer. 
27. The samples can be stored at -20°C at this stage if desired. 
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CRITICAL: If too much salt is carried over (the TLE buffer is not clear after resuspension 
of the DNA pellet), the resuspended DNA can be washed using Amicon Ultra-0.5 mL 
50K Centrifugal Filters for DNA and Protein Purification and Concentration devices, 
although some DNA loss may occur. 
 
28. Measure the concentration of the sample DNA at this stage using the Qubit dsDNA BR 
Assay Kit after diluting the 1µl of the sample 1:200. 
CONTROL: At this stage, the ligation efficiency can be tested by examining 50ng of 
LIGATED purified product, DIGESTED and UNDIGESTED CONTROL aliquots on a 0.8% 
agarose gel along with a 1 kb ladder (NEB #N3232S). The expected result is illustrated 
in Figure 2C. 
STEP 4: BIOTIN REMOVAL FROM NON-LIGATED DNA ENDS AND DNA PURIFICATION 
NOTE: 30µg of purified and precipitated DNA will be carried forward to the next steps. 
29. Prepare 6 individual reactions in 6 Eppendorf or PRC tubes by mixing 5μg of Hi-C library 
with 2μl 10 mM dATP, 2μl 10 mM dTTP, 2ul 10 mM dGTP, 10μl 10x NEB2 buffer, 1μl 
10 mg/ml BSA, and 15 Units (5µl) T4 DNA polymerase (NEB M0203S) in a total volume 
of 100μl. 
30. Incubate the reaction at 20°C for 4 hours without shaking. 
31. Stop the reaction by adding 2µl of 0.5M EDTA (pH8.0) to each of the 6 reaction tubes. 
Pool the 6 reactions into a 2ml Eppendorf tube.  
32. Purified the DNA by adding a 1:1 volume of phenol/chloroform/isoamyl alcohol 
(25:24:1) at pH 8.0. Centrifuge for 10 mins at 13000 RPM, followed by collecting the 
upper aqueous layer. 
33. Add 2.5 volumes of ice-cold ethanol and 0.1 volumes of Sodium acetate (pH 5.2) to 
the extracted aqueous layer containing the DNA, and incubate at -80°C for 1 hour. 
34. Pellet the DNA by centrifuging at 13000RPM for 45 minutes at 4°C. Discard the 
supernatant and wash the pellet with 70% ethanol. Pellet the DNA again by spinning 
at 13000RPM for 10 minutes at 4°C. 
35. Finally, resuspend the DNA pellet in 120µl of water. 
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NOTE: The DNA concentration can be measured at this stage before proceeding. 
Generally, >80% of DNA is recovered. If the yield is low, repeat from step 28. 
 
STEP 5: MECHANICAL SHEARING BY SONICATION, END REPAIR AND A-TAILING   
36. Shearing of the DNA is carried out using a sonicator. Depending on the instrument 
type, the protocol should be adjusted to achieve a smear of DNA between 200 and 
600bp (Figure 2D). 
37. For the Bioruptor Plus instrument (Diagenode), a setting of 20sec-on/20sec-off/4-
cycles generally provides optimal results. The ideal number of cycles might vary 
between samples. After 2 cycles, run 2 µl of the sample on a 2% agarose gel to check 
the DNA size-range. Add additional cycles if necessary. 
38. To perform end repair on DNA fragments damaged by the sonication step, to each 
library add: 20 µl 10x ligation buffer, 20µl dNTP mix 2.5 mM (25µl of each dNTP 
10mM), 9µl T4 DNA Pol (M0203), 9µl T4 PNK (M0201), 2.5µl (6.5u) Klenow (M0210),  
to 130µl sonicated sample (200µl in total final volume). Incubate at 30°C for 60 min.   
39. Use the Qiagen PCR Purification Kit to stop the reaction. Elute the DNA in total 60µl 
volume of TLE. It is important to note that the capacity of one column is 10µg, hence 
2 – 3 columns are required to recover all the DNA. 
40. To perform dATP-tailing, per 10µg of DNA, add 10µl 10x NEB2, 23µl 1mM dATP, 7µl 
Klenow (exo-) and incubate at 37°C for 1 hour. 
41. Pool the reactions and inactivate the enzyme by incubating at 65°C for 20 minutes. 
Immediately place tube on ice. Bring the total volume of the reaction to 400 µl with 
TLE. 
STEP 6: BIOTIN-STREPRTAVIDIN MAGNETIC BEAD PULLDOWN AND ADAPTER LIGATION 
Prepare before start: 
• TWB (tween wash buffer): 5mM Tris-HCl pH8.0, 0.5 mM EDTA, 1M NaCl, 0.05% 
Tween20. 
• 2x BB (2X Binding buffer): 10mM Tris-HCl pH8.0, 0.5 mM EDTA, 2M NaCl. 
• Bring to room temperature MyOne Streptavin C1 Beads. 
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42. Vortex the streptavidin beads and then transfer 2 µl of beads per 1 µg of Hi-C DNA to 
a 1.7ml LoBind tube.  
43. Wash the beads with 400 µl of TWB by pipetting up and down and incubating for 3 
minutes at RT on a rocking platform. 
44. Reclaim beads against the MPS (magnetic particle separator) for 1 minute, discard the 
supernatant. 
45. Resuspend beads in 400 µl of TWB and transfer to a new LoBind tube. 
46. Reclaim beads against the MPS for 1 minute, discard the supernatant. 
47. Resuspend beads in 400 µl of 2X Binding Buffer (BB) and add the 400 µl of DNA from 
step 41 
48. Incubate the sample for 30 minutes at RT with rotation. 
49. Reclaim the beads against the MPS for 1 minute, discard the supernatant. 
50. Resuspend the beads in 400 µl of 1X BB and transfer them to a new tube. 
51. Reclaim the beads against the MPS for 1 minute, discard the supernatant. 
52. Wash beads with 100 µl of 1X ligation buffer (made of 5X T4 DNA ligase buffer 
(Invitrogen) and transfer to a new tube. 
53. Reclaim the beads against the MPS for 1 minute, discard the supernatant. 
54. Finally, re-suspend the beads in 38.75 µl of 1X ligation buffer made from 5X T4 DNA 
ligase buffer (Invitrogen). 
55. To perform adapter ligation, add 4µl of pre-annealed Illumnia stock adapter mix and 
4µl NEB T4 Ligase 400U/µl (1200-1400U total) OR 1µl NEB T4 Ligase 2000U/µl. 
Incubate at room temp for 2 hours. 
56. Place beads on magnetic sample rack, remove supernatant and wash twice with 400µl 
TWB rotating for 2 minutes between washes. 
57. Wash with 200µl 1x BB. 
58. Wash with 100µl and then 50 µl 1x NEB2. 
59. Finally, re-suspend the beads in 40µl 1x NEB2. Pool all beads from each HiC library. 
NOTE: you can stop at this step by storing the sample at -20°C. 
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STEP 7: FINAL ON-BEAD PCR, PCR PURIFICATION AND SIZE SELECTION 
60. To perform the final PCR, to 40µl of beads suspension add: 100ul of 2X KAPA HiFi 
HotStart, 20µl of library amplification primers and 40µl of water. 
61. Divide the PCR mix into 4 PCR tubes with 50µl each and start the following program 
on the thermocycler: 
Step Temp Duration Cycles 
Initial denaturation 98°C 45 sec 1 
Denaturation 98°C 15 sec 
Annealing 60°C 30 sec 
Extension 72°C 30 sec 
Final extension 72°C 1 min 1 
HOLD 12°C ∞ 1 
 
CRITICAL: Use the minimum number for PCR cycles needed to generate 1.5µg to 2.5µg of 
DNA.  
62. Use the Qiagen PCR Purification Kit to stop the reaction. Elute the DNA in 30µl of TLE. 
63. Add 3µl of (1:2000) SYBR-Green dye to the Hi-C library DNA and to the 1Kb ladder. 
64. Make a preparative 1% agarose gel and run the Hi-C library in two wells along with a 
1Kb ladder. 
65. Under a UV transilluminator remove a gel slice containing DNA ranging from 300bp to 
800bp in size. 
66. Perform gel extraction on the excised gel slice containing the DNA using the QIAquick 
Gel Extraction Kit according to the manufacturer’s instructions. 
67. Measure the concentration of your Hi-C library using Qubit dsDNA BR Assay Kit. 
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CRITICAL: In certain cases, biotinylated Hi-C DNA may leech-out from the streptavidin 
beads and contaminate the subsequent capture steps. To prevent such contamination, 
following steps are recommended. 
68. Bring the volume of the Hi-C library to 100µl with TLE buffer. 
69. Vortex the streptavidin beads and then transfers 2 µl of beads per 1 µg of Hi-C DNA to 
a 1.7ml LoBind tube.  
70. Wash the beads with 100 µl of TWB by pipetting up and down and incubating for 3 
minutes at RT on a rocking platform. 
71. Reclaim beads against the MPS (magnetic particle separator) for 1 minute, discard the 
supernatant. 
72. Resuspend beads in 100 µl of TWB and transfer to a new LoBind tube. 
73. Reclaim beads against the MPS for 1 minute, discard the supernatant. 
74. Resuspend beads in 100 µl of 2X Binding Buffer (BB) and add the 400 µl of DNA from 
step 67. 
75. Incubate the sample for 30 minutes at RT with rotation. 
76. Reclaim the beads against the MPS for 1 minute. 
77. Collect the supernatant. 
78. Use Qiagen DNA Purification Kit to stop the reaction. Elute the DNA in 50µl of water. 
79. Finally measure the concentration of your Hi-C library using the Qubit dsDNA BR Assay 
Kit. 
STEP 8: HYBRIDIZATION OF SAMPLE WITH SEQCAP CUSTOM CAPTURE PROBES 
NOTE: Consultation with Roche Sequencing Bioinformatics and Technical Support before 
beginning is advisable to ensure that the probe design is compatible with the goals of the 
project and protocol details (e.g. the specific choice of restriction sites)  
Prepare before start: 
• SeqCap EZ developer reagents/kit and SeqCap custom capture probes 
• Set a heat block to +95°C 
• Set a thermocycler to 47°C with the heated lid set to 57°C 
• Thaw 4.5µl of SeqCap custom design capture probes and 5µl mouse COT-1 DNA on ice 
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• Thaw on ice each of the uniquely indexed amplified DNA sample library that will be 
included in the capture experiment. 
• In a tube collect 1.25µg of Hi-C DNA in 50µl of water. 
• Thaw on ice the SeqCap HE Universal Oligo (1,000 μM) and SeqCap HE Index oligo 
(1,000 μM) that matches a Hi-C DNA Adapter Index (it is critical that the HE Index oligo 
matches the index of the sequencing adapter it is intended to block). Mix the two 
oligos as following: SeqCap HE Universal Oligo 1,000 pmol (1 μl of 1,000 μM) + SeqCap 
HE Index X Oligo 1,000 pmol (1 μl of 1,000 μM). This mix is called 2000pmol of 
Hybridization Enhancing Oligo Pool. 
80. To the 1.5ml tube containing 50µl of 1.2µg of Hi-C DNA library add 5µl mouse COT-1 
DNA (Catalogue number: 18440016) and 2000pmol of Hybridization Enhancing oligo 
Pool. 
CRITICAL: Use COT DNA according to the species of sample DNA used. For human cells used 
human COT DNA. 
81. Make 5 holes in the tube lid with a 20-gauge needle and dry the mix in a DNA vacuum 
centrifuge concentrator at 60°C. 
CRITICAL: Do not let any pieces of plastic enter the tube. The solution can also be 
transferred to a new clean tube with holes.  
82. When the sample is completely dry, add 7.5µl of 2X hybridization buffer (vial5) and 
3µl of Hybridization Component A (vial6). Cover the holes in the tube with clean tape. 
83. Vortex the tube for 10 seconds and then centrifuge for 10 seconds at 13000 RPM. 
84. Place the tube in the heat block at 95°C for 10 minutes to denature the DNA. 
Immediately spin the tube at 13000 RPM for 10 seconds  
CRITICAL: Make sure the heat block at 95°C is correctly equilibrated beforehand with a 
thermometer. 
85. Transfer the Hi-C DNA sample cocktail to the PCR tube with 4.5ul of hybridization 
capture oligos library. 
86. Vortex for 3 seconds and spin briefly at full speed to collect contents in the bottom of 
the tube. 
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87. Quickly transfer the tube to a thermocycler set at 47°C, with the heated lid set at 57°C, 
for 64 to 72 hours. 
 
STEP 9: WASH AND RECOVER CAPTURED Hi-C DNA 
Prepare before start: 
• Set water bath at exactly 47°C (verify with a thermometer). 
• Equilibrate 1X stringent wash buffer and 1X wash buffer I at 47°C for at least 2hrs 
before washing and capture experiments. 
• Preheat the following wash buffers to 47°C in a water bath: 
o 400ul of 1X Stringent wash buffer 
o 100ul of 1X Wash buffer 1. 
 
88. Allow the Capture Beads from the SeqCap EZ Pure Capture Bead Kit to warm to room 
temperature for 30 minutes prior to use. Vortex beads thoroughly for 15 seconds.  
89. Aliquot 100 μl of beads for into a single 1.5 ml tube.     
90. Place the tube in a DynaMag-2 device. When the liquid becomes clear, remove and 
discard the liquid without disturbing the beads. 
91. Without removing the TBE add 200µl of 1X bead wash buffer provided in the kit. 
Remove the tube from the rack and vortex for 10 seconds. 
92.  Place the tube back in the DynaMag-2 device to bind the beads. Once clear, remove 
and discard the liquid. Repeat Steps 90-92 for a total of two washes. 
93. Now, resuspend the beads in 100µl of 1X Beads Was Buffer and transfer to a new PCR 
tube. 
94. Place the tube in the DynaMag-2 device to arrest the beads, remove and discard the 
liquid. 
95. The Capture Beads are now ready to bind the captured DNA. Proceed immediately to 
the next step. 
CRITICLE: Do not let the beads dry and work as fast as possible to minimise loss of 
temperature in all following steps. 
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96. For BINDING DNA TO THE CAPTURE BEADS and WASHING THE CAPTURE BEADS PLUS 
BOUND DNA follow the instruction as described by the kit manufacturer manual 
exactly. 
STEP10: FINAL ON-BEAD PCR, PCR PURIFICATION 
97. To perform the final PCR, to 50µl of beads suspension add: 100ul of 2X KAPA HiFi 
HotStart, 20µl of Library amplification primers and 30µl of water. 
98. Divide the PCR mix into 4 PCR tubes with 50µl each and start the following program 
on the thermocycler: 
Step Temp Duration Cycles 
Initial denaturation 98°C 45 sec 1 
Denaturation 98°C 15 sec 
Annealing 60°C 30 sec 
Extension 72°C 30 sec 
Final extension 72°C 1 min 1 
HOLD 12°C ∞ 1 
 
99. Use Qiagen PCR Purification Kit to stop the reaction. Elute the DNA in 50µl of elution 
buffer. 
100. Finally measure the concentration of your Hi-C library using Qubit dsDNA BR Assay 
Kit.  
101. The final Capture Hi-C DNA library is now ready. You can proceed to sequencing 
according to the platform available. 
CONTROL: To test enrichment performing a qPCR for captured Hi-C DNA VS non-captured 
DNA is recommended.  
DATA PREPARATION, ANALYSIS AND VISUALIZATION 
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The paired end capture Hi-C files can now be mapped to the reference genome with HiCUP 
(Wingett et al., 2015). HiCUP creates a digested reference genome based on the restriction 
enzyme that was used, maps the reads to the right restriction fragment, removes duplicates 
and filter for uninformative reads such as those that map to the same restriction fragment 
(self-ligation). The resulting bam file should be filtered for reads with low mapping quality (e.g 
mapq < 5) using samtools (Li et al., 2009).To increase cost efficiency, signal to noise ratio and 
confidence, virtual restriction fragments can be created by merging consecutive restriction 
fragments. Note, that although this generally increases the confidence, it reduces the 
effective resolution of the capture Hi-C experiment.  
Significant interaction can now be derived using the CHiCAGO capture Hi-C pipeline (Cairns et 
al., 2015).  
Briefly, CHICAGO uses a model that finds statistically enriched interactions between two loci. 
Two major components of the model are the interaction frequency (the number of reads) and 
the interaction distance in linear space. Informally, interactions are called significant when 
the read count is significantly higher than expected at the distance considered. Finally, a 
weighted correction for multiple testing is applied, to avoid “over-correction” of significant 
interactions between very distal elements. Typically, long-range interactions with a high 
number of reads receive the most significant score. Note that interactions over very large 
distances can have a high CHiCAGO-score, despite having very few reads. Therefore, we apply 
a significance threshold of at least 5 reads and a CHICAGO score >=5.  
The CHICAGO pipeline offers functionality to export the significant interactions to the 
Washington University Epigenome (Washu) browser (Zhou et al., 2013). Interactions can be 
uploaded to the Washu browser as a pairwise interaction file and viewed as arcs between 
interacting loci. 
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FIGURE LEGENDS 
Figure 1. Overview of open chromatin focused capture Hi-C. (A) A schematic overview of 
capture Hi-C protocol representing the amalgamation of Hi-C and biotinylated single-stranded 
DNA (ssDNA) probe capture steps. (B) A schematic representation of the capture reaction, 
showing hybridization of a hypothetical sequencing adapter-ligated Hi-C library DNA fragment 
and a biotinylated ssDNA capture probe, as well as adapter blocking oligos caps. 
Figure 2. Capture Hi-C, higher-order structure of chromatin and quality control. (A) A bar-plot 
representing cis (per chromosome) and trans-capture efficiency (%) of open chromatin DNA 
fragments. Interactions with one-end-captured (per chromosome) are represented in blue 
(bait - other end), and those with both-ends captured are represented in green (bait - bait). 
(B) A bar-plot representation of comparison of ‘TADs called’, using capture Hi-C data (Joshi et 
al., 2015) and standard Hi-C data (Dixon et al., 2012). (C) A representative picture for capture 
Hi-C digestion and ligation controls. (D) A representative picture for shearing of DNA upon 
ligation using sonication, showing a DNA distribution between 150-600bp. Visualization of 
capture Hi-C. (E) Raw matrix of a 4mb window on chromosome 4 at a 40kb resolution. Even 
in this unnormalized matrix, the higher order chromatin features (e.g. the topologically 
associated domains) are visible. The Hi-C derived TADs (Dixon et al. 2012) are shown below 
the matrix. (F) Zoom in of a 2mb regions in the locus at a 10kb resolution. The darker spots in 
the green band below the matrix depict the location of the capture probes. At this higher 
resolution, the capture enrichment is clearly visible as darker bands (indicating a higher 
number of reads) departing from regions with a capture bait. (G) Screenshot from the Washu 
Epigenome Browser (Zhou et al., 2013) displaying part of the locus in Fig 3B. The KLF4 gene, 
an important pluripotency associated transcription factor resides in this locus. Statistically 
enriched interactions (derived with the CHICAGO pipeline) between the KLF4 promoter and 
its enhancer are visible as red arcs. This gene is expressed (RNAseq track) and H3K4me3 
covers its promoter. The chromatin of the interacting enhancer is accessible (DNAse1), binds 
the core pluripotency factors (Pou5f1, Sox2, Nanog) and is covered by H3K27ac, a mark of 
active enhancers. 
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Figure 3. Visualization of capture Hi-C. (A) Image of the WashU EpiGenome Browser interface 
showing the interaction profile for a large genomic locus (chr3:143607173-146895788) made 
up of >3 TADs, in WT serum mESCs (B) Image of the WashU EpiGenome Browser interface 
showing spatial constriction of the HoxD locus in WT serum mESCs (maroon arcs) compared 
to WT 2i mESCs (teal arcs). 
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HIGHLIGHTS  
  Capture Hi-C identified Extremely Long Range Promoter-Promoter Interactions (ELRIs) 
  ELRIs are established during ground-state to primed pluripotency transition 
  ELRIs involve Hox and a subset of bivalent loci  
  H3K27me3 and Eed are necessary but not sufficient to mediate ELRIs  
 
eTOC BLURB 
Stunnenberg and colleagues used CHi-C to identify Extremely Long Range Promoter-Promoter 
Interactions (ELRIs) in mESCs. Their analysis points to a spatiotemporal mechanism for 
repressing Hox and other developmentally important genes during transition from the 2i 
ground state to the primed serum state regulated by PRC2. 
 
SUMMARY 
Serum-to-2i interconversion of mouse Embryonic Stem Cells (mESCs) is a valuable in vitro 
model for early embryonic development. To assess whether 3D chromatin organization changes 
during this transition, we established Capture Hi-C with target-sequence enrichment of DNase I 
hypersensitive sites. We detected extremely long-range intra- and inter-chromosomal 
interactions between a small subset of H3K27me3 marked bivalent promoters involving the Hox 
clusters in serum grown cells. Notably, these promoter-mediated interactions are not present 
in 2i ground-state pluripotent mESCs but appear upon further development into primed-like 
serum mESCs. Reverting serum mESCs to ground-state 2i mESCs removes these promoter-
promoter interactions in a spatiotemporal manner. H3K27me3, which is largely absent at 
bivalent promoters in ground-state 2i mESCs, is necessary but not sufficient to establish these 
interactions, as confirmed by Capture Hi-C on Eed-/- serum mESCs. Our results implicate 
H3K27me3 and PRC2 as critical players in chromatin alteration during priming of ESCs for 
differentiation. 
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INTRODUCTION 
The pluripotent properties of mouse embryonic stem cells (mESCs) make them an invaluable 
model for fundamental research into the regulatory mechanisms in early development. mESCs 
are classically cultured in growth-media supplemented with fetal calf serum and leukemia 
Inhibitory Factor (LIF) or, more recently, in serum-free 2i medium that contains LIF plus 2 small-
molecule kinase inhibitors: PD0325901 targeting mitogen-activated protein kinase (MEK) 
pathway and CHIR99021 targeting glycogen synthase kinase-3 (GSK3) pathway (Ying et al., 
2008). It is well accepted that 2i mESCs represent a ground-state pluripotency, whereas the 
classical serum-derived mESCs are reminiscent of post-implantation pluripotent stem cells 
(Marks and Stunnenberg, 2014; Marks et al., 2012; Nichols and Smith, 2009; Odsworth et al., 
2015; Plusa and Hadjantonakis, 2014; Ying et al., 2008). 
 
mESCs grown in serum+LIF (“serum mESCs”) and 2i+LIF media (“2i mESCs”) are both 
pluripotent, however, they show distinct epigenetic landscapes and transcriptomic profiles 
(Habibi et al., 2013; Marks et al., 2012). 2i mESCs have higher expression of metabolic genes 
and diminished expression of lineage priming genes compared to serum mESCs (Marks et al., 
2012). In serum mESCs, around 3000 genes have a bivalent chromatin state (co-occurrence of 
H3K27me3 and H3K4me3 marks), and are said to be poised for activation and predominantly 
coincide with promoters of genes involved in cell-fate determination and development (Azuara 
et al., 2006; Bernstein et al., 2006; Ku et al., 2008). In 2i mESCs, the number of bivalent genes 
reduces drastically, however, loss of repressive H3K27me3 does not result in transcriptional 
activation (Marks et al., 2012; Pasini et al., 2007). 2i mESCs have a hypo-methylated DNA similar 
to pre-implantation embryos, whereas serum mESCs are hyper-methylated, reminiscent of 
post-implantation embryos (Habibi et al., 2013; Leitch et al., 2013; Seisenberger et al., 2012; 
Smith et al., 2012). Together, this suggests that serum mESCs are epigenetically more restricted 
and developmentally primed as compared to ground-state 2i mESCs. 
 
The 3D organization of chromatin may well play a role in initiation and/or maintenance of the 
distinct epigenetic landscapes and gene expression in the two states of pluripotency. The 
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plasticity of the 3D conformation and its instructive role has been a subject of debate in recent 
years. The prevailing view is that in closely related cell types global interaction dynamics are 
limited, while fine-tuning of local interactions is potentially more frequent and linked to the 
transcriptional state (Bickmore, 2013; Dixon et al., 2015; Gibcus and Dekker, 2013; de Wit et al., 
2013). Most of the promoter-promoter and promoter-enhancer interactions take place within 
Topologically Associated Domains (TADs) which are on average 880kb in size (Dixon et al., 
2012). On the other hand, long-range interactions that span across TADs as well as 
chromosomes are rare when compared to the frequency of intra-TAD interactions (Gibcus and 
Dekker, 2013; Schwartz et al., 2012; Seitan et al., 2013; Sofueva et al., 2013). 
 
In this study, we assessed the dynamic reorganization of the 3D chromatin architecture in two 
closely related states of pluripotency, using Capture Hi-C approach. 
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RESULTS 
 
Capture Hi-C  
To study dynamics in chromatin architecture and to characterize long-range interactions, we 
performed Hi-C using DpnII as the restriction enzyme, potentially reaching a genome-wide 
coverage at a resolution of less than 1Kb. We subsequently performed enrichment of 
interactions by a target-capture (called CHi-C), similar to the exome sequencing approach. We 
enriched for all DNase I hyper-sensitive sites (DHSs) in chromatin from mESCs (Table S1). Probes 
were designed against the union of all DHSs of serum and 2i mESCs chromatin (Figures S1A-S1B, 
Table S1). This elaborate representation of the genome of ~100k loci allows probing of 
promoter-promoter, promoter-enhancer and enhancer-enhancer contacts (Figure 1A).  After 
paired-end sequencing, we removed unanchored reads and duplicates, yielding a total of 784 
million reads (Table S1) with ~2 million significant long-range contacts. The fold enrichment for 
the probe-targeted open chromatin regions was ~20 fold with capturing efficiency of 58.4% on 
average (at least one-end overlap with targeted regions). To validate the robustness of the CHi-
C approach, all experiments were conducted in two biological replicates and resulted in high 
reproducibility (Figures S1C-S1H). The distributions of promoter-promoter, promoter-enhancer 
and enhancer-enhancer interactions between 2i and serum mESCs were found to be very 
similar (Figure 1A). 
 
Extremely Long-Range Interactions (ELRIs) 
We computed a score for each interaction that is a function of distance and frequency of 
contact between two genomic fragments, using a pipeline specifically developed to analyze CHi-
C data, called “CHiCAGO” (Cairns et al., 2015). We used 5 di-tag reads within 5 adjacent DpnII 
fragments as a cut-off. Visual inspection showed high-ranking interactions involving Hox and 
other genomic loci in serum mESCs that were absent or very low in 2i CHi-C (Table S2). Next, we 
performed virtual-4C analyses to identify long-range interactions excluding intra-TAD 
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interactions. We filtered for differential long-range interactions between serum and 2i mESCs 
(>3 fold change). The Circos plots revealed prominent interactions that are intra- as well as 
inter-chromosomal (Figure 1B, red lines), henceforth defined as Extremely Long-Range 
Interactions (ELRIs). Including Hox genes, 108 protein coding genes and 93 non-coding genes 
were identified to be directly overlapping with ELRI loci (Table S2). Most of the previously 
reported Hox interactions in serum mESCs (Vieux-Rochas et al., 2015) were independently 
identified by our CHi-C approach. ELRIs nearly exclusively occur in serum mESCs and are absent 
or strongly reduced in ground-state 2i mESCs. Local intra-TAD contacts appear largely 
unaffected (Figure 1B, blue lines and Figure S1I). Examples of dynamic interactions between 
HoxD locus and Lmx1b or Wt1 loci on chromosome 2 as well as the reverse from Lmx1b to HoxD 
locus, Lhx2 and Dlx1/Dlx2 are illustrated (Figures 1C-1E). To validate the results obtained from 
CHi-C, we performed 4C on selected ELRI loci and found high consistency, showing the 
robustness of the CHi-C approach (Figure S2). FISH experiments proved to be challenging 
because of the refractory properties of 2i mESCs and did not yield confident results. 
 
Characteristics of ELRI loci 
We next investigated the epigenetic makeup of ELRI loci by profiling histone marks: H3K4me3, 
H3K36me3, H3K4me1, H3K27ac, H3K9me3 and H3K27me3. In addition, we also profiled other 
DNA-binding proteins: RNA Polymerase II, Ring1B, Suz12 and CTCF (Figure 1F). The analysis 
reveals H3K27me3 as the prominent feature of ELRI loci. The presence of H3K27me3 with low 
levels of H3K4me3 is the hallmarks of bivalent loci. Like H3K27me3, Ring1B and Suz12 are also 
prominent factors localized at ELRI loci (Figure 1F). The presence of H3K27me3 is not an 
exclusive feature of ELRI loci as the vast majority of bivalent loci, even those with very high 
H3K27me3 marking, do not participate in ELRIs (Figure 1G). Virtual-4C plot from the HoxD view-
point underscores the selective nature of ELRIs (Figure 1D). Thus, the presence of H3K27me3 is 
a prominent but not selective feature of ELRIs. 
It is well established that bivalent loci coincide with promoters of genes involved in cell-fate 
determination and development (Azuara et al., 2006; Bernstein et al., 2006). Accordingly, ELRI 
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loci also largely overlap with promoters of transcription factors involved in cell fate-
determination (78/108) and possess a homeobox DNA-binding domain (63/108) (Figure 1H, 
Table S2). Plotting the distributions of ELRI CHi-C and H3K27me3 tags reveals their spatial co-
localization and confinement to a region (average size of 36 kb) centered on the transcription 
start sites (Figure 1I). The intimate connection between ELRI contacts and H3K27me3 can also 
be appreciated from Lmx1b and Wt1 ELRI promoters (Figures 1C-1D). 
After establishing the connection between ELRI loci and colocalization with promoters, we 
compared the strength of ELRIs with other classes of promoter-promoter interactions. We 
computed the average normalized di-tags for promoter-promoter interactions representing 
intra-TAD interactions (300kb to 1Mb), inter-TAD interactions (>1Mb) and ELRI contacts 
identified by CHiCAGO pipeline (Figure 1J). Notwithstanding the extreme long-distance, ELRI 
contacts were of similar strength as promoter-promoter intra-TAD contacts, and were stronger 
than non-ELRI promoter-promoter inter-TAD interactions (Figure 1J). 
 
Loss of ELRIs in Eed-/- serum mESCs 
Epigenetic profiling of ELRI promoters points to a role of H3K27me3 in the interactions. To 
investigate the putative role of PRC2 and H3K27me3 deposition in ELRIs, we performed CHi-C 
on Eed-/- mESCs cultured in serum media. Eed is one of the core components of the PRC2 
complex and absence of Eed results in destabilization of the PRC2 complex and a complete loss 
of H3K27me3 (Boyer et al., 2006a; Wang et al., 2002). We observed that in Eed-/- mESCs, ELRIs 
are lost or strongly reduced, similar to the situation in 2i mESCs (Figure 2A-2B). To quantify the 
loss of ELRI strength, we compared average normalized di-tags on ELRI promoters of Eed-/- 
mESCs with WT serum mESCs and 2i mESCs (Figure 2C). The strength of ELRIs in Eed-/- mESCs 
was comparable to the strength observed in 2i mESCs. In contrast, the intra-TAD interactions 
(Figure 2A, blue line) were generally not affected by the loss of the H3K27me3 mark in Eed-/- 
mESCs as in 2i mESCs (Figure 2A). This implicates that unlike ELRIs, these intra-TAD interactions 
are not dependent on H3K27me3 and PRC2. We validated the Eed-/- CHi-C experiments by 4C on 
HoxA and HoxD as well as on selected ELRI promoters (Figures S2A-S2B). We also compared 
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Eed-/- CHi-C data with existing 4C data, showing good overlap (Figure S2C, Denholtz et al., 2013). 
Thus, PRC2 and H3K27me3 play indispensable roles in the formation of ELRIs. 
 
Time-dependent loss of ELRIs during transition from serum-to-2i mESCs 
To study the dynamics of ELRIs during transition from serum-to-2i, we performed CHi-C on Day1 
and Day3 after medium exchange (Figure 3A). The interaction patterns of ELRIs show a gradual 
loss starting as early as Day1. Most ELRI contacts are drastically reduced, or were not detected 
anymore at Day3, such as interaction between Bmi1 and HoxD locus (Figure 3A). Other ELRI 
contacts such as Meis2 and Pax6 are still observable at Day3, although at severely reduced 
strengths (Figure 3A). This dynamic loss of ELRI strength was validated using 4C approach on 
Day1 and Day3 mESCs, as exemplified by HoxA and Vax2 (Figures 3B and S3A) as well as other 
ELRI contacts (Figure S3B). To quantify the loss of ELRI strength we compared average 
normalized di-tags on ELRI promoters during transition from serum-to-2i mESCs (Figure 3C). 
Compared to the strength of ELRIs in WT serum mESCs, we observed on average a 67% 
reduction on Day1 and a 85% reduction on Day3. 
The loss of ELRIs in Eed-/- and in wild-type 2i mESCs cells shows that H3K27me3 deposited by 
PRC2 complex is necessary for ELRIs. However, H3K27me3 deposition is not sufficient for ELRIs, 
because most bivalent loci that are equally marked with H3K27me3 are not involved in ELRIs. 
Given the interplay between PRC2 and PRC1 in epigenetic shaping of repressive chromatin, we 
investigated the role of PRC1 in ELRIs as PRC1 has been shown to be recruited to H3K27me3 to 
reinforce the function of PRC2 (Ku et al., 2008). We performed ChIP-seq experiments on Suz12 
and Ring1B during serum-to-2i transition. The occupancy of the PRC2 component, Suz12, on 
ELRI loci was unaltered in serum mESCs even up to Day3 (Figure 3D, mid-panel), whereas 
H3K27me3 and ELRI contacts were largely lost (Figure 3D, left-panel). In contrast, Ring1B, a 
central component of PRC1, shows a gradual reduction starting as early as Day1, and the loss of 
occupancy becomes pronounced or completed at Day3 in excellent synchrony with the loss of 
ELRIs (Figure 3D, right-panel). The reduced occupancy observed is not due to reduced 
80 
 
expression of Ring1B or other detected PRC components, as determined by quantitative Mass 
Spectrometry (Figure S3C). 
This temporal concordance between loss of ELRIs and PRC1 indicates a role of PRC1 as a reader 
of H3K27me3 and possibly in mediating ELRIs. We observed that bivalent genes which do not 
display ELRIs also have occupancy of PRC1 (Ring1B) similar to that of ELRI loci. During the 
serum-to-2i transition, bivalent loci in general show the same kinetics as ELRI loci with respect 
to loss of Ring1B (Figure 3D). It seems likely that ELRIs require a specific composition of the 
modular PRC1 or specific transcription factor co-binding and/or epigenetic context that act only 
on ELRI loci.  
 
ELRI related local chromatin dynamics and gene transcription 
We next investigated the effect of ELRIs on gene expression. We previously showed that in 2i, 
two-thirds of the bivalent genes (total ~3000) are not yet marked with the H3K27me3, but only 
~10 percent show significant transcriptional activity (Marks et al., 2012). Similarly, ~18 percent 
of ELRI genes are significantly expressed in 2i, and become repressed in serum having gained 
H3K27me3 and ELRIs (Figures 4A-4B, Table S3). Strikingly, these genes encode subunits of PRC1: 
Cbx4, Cbx8 as well as Bmi1 (Morey et al., 2012). This suggests a potential change in the 
composition of PRC1 in the transition from ground-state 2i to primed serum mESCs. Another 
ELRI gene that is significantly higher expressed in 2i mESCs is Tbx3, which has been shown to be 
important for self-renewal of mESCs (Ivanova et al., 2006). 
Next, we looked at the temporal changes in local chromatin architecture of the ELRI genes 
during transition from serum-to-2i mESCs state. Loss of ELRIs coincides with diverse 
spatiotemporal changes in local intra-TAD interaction patterns and gene expression. The 
diverse changes in the local 3D chromatin structure and their effects on gene expression are 
illustrated by the following four examples. 
ELRI loci such as encoding Bmi1 gradually lost the H3K27me3 mark, their interactions with Hox 
and with local inter-TAD H3K27me3 marked regions were also lost. These changes were 
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accompanied by gain of H3K27ac at Bmi1 promoter i.e. a change in chromatin state (Figure 4C, 
orange shaded region) and resulted in increased transcriptional activity. The Lbx1 locus also 
gradually lost ‘negative’ H3K27me3-mediated interactions, while some of the interacting 
regions in serum mESCs, which had been decorated with the repressive H3K27me3, gained 
‘positive’ histone modifications H3K27ac and H3K4me1 in 2i mESCs (Figure 4F, green shaded 
region). In contrast to Bmi1, the transcriptional activity of Lbx1 was not significantly increased 
(Figure 4F). In the case of Tbx3, interactions with H3K27me3 loci were lost (Figure 4E, orange 
shaded regions), contacts with enhancer-like loci (marked with H3K27ac and H3K4me1) were 
strengthened (Figure 4E, green shaded region). However, unlike Lbx1, the transcriptional 
activity was increased in response to local chromatin changes. Finally, at the Meis2 locus, the 
loss of ELRI and H3K27me3 resulted in the formation of novel contacts between the promoter 
and potential enhancers (H3K27ac and H3K4me1 marked loci) and enhanced transcription of 
Meis2 (Figure 4D, green shaded regions). 
ELRI genes move from a relatively active chromatin state (in 2i mESCs) to a repressed chromatin 
state (in serum mESCs) when these changes are considered in a developmental context (2i-to-
serum state pluripotency). The changes in the chromatin state are illustrated in a heat map 
(Figure S4A). The gradual gain of H3K27me3 is evident on all ELRI loci during the transition from 
ground-state to primed mESCs. However, only a subset of ~30 genes lose H3K27ac during the 
transition from the 2i-to-serum state and are transcriptionally repressed. 
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DISCUSSION 
In this study, we show that extremely long-range interactions (ELRIs) involving Hox and other 
genomic loci are present in serum mESCs but not yet established in ground-state 2i condition. 
Our analysis provides evidence for spatiotemporal changes in 3D chromatin structure involving 
establishment of ELRIs during the 2i to serum transition. The overall organization of ELRI 
contacts established during this transition suggests a coordinated program that encompasses 
extensive reshaping of the transcriptome, epigenome and the 3D interactome during early stem 
cell differentiation. The absence of ELRIs in 2i ground-state seems to indicate that these 
interactions are not essential for maintenance of pluripotency. Based on the idea that 2i mESCs 
represents an earlier developmental state (ICM) and serum a later developmental state 
(Boroviak et al., 2014; Habibi et al., 2013; Hackett and Surani, 2014; Huang et al., 2014; Marks 
and Stunnenberg, 2014; Nichols and Smith, 2009; Odsworth et al., 2015; Plusa and 
Hadjantonakis, 2014; Ying et al., 2008), we hypothesize that ELRIs are absent in embryos prior 
to implantation and that these interactions are acquired at later stages, probably to restrict or 
poise controlled genes for transcriptional activity. This proposal would be in line with the 
previous findings that H3K27me3 and PRC2 are not essential for pre-implantation embryos, but 
are essential for differentiation and formation of primary cell layers (Pasini et al., 2007; Wang et 
al., 2002). 
The severe reduction in levels of H3K27me3 at ELRI loci in 2i mESCs, compared to serum mESCs, 
hints at a role of PRCs in ELRIs. CHi-C on Eed-/- showed that PRC2 activity is necessary. The 
occupancy of ELRI loci by Suz12 remains unaltered up to Day3 at which 85% of ELRI strength is 
lost, showing that the enzymatic activity of PRC2 is a critical factor, rather than its binding at 
ELRI loci. 
The synchrony between loss of ELRIs and loss of the PRC1 component Ring1B is suggestive of its 
role in ELRIs. The traditional view is that PRC2 acts as the initiator in the formation of a 
PRC2/PRC1 chromatin state by depositing H3K27me3 that recruits PRC1 through the Cbx reader 
protein family (Boyer et al., 2006a; Simon and Kingston, 2009). In serum mESCs, PRC2 has been 
shown to recruit PRC1 components to Hox loci (Boyer et al., 2006a). Hence, it is possible that 
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PRC2 acts only as the recruiter of PRC1, which then mediates ELRIs. In line with this model, the 
knock-out of Eed precludes H3K27me3 deposition and consequently recruitment of a PRC1 
complex (Boyer et al., 2006b; Wang et al., 2002). In 2i mESCs, similar to Eed-/- mESCs, 
H3K27me3 mark is strongly diminished, resulting in poor recruitment of PRC1 fully 2i-converted 
cells (Day 15-18, Habibi et al., 2013). We postulate that, in 2i mESCs, the loss of enzymatic 
activity of Ezh2 results in poor or lack of H3K27me3 deposition; consequently, canonical PRC1 
cannot bind and ELRIs cannot be established. In the past, Denholtz et al., 2013 have also 
suggested a role of PRC2 in chromatin compaction in serum mESCs, although the HindIII based 
4C did not have sufficient resolution to reveal the promoter-promoter nature of ELRI contacts 
described in this study. 
The subunit composition of the PRC1 complex involved in ELRIs remains to be established. Our 
data show that Ring1B occupancy is not only reduced at ELRI loci but also at other bivalent loci 
and display the same kinetics during the transition. Thus, the mere presence of Ring1b (PRC1) is 
insufficient to generate selectivity in ELRIs. A role of Ring1B in canonical PRC1 has been 
reported in local compaction at Hox loci (Eskeland et al., 2011). A striking parallel with our 
study, using the Eed-/- mESCs, is that PRC2 is not sufficient for local compaction of chromatin in 
mESCs. Given the highly modular composition of PRC1 complexes (Chen and Dent, 2014; 
Creppe et al., 2014; Senthilkumar and Mishra, 2009), we hypothesize that a specific PRC1 
subunit composition is required for ELRI formation, and this specific PRC1 complex distinguishes 
ELRI loci from other bivalent loci. 
While our manuscript was in revision, Schoenfelder and coworkers, identified extremely long-
range interactions in serum mESCs, using a promoter capture Hi-C approach. Based on Ring1A-
Ring1B-dKO mESCs, they pointed to a role of PRC1, in line with our speculation (Schoenfelder et 
al., 2015). Their promoter and our DHS capture approaches identify extremely long-range 
interactions that largely overlap (80% of coding genes in Schoenfelder et al. 2015 are 
independently identified in our study as ELRIs, Figure S4B).  While we firmly established a role 
of PRC2 using the CHi-C on the Eed-/- mESCs, they revealed the critical role of PRC1 in the 
process. In the Ring1A-Ring1B-dKO mESCs, ELRIs cannot be established because these dKO 
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mESCs have an active PRC2 complex but a defunct PRC1 complex. Taking both studies together, 
it is prudent to postulate that PRC2 acts as an initiator of ELRIs by deposition of H3K27me3, and 
subsequent recruitment of canonical PRC1 which may act as the physical mediator of ELRIs. 
 
 
EXPERIMENTAL PROCEDURES 
Cell Culture 
E14 Tg2a (E14) is a male mES cell line of 129 background. Serum (E14) mESCs were grown in 
DMEM containing 10% fetal-calf serum in presence of LIF, together called ‘serum medium’. 2i 
(E14) mESCs were grown in serum free NDiff 227 supplemented with MEK inhibitor PD0325901 
(1µM) and GSK3 inhibitor CHIR99021 (3µM) in presence of LIF, together called ‘2i medium’ 
(Ying et al., 2008). All cell-culture was conducted in feeder-free condition. Serum-to-2i 
transition was carried out by washing the mESCs in serum medium twice with PBS and then 
switching to 2i medium. Eed-/- mESCs were provided to us by Luciano di Croce and Anton Wutz, 
and are described in Morey et al., 2012; Schoeftner et al., 2006. Eed-/- mESCs were also grown 
in identical condition to WT E14 serum mESCs.  
 
Capture Hi-C (CHi-C)  
The Capture Hi-C experiment was divided into two parts, in-nucleus Hi-C and ss-DNA probe 
capture enrichment. In-nucleus Hi-C was carried out as described in Nagano et al., 2015. DpnII 
was used as the restriction enzyme. On beads DNA amplification PCR was carried out with 7-9 
cycles to generate around 1µg of Hi-C library DNA. ssDNA probe capture step was carried out 
using the protocol provided by Roche NimbleGen Inc. 
(http://sequencing.roche.com/products/nimblegen-seqcap-target-enrichment/seqcap-ez-
system/seqcap-ez-developer.html) optimized for the probe capture library. Libraries were 
indexed using NEXTflex adapters (Bioo-Scientific Corporation, Austin, TX, USA) and 75bp or 
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43bp paired-end sequencing was performed on Illumina instruments using TruSeq reagents 
(Illumina, San Diego, CA, USA), according to manufacturer’s instructions. 
 
DNase I-seq, ChIP-seq, 4C and RNA-seq 
Detailed description of sample preparation and data analysis is available in the Supplemental 
Experimental Procedures. 
 
Public datasets used in this study 
4C primers and 4C data for Eed-/- mESCs and serum mESCs from Denholtz et al., 2013. 
CHi-C Hox loci interactors list from Schoenfelder et al., 2015. 
H3K4me3, H3K9me3, H3K36me3 ChIP-seq data from Marks et al., 2012. 
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database of GEO (accession number GSE72164). 
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FIGURE LEGENDS 
 
Figure 1. Extremely Long-Range Interactions (ELRIs) in serum mESCs are lost in 2i mESCs. (A) 
The bar plots show abundance of different classes of all CHi-C interactions in serum and 2i 
mESCs. (B) A graphical representation of ELRIs using circos plot for the chromosomes involved 
(outer-most ring). The plots show the interactions for all H3K27me3 marked loci (blue outer 
ring) in serum mESCs (left) and 2i (right). Inter- and intra-chromosomal ELRI contacts (red lines) 
and interactions between other bivalent genes (blue lines) are represented in the inner of the 
plots. The four Hox gene clusters are marked in red. (C) Schematic representation of 
chromosome 2 and positions of genes indicated by dashed squares. Density plots of CHi-C 
signals are plotted along with the chromosome. Two ELRI contacts (Lmx1b and Wt1) interacting 
with HoxD are highlighted in red, while non-ELRI genes (Dll4 and Gad2) are highlighted in black. 
(D) Zoom-in snapshots of browser view for Lmx1b, Wt1 and Dll4, Gad2 from HoxD locus as 
viewpoint. Snapshots for Lmx1b and Wt1 depict differential ELRI contacts with HoxD locus, in 
serum mESCs (orange track) and 2i mESCs (dark blue track). Single DpnII fragment resolution of 
CHi-C shows ELRI contacts focalized on promoters that overlap with H3K27me3 peaks in serum 
mESCs and are absent in 2i mESCs. H3K27me3 tracks for serum mESCs and 2i mESCs are colored 
red and light blue, respectively. (E) Zoom-in snapshots as in (D) from Lmx1b as viewpoint 
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showing interaction patterns with HoxD locus, Lhx2 and Dlx1/Dlx2. (F) A heat-map showing 
topography of histone marks and DNA binding factors on ELRI loci compared to other bivalent 
and active genes. Color scheme indicates highest to lowest enrichment. (G) A box-plot showing 
comparable H3K27me3 intensity (log2RPKM) on ELRI and other bivalent loci. (H) Diagrams of 
the gene functional classes of ELRIs. (I) Average profiles of CHi-C and H3K27me3 signals from 
serum mESCs on the Transcription Start Sites (TSS) of ELRI genes. CHi-C signal (orange line) 
shows the focal nature of ELRI contacts around the TSS of ELRI genes and its correlation with 
H3K27me3 mark (blue line). (J) Comparison between strengths of ELRIs and all other promoter-
promoter contacts. Promoter-promoter contacts are illustrated in 3 distance intervals: 300kb to 
500kb, 500kb to 1Mb and >1Mb. The strengths of other significant promoter-promoter 
interactions, ELRI contacts and  random promoter-promoter contacts are represented in blue, 
red and grey respectively. The definition of strength can be accessed in Supplemental 
Information. 
Also see Supplemental Figure 1. 
 
Figure 2. Eed-/- mESCs lack ELRI contacts as in 2i mESCs. (A) Circos plots for serum and 2i mESCs 
(left two plots) and for Eed-/- (right), description as in Figure 1B. (B) An example showing the 
lack of ELRIs in Eed-/- mESCs as in 2i mESCs. Using HoxA locus (blue shaded regions) as the 
viewpoint, CHi-C signals on chromosome 6 (sum of normalized di-tags in a sliding window of 
100 DpnII fragments) are plotted for serum, 2i and Eed-/- mESCs. Differential ELRI regions are 
shaded in red. On top, ELRI contacts are indicated by red arches. (C) Bar plots of relative 
strength of ELRI contacts in serum, 2i and Eed-/- mESCs. 
Also see Supplemental Figure 2. 
 
Figure 3. Dynamics of ELRIs and PRC subunit occupancy during serum-to-2i transition. (A) 
Differential ELRI contacts during serum-to-2i transition. Using HoxD locus (blue shaded regions) 
as the viewpoint, CHi-C signals on chromosome 2 (sum of normalized di-tags in a sliding window 
of 10 DpnII fragments) are plotted for serum, Day1 and Day3 of serum-to-2i transition and 2i. 
Dynamics of ELRIs are highlighted as red shaded regions. On top, ELRI contacts are indicated by 
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red arches. (B) A browser view of interaction between the viewpoint HoxA locus (shaded blue) 
and Vax2 (shaded red) during serum-to-2i transition and in Eed-/- mESCs (sliding window of 25 
HindIII fragments). Red dashed arch indicates ELRI contact. A zoom-in view on the right shows 
the loss of ELRI on Vax2 during serum-to-2i transition and in Eed-/- mESCs. (C) Bar plots of 
relative strength of ELRI contacts in serum, Day1 and Day3 of serum-to-2i transition and 2i. (D) 
Box plots for intensities of H3K27me3, Suz12 and Ring1B on ELRI loci and other bivalent genes 
in serum, Day1 and Day3 of serum-to-2i transition and 2i mESCs. 
Also see Supplemental Figure 3  
 
Figure 4. Transcriptional and chromatin state changes at ELRI loci. (A, B) Left panel: a histogram 
for probabilities of differential expression for 108 ELRI genes (top) and 2985 other bivalent 
genes (bottom); genes with a probability value of greater than 0.2 considered as differentially 
expressed (represented as green). Right panel: of the 108 ELRI genes, 89 genes remained 
unchanged in transcriptional activity and 19 genes were up regulated in 2i mESCs, compared to 
serum condition. (C-F) Snapshots of ELRI loci of Bmi1, Meis2, Tbx3 and Lbx1 genes, respectively. 
ELRI genes (blue shaded) interact with local H3K27me3 regions (orange shaded). While 
resolving H3K27me3 marked ‘negative’ interactions, new ‘positive’ interactions between the 
promoters and H3K27ac marked regions (green shaded) are established. On top of the black 
boxes for the exemplified loci, intra- and inter-chromosomal interactions between Hox loci and 
other ELRI loci are represented as density plots. The red dashed arches represent repressive 
interactions, whereas the green dashed arches represent positive interactions. 
Also see Supplemental Figure 4. 
 
SUPPLEMENTAL INFORMATION 
Figure S1, related to Figure 1. Characteristics of the DHSs for probe design and reproducibility 
between CHi-C biological duplicates. 
Figure S2, related to Figure 2. Comparison between CHi-C, in-lab generated 4C and 4C from 
public data sets. 
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Figure S3, related to Figure 3. In-lab generated 4C validation for ELRIs detected by CHi-C on the 
complete serum-to-2i transition and Eed-/- mESCs. 
Figure S4, related to Figure 4. Switching of chromatin state of ELRI promoters from serum to 2i 
pluripotent state. 
Table S1, related to Figure 1. Experimental information of Capture Hi-C and 4C. The union of 
DHSs in serum and 2i mESCs; all DpnII fragments targeted by CHi-C Probes; list of all virtual baits 
used; sequencing statistics of CHi-C; list of all primers used for 4C. 
Table S2, related to Figure 1. Identification of ELRIs and annotation of ELRI genes. List of ELRI 
regions from CHiCAGO pipeline and virtual 4C analysis; list of all ELRI genes; all homeobox 
containing ELRI genes; all ELRI transcription factors;  
Table S3, related to Figure 4. ELRI genes that up-regulated in 2i. List of all ELRI genes with 
significantly increased transcriptional activity in 2i.  
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SUPPLEMENTAL FIGURE LEGENDS 
 
Figure S1, related to Figure 1. Characteristics of the DHSs for probe design and reproducibility 
between CHi-C biological duplicates. (A) Venn diagram for DHSs in serum and 2i mESCs. CHi-C 
probes were designed against the union. (B) Genomic distribution of DHSs based on gene 
annotation and ChIP-seq of histone marks (C) SmoothScatter plots show the numbers of di-tags 
captured by each probe between experiments with high reproducibility. (D) SmoothScatter 
plots show the number of tags for each fragment pairs (fragments of 20kb binned genome) 
between biological replicates. (E) SmoothScatter plots show the number of tags for each called 
interaction between biological replicates, signifying high reproducibility. (F) Both top and 
bottom figures show high robustness between the normalized tag approach and Hit% 
approach. Top and bottom figures were generated using a sliding window of 30 DpnII and 100 
DpnII fragments, respectively. Top and bottom figures together show high robustness when 
using different sizes of sliding window. (G) Virtual-4C plots showing ELRIs observed on 
chromosome 2 with high reproducibility between biological duplicates. The rate of the loss of 
ELRIs in the second experiment (rep2) for serum-to-2i transition was observed to be higher. (H) 
Heat-map of correlations for ELRI contacts between all CHi-C samples. (I) Non-ELRI contacts 
between H3K27me3 marked regions largely unchanged in serum and 2i mESCs.  
Figure S2, related to Figure 2. Comparison between CHi-C, in-lab generated 4C and 4C from 
public data sets. (A) 4C validation of differential ELRI contact from HoxA locus to Vax2 and 
reverse, using 2 different baits for serum, 2i and Eed-/- mESCs. (B) 4C validation of differential 
ELRI contacts from HoxA locus to other ELRI genes highlighted using blue shaded area. (C) High 
correlation visualized between ELRIs detected by CHi-C and publically available 4C data 
(Denholtz et al., 2013) for serum mESCs and Eed-/- mESCs. ELRIs detected from HoxD to other 
loci on chromosome 2 are highlighted by red bands. All ELRI contacts are represented as red 
arches.  
Figure S3, related to Figure 3. In-lab generated 4C validation for ELRIs detected by CHi-C on the 
complete serum-to-2i transition and Eed-/- mESCs. (A) Loss of the interaction between HoxA and 
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Vax2 revealed by CHi-C validated using 4C experiments on serum-to-2i transition and Eed-/- 
mESCs. (B) Loss of the interaction between HoxD and other ELRI loci revealed by CHi-C validated 
using 4C experiments on serum-to-2i transition and Eed-/- mESCs. All ELRI contacts are 
represented as red arches. (C) Bar plot showing the changes of whole cell protein levels of PRC 
components detected using quantitative Mass Spectroscopy for serum-to-2i transition. Y-axis 
represents Log2 fold change compared to serum mESCs. X-axis represents the time points 
during serum-to-2i transition (4hrs, 8hrs, 16hrs, 24hrs, 32hrs and 18Days/2i mESCs after 
medium switch).  
Figure S4, related to Figure 4. Switching of chromatin state of ELRI promoters from serum to 2i 
pluripotent state. (A) Heat-map shows a gradual loss of H3K27me3 mark on Day1 and Day3 of 
serum-to-2i transition on all ELRI promoters. A subset of genes (black dash-lined boxes) show a 
gradual gain in H3K27ac during the transition. All ELRI genes with increased transcriptional 
activity in 2i form a part of the subset and are labeled in red. (B) Venn diagram showing high 
overlap between ELRI loci detected by our DHS-based CHi-C and promoter-based CHi-C in a 
parallel study (Schoenfelder et al., 2015).  
 
SUPPLEMENTAL TABLE LEGENDS 
 
Table S1, related to Figure 1. Experimental information of Capture Hi-C and 4C. The union of 
DHSs in serum and 2i mESCs; all DpnII fragments targeted by CHi-C Probes; list of all virtual baits 
used; sequencing statistics of CHi-C; list of all primers used for 4C. 
Table S2, related to Figure 1. Identification of ELRIs and annotation of ELRI genes. List of ELRI 
regions from CHiCAGO pipeline and virtual 4C analysis; list of all ELRI genes; all homeobox 
containing ELRI genes; all ELRI transcription factors;  
Table S3, related to Figure 4. ELRI genes that up-regulated in 2i. List of all ELRI genes with 
significantly increased transcriptional activity in 2i.  
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EXTENDED EXPERIMENTAL PROCEDURES 
DNase I-seq 
DNase I libraries were prepared as described in (Shen et al., 2002). Nuclei were isolated using 
Buffer A (15 mM NaCl, 60 mM KCl, 1 mM EDTA, pH 8.0, 0.5 mM EGTA, pH 8.0, 15 mM Tris-HCl, 
pH 8.0, 0.5 mM Spermidine) supplemented with 0.015 % IGEPAL CA-630 detergent. DNase I 
treatment was done for 3 minutes and the reaction was stopped with stop buffer (50 mM Tris-
HCl, pH 8, 100 mM NaCl, 0.10 % SDS, 100 mM EDTA, pH 8.0, 1 mM Spermidine, 0.3 mM 
Spermine). The sample was further fractionated on 9% Sucrose gradient for 24 hours at 25000 
rpm at 16 °C. Fractions containing fragments smaller than 1kb were purified and processed 
according to the Illumina library preparation protocol. 
ss-DNA probe design for CHi-C 
ss-DNA probes were designed by Roche NimbleGen Inc. as a custom design. Probes were 
generated for the union of DNase I hotspots (~100,000) for serum and 2i mESCs (~250,000 tiled 
individual probes), hence providing coverage for all of the open chromatin (Table S1). The 
length of each probe was on an average 75 nucleotides. The probes were biotinylated for easy 
capture with streptavidin beads. Total size of the capture probe library was 41.9Mb. 
ChIP-seq 
ChIP experiments were carried out according to the protocol described (Marks et al., 2012). For 
Ring-1B and Suz12 ChIPs, 6 million cells per ChIP were used; for H3K27me3, H3K4me1 and 
H3K27ac ChIPs, 1 million cells per ChIP were used. The antibodies used are as follows: Anti-
Ring1B (D22F2) antibody from Cell Signaling and 5µl was used per ChIP; Anti-Suz12 (ab1207) 
antibody from Abcam and 3µl was used per ChIP; Anti-H3K27me3 (07-449) antibody from 
Upstate (Millipore) and 3µl was used per ChIP; Anti-H3K27ac (C15410196-10) and Anti-
H3K4me1 (CS-037-100) antibodies from Diagenode and 3µl was used per ChIP. 
RNA-seq 
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Total RNA was extracted using RNeasy mini kit (QIAGEN) following the manufacturer’s 
instructions. 5ug of extracted RNA was depleted from ribosomal RNA using Ribo-Zero Gold Kit 
(Epicentre Madison, Winsconsin, USA). Then, rRNA-depleted RNA was used for library 
preparation using the TruSeq RNA Sample Prep Kit (Illumina) following the manufacturer’s 
instructions. Libraries were indexed using NEXTflex adapters (Bioo-Scientific Corporation, 
Austin, TX, USA) and 43bp paired-end sequencing was performed on Illumina instruments using 
TruSeq reagents (Illumina, San Diego, CA, USA), according to manufacturer’s instructions. 
4C-Seq 
4C assays were performed as described previously (Splinter et al., 2012) with minor 
modifications. Briefly, 10 million cells were cross-linked for 10 minutes with 2% 
paraformaldehyde, quenched with glycine and lysed in 50 ml lysis buffer (10mM Tris pH 7.5, 
10mM NaCl, 2% NP-40, 1X protease inhibitors) for 30 minutes. Nuclei were then digested with 
800U HindIII enzyme followed by 4 hours ‘in nuclei’ ligation at 16˚ C with 2000U T4 ligase (NEB) 
(Nagano et al., 2015). Reverse crosslinked and purified DNA was further digested with 50U 
DpnII enzyme, followed by circularization. 3200ng of 4C library was amplified with bait-specific 
inverse primers (Table S1), pooled and purified. Amplified library was adaptor ligated, PCR 
amplified (8 cycles) and paired-end sequenced on the Illumina NextSeq 500 to obtain 50bp x2 
long reads.  
Quantitative Mass Spectrometry 
Total proteins for each sample were isolated and tryptic digested following a published label-
free proteomics protocol (Liu et al., 2012). Three measurements were made for each sample. At 
least two biological replicates were carried out for each time point. Protein identification and 
quantification were performed using MaxQuant software (version 1.3.5.7) with standard 
settings (Cox and Mann, 2008) and searched against the UniProtKB/Swiss-Prot mouse database 
(generated from version 06-2012).  
DNase I-seq and ChIP-seq data analysis 
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Reads were mapped to the reference mouse genome (mm9) using BWA (Li, 2014) with default 
parameters and only uniquely mapped reads were kept. PCR duplicates were removed. MACS2 
(Zhang et al., 2008) was used to call peaks with parameters “--nomodel --broad”. Peaks were 
filtered based on peak score. Overlap peaks were merged if they are from ChIP-seq samples of 
the same antibody or DNase I-seq samples.  
RNA-seq data analysis 
MMSEQ package (Turro et al., 2011) was used to infer gene expression levels. Reads were 
mapped to mouse gene annotation (Ensemble release 67). MMDIFF (Turro et al., 2014) was 
used to calculate probability of differential expression with default settings. Genes were 
considered to be up regulated in 2i, if RPKM > 1 in each 2i biological replicate and probability > 
0.2.  
4C-Seq Data analysis 
To improve the mappability of the sequencing reads, we generated a reduced genome by 
extracting the sequences flanking the HindIII cutting sites (30bp on each strand from the HindIII 
cutting sites to downstream) based on the reference mouse genome (mm9). Then we evaluated 
the mappability of the extracted sequences (each strand separately) and only uniquely 
mappable HindIII cutting sites were considered for downstream analysis.  
All the reads from each library were parsed based on the bait-specific primer sequence and 
mapped to the reduced genome using BWA with the default parameters. 4C signals and 4C hits 
were calculated using a sliding window of a fixed number of HindIII fragments and normalized 
to the total number of uniquely mapped reads.  
 
Capture Hi-C data analysis 
Overview of analysis and file preparation 
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The two ends of paired-end reads were mapped to the reference mouse genome (mm9) 
separately, using BWA MEM (Li, 2014) with default parameters. Reads were filtered based on 
mapping quality score (both ends mapQ ≥ 10) and PCR duplicates were removed. Reads were 
removed if the two ends are from the same DpnII fragment. CHiCAGO CHi-C analysis package 
(http://regulatorygenomicsgroup.org/chicago) was used to call significant contacts. To improve 
quality, the whole genome was windowed into 5 DpnII site tiles. Virtual baits were created by 
merging adjacent targeted tiles. Interactions were filtered based on interaction score and 
number of reads (score ≥ 5 and at least 5 reads). Sliding window approach was used to a 
generate interaction profile from a given point of view.  
Interaction calling using CHiCAGO pipeline 
All Capture Hi-C data reported in this paper was generated using Illumina paired-end 
sequencing. The Illumina sequencer produces two fastq files, one for each read end. Each file is 
sorted by “read name”. The two fastq files were split into multiple chunks containing 1 million 
single end reads. The chunks then were mapped to the reference mouse genome (mm9) 
separately, using BWA MEM (Li, 2014) with default parameters. After filtering out reads based 
on mapping quality, PCR duplicates and self-ligations the remaining reads were called 
“informative reads”. We use these reads to calculate capture efficiency and do downstream 
analysis.  
We used the CHiCAGO pipeline, which is designed specifically for analyzing CHi-C data, on the 
set of informative reads. A manuscript on the CHiCAGO pipeline (Cairns et al., 2015) is publically 
available, with the pipeline itself publicly available at regulatorygenomicsgroup.org/chicago. 
Briefly, CHiCAGO uses a convolution noise model accounting for both 'Brownian' noise, that is 
dependent on the linear distance between the interacting fragments, and sequencing noise 
arising from assay artefacts. Each noise component is learned on different subsets of data with 
appropriate normalization. For Brownian noise, normalization scaling factors are computed for 
both “targeted” fragments (directly) and the other ends using pools (due to data sparsity) that 
are defined on the basis of the numbers of trans-interactions. Technical noise is computed 
separately for each pool of fragments defined on the basis of the numbers of trans-interactions. 
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Interaction p-values are then obtained from a one-tailed test on the convolution model. 
Multiple testing correction is performed through a p-value weighting procedure based on 
Genovese et al., 2006, to account for the fact that the majority of tests are performed for pairs 
of fragments separated by large linear distances or located on different chromosomes, where 
the expected true-positive rates are much lower than for closely spaced fragments. The 
dependence of the relative true-positive rates on distance was estimated based on signal 
reproducibility across multiple replicates of a blood cell promoter Capture Hi-C sample for a 
different study. CHiCAGO scores represent soft-threshold weighted log-p-values. A threshold of 
5 has been used to call interactions on basis of the enrichment of resulting promoter-
interacting fragments for the chromatin features of regulatory regions.  
To run CHiCAGO pipeline, “targeted” fragments and “non-targeted” fragments for the whole 
genome are needed as part of the input. Using DpnII, the mouse genome is digested into ~6.6 
million fragments, which is 8 times more compared to when HindIII is used as the restriction 
enzyme. To achieve a 3D map at single DpnII resolution, innumerous reads will be needed. 
Therefore, to lower the need of sequencing depth, we created “virtual targeted fragments” by 
merging adjacent targeted DpnII fragments and “virtual non-targeted fragments” using tiles of 
5 DpnII fragments. Besides the default threshold of 5 for the CHiCAGO score, we also called for 
at least 5 reads to support an interaction.  
Identification of ELRIs 
We defined Hox related extremely long-range interactions as ELRIs. Hence, we used the loci of 
the four Hox gene clusters as the viewpoints separately and did comprehensive identification of 
ELRI genes with a 4C-like analysis approach (Van De Werken et al., 2012). Firstly, we extracted 
the reads that one-end is from a given point of view (one of the four Hox gene clusters). 
Secondly, CHi-C signal was calculated using the numbers of di-tags in a sliding window of a 20 
DpnII fragments and normalized to sequencing depth; we also calculated the percentage of hits 
in the sliding window. ELRIs are extremely long-range interactions, hence the intrinsic 
background from CHi-C is virtually non-existent at these interacting loci. Considering the noise, 
a stringent cutoff for both CHi-C signal (at least 5) and percentage of hits (at least 15%) were 
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used to identify the candidates of ELRI loci. We filtered for differential long-range interactions 
between serum and 2i mESCs by calling for the sum of normalized di-tags in a sliding window of 
20 DpnII fragments with at least three fold changes. All the above parameters were used for the 
identification of ELRIs.  
Calculation of the strength of chromatin contact 
We defined the chromatin contact strength as the number of di-tags for the contact between 
two genomic fragments normalized to sequencing depth (100M informative reads), the length 
of the first fragment and the length of the second fragment. To avoid zero, 0.01 was added to 
the strength before performing log2.  
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Figure S1, related to Figure 1. Characteristics of the DHSs for probe design and reproducibility between CHi-C 
biological duplicates. (A) Venn diagram for DHSs in serum and 2i mESCs. CHi-C probes were designed against the 
union. (B) Genomic distribution of DHSs based on gene annotation and ChIP-seq of histone marks (C) 
SmoothScatter plots show the numbers of di-tags captured by each probe between experiments with high 
reproducibility. (D) SmoothScatter plots show the number of tags for each fragment pairs (fragments of 20kb binned 
genome) between biological replicates. (E) SmoothScatter plots show the number of tags for each called interaction 
between biological replicates, signifying high reproducibility. (F) Both top and bottom figures show high robustness 
between the normalized tag approach and Hit% approach. Top and bottom figures were generated using a sliding 
window of 30 DpnII and 100 DpnII fragments, respectively. Top and bottom figures together show high robustness 
when using different sizes of sliding window. (G) Virtual-4C plots showing ELRIs observed on chromosome 2 with 
high reproducibility between biological duplicates. The rate of the loss of ELRIs in the second experiment (rep2) for 
serum-to-2i transition was observed to be higher. (H) Heat-map of correlations for ELRI contacts between all CHi-C 
samples. (I) Non-ELRI contacts between H3K27me3 marked regions largely unchanged in serum and 2i mESCs.  
Figure S2, related to Figure 2. Comparison between CHi-C, in-lab generated 4C and 4C from public data sets. (A) 
4C validation of differential ELRI contact from HoxA locus to Vax2 and reverse, using 2 different baits for serum, 2i 
and Eed-/- mESCs. (B) 4C validation of differential ELRI contacts from HoxA locus to other ELRI genes highlighted 
using blue shaded area. (C) High correlation visualized between ELRIs detected by CHi-C and publically available 
4C data (Denholtz et al., 2013) for serum mESCs and Eed-/- mESCs. ELRIs detected from HoxD to other loci on 
chromosome 2 are highlighted by red bands. All ELRI contacts are represented as red arches.  
Figure S3, related to Figure 3. In-lab generated 4C validation for ELRIs detected by CHi-C on the complete serum-
to-2i transition and Eed-/- mESCs. (A) Loss of the interaction between HoxA and Vax2 revealed by CHi-C validated 
using 4C experiments on serum-to-2i transition and Eed-/- mESCs. (B) Loss of the interaction between HoxD and 
other ELRI loci revealed by CHi-C validated using 4C experiments on serum-to-2i transition and Eed-/- mESCs. All 
ELRI contacts are represented as red arches. (C) Bar plot showing the changes of whole cell protein levels of PRC 
components detected using quantitative Mass Spectroscopy for serum-to-2i transition. Y-axis represents Log2 fold 
change compared to serum mESCs. X-axis represents the time points during serum-to-2i transition (4hrs, 8hrs, 
16hrs, 24hrs, 32hrs and 18Days/2i mESCs after medium switch).  
Figure S4, related to Figure 4. Switching of chromatin state of ELRI promoters from serum to 2i pluripotent state. 
(A) Heat-map shows a gradual loss of H3K27me3 mark on Day1 and Day3 of serum-to-2i transition on all ELRI 
promoters. A subset of genes (black dash-lined boxes) show a gradual gain in H3K27ac during the transition. All 
ELRI genes with increased transcriptional activity in 2i form a part of the subset and are labeled in red. (B) Venn 
diagram showing high overlap between ELRI loci detected by our DHS-based CHi-C and promoter-based CHi-C in 
a parallel study (Schoenfelder et al., 2015).  
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Table S1, related to Figure 1. Experimental information of Capture Hi-C and 4C. The union of DHSs in serum and 
2i mESCs; all DpnII fragments targeted by CHi-C Probes; list of all virtual baits used; sequencing statistics of CHi-
C; list of all primers used for 4C. 
Table S2, related to Figure 1. Identification of ELRIs and annotation of ELRI genes. List of ELRI regions from 
CHiCAGO pipeline and virtual 4C analysis; list of all ELRI genes; all homeobox containing ELRI genes; all ELRI 
transcription factors;  
Table S3, related to Figure 4. ELRI genes that up-regulated in 2i. List of all ELRI genes with significantly increased 
transcriptional activity in 2i.  
 
	  
EXTENDED EXPERIMENTAL PROCEDURES 
DNase I-seq 
DNase I libraries were prepared as described in (Shen et al., 2002). Nuclei were isolated using Buffer A (15 mM 
NaCl, 60 mM KCl, 1 mM EDTA, pH 8.0, 0.5 mM EGTA, pH 8.0, 15 mM Tris-HCl, pH 8.0, 0.5 mM Spermidine) 
supplemented with 0.015 % IGEPAL CA-630 detergent. DNase I treatment was done for 3 minutes and the reaction 
was stopped with stop buffer (50 mM Tris-HCl, pH 8, 100 mM NaCl, 0.10 % SDS, 100 mM EDTA, pH 8.0, 1 mM 
Spermidine, 0.3 mM Spermine). The sample was further fractionated on 9% Sucrose gradient for 24 hours at 25000 
rpm at 16 °C. Fractions containing fragments smaller than 1kb were purified and processed according to the 
Illumina library preparation protocol. 
ss-DNA probe design for CHi-C 
ss-DNA probes were designed by Roche NimbleGen Inc. as a custom design. Probes were generated for the union of 
DNase I hotspots (~100,000) for serum and 2i mESCs (~250,000 tiled individual probes), hence providing coverage 
for all of the open chromatin (Table S1). The length of each probe was on an average 75 nucleotides. The probes 
were biotinylated for easy capture with streptavidin beads. Total size of the capture probe library was 41.9Mb. 
ChIP-seq 
ChIP experiments were carried out according to the protocol described (Marks et al., 2012). For Ring-1B and Suz12 
ChIPs, 6 million cells per ChIP were used; for H3K27me3, H3K4me1 and H3K27ac ChIPs, 1 million cells per ChIP 
were used. The antibodies used are as follows: Anti-Ring1B (D22F2) antibody from Cell Signaling and 5µl was 
used per ChIP; Anti-Suz12 (ab1207) antibody from Abcam and 3µl was used per ChIP; Anti-H3K27me3 (07-449) 
antibody from Upstate (Millipore) and 3µl was used per ChIP; Anti-H3K27ac (C15410196-10) and Anti-H3K4me1 
(CS-037-100) antibodies from Diagenode and 3µl was used per ChIP. 
RNA-seq 
Total RNA was extracted using RNeasy mini kit (QIAGEN) following the manufacturer’s instructions. 5ug of 
extracted RNA was depleted from ribosomal RNA using Ribo-Zero Gold Kit (Epicentre Madison, Winsconsin, 
USA). Then, rRNA-depleted RNA was used for library preparation using the TruSeq RNA Sample Prep Kit 
(Illumina) following the manufacturer’s instructions. Libraries were indexed using NEXTflex adapters (Bioo-
Scientific Corporation, Austin, TX, USA) and 43bp paired-end sequencing was performed on Illumina instruments 
using TruSeq reagents (Illumina, San Diego, CA, USA), according to manufacturer’s instructions. 
4C-Seq 
4C assays were performed as described previously (Splinter et al., 2012) with minor modifications. Briefly, 10 
million cells were cross-linked for 10 minutes with 2% paraformaldehyde, quenched with glycine and lysed in 50 ml 
lysis buffer (10mM Tris pH 7.5, 10mM NaCl, 2% NP-40, 1X protease inhibitors) for 30 minutes. Nuclei were then 
digested with 800U HindIII enzyme followed by 4 hours ‘in nuclei’ ligation at 16˚ C with 2000U T4 ligase (NEB) 
(Nagano et al., 2015). Reverse crosslinked and purified DNA was further digested with 50U DpnII enzyme, 
followed by circularization. 3200ng of 4C library was amplified with bait-specific inverse primers (Table S1), 
pooled and purified. Amplified library was adaptor ligated, PCR amplified (8 cycles) and paired-end sequenced on 
the Illumina NextSeq 500 to obtain 50bp x2 long reads.  
Quantitative Mass Spectrometry 
Total proteins for each sample were isolated and tryptic digested following a published label-free proteomics 
protocol (Liu et al., 2012). Three measurements were made for each sample. At least two biological replicates were 
carried out for each time point. Protein identification and quantification were performed using MaxQuant software 
(version 1.3.5.7) with standard settings (Cox and Mann, 2008) and searched against the UniProtKB/Swiss-Prot 
mouse database (generated from version 06-2012).  
DNase I-seq and ChIP-seq data analysis 
Reads were mapped to the reference mouse genome (mm9) using BWA (Li, 2014) with default parameters and only 
uniquely mapped reads were kept. PCR duplicates were removed. MACS2 (Zhang et al., 2008) was used to call 
peaks with parameters “--nomodel --broad”. Peaks were filtered based on peak score. Overlap peaks were merged if 
they are from ChIP-seq samples of the same antibody or DNase I-seq samples.  
RNA-seq data analysis 
MMSEQ package (Turro et al., 2011) was used to infer gene expression levels. Reads were mapped to mouse gene 
annotation (Ensemble release 67). MMDIFF (Turro et al., 2014) was used to calculate probability of differential 
expression with default settings. Genes were considered to be up regulated in 2i, if RPKM > 1 in each 2i biological 
replicate and probability > 0.2.  
4C-Seq Data analysis 
To improve the mappability of the sequencing reads, we generated a reduced genome by extracting the sequences 
flanking the HindIII cutting sites (30bp on each strand from the HindIII cutting sites to downstream) based on the 
reference mouse genome (mm9). Then we evaluated the mappability of the extracted sequences (each strand 
separately) and only uniquely mappable HindIII cutting sites were considered for downstream analysis.  
All the reads from each library were parsed based on the bait-specific primer sequence and mapped to the reduced 
genome using BWA with the default parameters. 4C signals and 4C hits were calculated using a sliding window of a 
fixed number of HindIII fragments and normalized to the total number of uniquely mapped reads.  
 
Capture Hi-C data analysis 
Overview of analysis and file preparation 
The two ends of paired-end reads were mapped to the reference mouse genome (mm9) separately, using BWA 
MEM (Li, 2014) with default parameters. Reads were filtered based on mapping quality score (both ends mapQ ≥ 
10) and PCR duplicates were removed. Reads were removed if the two ends are from the same DpnII fragment. 
CHiCAGO CHi-C analysis package (http://regulatorygenomicsgroup.org/chicago) was used to call significant 
contacts. To improve quality, the whole genome was windowed into 5 DpnII site tiles. Virtual baits were created by 
merging adjacent targeted tiles. Interactions were filtered based on interaction score and number of reads (score ≥ 5 
and at least 5 reads). Sliding window approach was used to a generate interaction profile from a given point of view.  
Interaction calling using CHiCAGO pipeline 
All Capture Hi-C data reported in this paper was generated using Illumina paired-end sequencing. The Illumina 
sequencer produces two fastq files, one for each read end. Each file is sorted by “read name”. The two fastq files 
were split into multiple chunks containing 1 million single end reads. The chunks then were mapped to the reference 
mouse genome (mm9) separately, using BWA MEM (Li, 2014) with default parameters. After filtering out reads 
based on mapping quality, PCR duplicates and self-ligations the remaining reads were called “informative reads”. 
We use these reads to calculate capture efficiency and do downstream analysis.  
We used the CHiCAGO pipeline, which is designed specifically for analyzing CHi-C data, on the set of informative 
reads. A manuscript on the CHiCAGO pipeline (Cairns et al., 2015) is publically available, with the pipeline itself 
publicly available at regulatorygenomicsgroup.org/chicago. Briefly, CHiCAGO uses a convolution noise model 
accounting for both 'Brownian' noise, that is dependent on the linear distance between the interacting fragments, and 
sequencing noise arising from assay artefacts. Each noise component is learned on different subsets of data with 
appropriate normalization. For Brownian noise, normalization scaling factors are computed for both “targeted” 
fragments (directly) and the other ends using pools (due to data sparsity) that are defined on the basis of the numbers 
of trans-interactions. Technical noise is computed separately for each pool of fragments defined on the basis of the 
numbers of trans-interactions. Interaction p-values are then obtained from a one-tailed test on the convolution 
model. Multiple testing correction is performed through a p-value weighting procedure based on Genovese et al., 
2006, to account for the fact that the majority of tests are performed for pairs of fragments separated by large linear 
distances or located on different chromosomes, where the expected true-positive rates are much lower than for 
closely spaced fragments. The dependence of the relative true-positive rates on distance was estimated based on 
signal reproducibility across multiple replicates of a blood cell promoter Capture Hi-C sample for a different study. 
CHiCAGO scores represent soft-threshold weighted log-p-values. A threshold of 5 has been used to call interactions 
on basis of the enrichment of resulting promoter-interacting fragments for the chromatin features of regulatory 
regions.  
To run CHiCAGO pipeline, “targeted” fragments and “non-targeted” fragments for the whole genome are needed as 
part of the input. Using DpnII, the mouse genome is digested into ~6.6 million fragments, which is 8 times more 
compared to when HindIII is used as the restriction enzyme. To achieve a 3D map at single DpnII resolution, 
innumerous reads will be needed. Therefore, to lower the need of sequencing depth, we created “virtual targeted 
fragments” by merging adjacent targeted DpnII fragments and “virtual non-targeted fragments” using tiles of 5 
DpnII fragments. Besides the default threshold of 5 for the CHiCAGO score, we also called for at least 5 reads to 
support an interaction.  
Identification of ELRIs 
We defined Hox related extremely long-range interactions as ELRIs. Hence, we used the loci of the four Hox gene 
clusters as the viewpoints separately and did comprehensive identification of ELRI genes with a 4C-like analysis 
approach (Van De Werken et al., 2012). Firstly, we extracted the reads that one-end is from a given point of view 
(one of the four Hox gene clusters). Secondly, CHi-C signal was calculated using the numbers of di-tags in a sliding 
window of a 20 DpnII fragments and normalized to sequencing depth; we also calculated the percentage of hits in 
the sliding window. ELRIs are extremely long-range interactions, hence the intrinsic background from CHi-C is 
virtually non-existent at these interacting loci. Considering the noise, a stringent cutoff for both CHi-C signal (at 
least 5) and percentage of hits (at least 15%) were used to identify the candidates of ELRI loci. We filtered for 
differential long-range interactions between serum and 2i mESCs by calling for the sum of normalized di-tags in a 
sliding window of 20 DpnII fragments with at least three fold changes. All the above parameters were used for the 
identification of ELRIs.  
Calculation of the strength of chromatin contact 
We defined the chromatin contact strength as the number of di-tags for the contact between two genomic fragments 
normalized to sequencing depth (100M informative reads), the length of the first fragment and the length of the 
second fragment. To avoid zero, 0.01 was added to the strength before performing log2.  
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CHAPTER 4 
ROLE OF DNA METHYLATION AND CBX7 ON EXTREMELY 
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ABSTRACT 
Studies of the 3D organization of chromatin led to identification of extremely long-range 
interactions (ELRIs) involving Hox loci in serum-cultured mESCs (Joshi et al., 2015; Schoenfelder 
et al., 2015a; Vieux-Rochas et al., 2015). The features of ELRI loci are the presence of high levels 
of the H3K27me3 histone mark along with occupancy of PRC2 and PRC1. Transition of mESCs 
from the serum-cultured (‘primed’) state of pluripotency to the 2i-cultured (‘ground’) state of 
pluripotency led to complete abolishment of these interactions (Joshi et al., 2015).  
Here, we show that in serum-cultured Dnmt3KO mESCs the loss of DNA methylation and 
consequent loss of localized H3K27me3 accumulation results in loss of ELRI corroborating the 
critical role of H3K27me3 in ELRI. Knock-out of Cbx7, a component of canonical PRC1 involved 
in anchoring of PRC1 to H3K27me3 loci via its chromodomain, results in reduction of Ring1B 
recruitment (a core component of PRC1) to ELRI and other bivalent loci but, only marginally 
affects ELRI. Cbx7 however contributes to establishment of ELRI during acquisition of 
H3K27me3 when moving from the 2i-to-serum state mESCs. We observed that the level of PRC2 
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monitored by Suz12, does not recover to levels observed in mESCs that are established and 
long-term cultured in serum. The experiments show that Cbx7 may play an important role in 
establishment or maintenance of ELRIs in primed pluripotent stem cells. 
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INTRODUCTION 
Serum-to-2i interconversion of mouse Embryonic Stem Cells (mESCs) is a valuable in vitro 
model for early embryonic development. mESCs are classically cultured in media supplemented 
with fetal calf serum and leukemia Inhibitory Factor (LIF) but, more recently in serum-free 2i 
medium that contains LIF plus 2 small-molecule kinase inhibitors: PD0325901 targeting 
mitogen-activated protein kinase (MEK) pathway and CHIR99021 targeting glycogen synthase 
kinase-3 (GSK3) pathway (Ying et al., 2008). It is well accepted that 2i mESCs represent a 
‘ground-state’ of pluripotency, whereas the classical serum-derived mESCs are reminiscent of 
‘post-implantation’ pluripotent stem cells (often referred to as ‘primed’ ( Ying et al., 2008; 
Nichols and Smith, 2009; Habibi et al, 2013; Marks and Stunnenberg, 2014; Marks et al., 2012; 
Odsworth et al., 2015; Plusa and Hadjantonakis, 2014). In recent studies, we and others have 
shown that the closely related pluripotent serum- and 2i-cultured mESCs (referred to as serum 
and 2i ESCs) have remarkably distinct epigenetic features (Marks et al 2012; Habibi et al., 2013) 
as well as a highly dynamic extreme long-range chromatin interactions structure (ELRI) (Joshi et 
al., 2015; Schoenfelder et al., 2015b).  
The 3D chromatin architecture has been reported to play an important role in establishing and 
maintaining distinct epigenetic landscapes in various cell types. Studies have shown that these 
changes in the 3D chromatin architecture are often inside the functional interaction domains, 
called - topologically associated domains (TADs), for fine tuning of gene expression at relatively 
small distances (Bickmore, 2013; Dixon et al., 2015; Gibcus and Dekker, 2013). Interestingly, our 
capture Hi-C experiments (Joshi et al., 2015) and other studies  (Schoenfelder et al., 2015b; 
Vieux-Rochas et al., 2015), revealed the presence of ELRIs which range from inter-TAD, Mega-
base long interaction contacts, to inter-chromosomal interactions in serum mESCs (Joshi et al., 
2015; Schoenfelder et al., 2015b; Vieux-Rochas et al., 2015). These ELRIs connect 108 protein 
coding genes including the Hox cluster as well as 93 non-coding genes at extreme linear 
distances or between distinct chromosomes. In ground-state 2i mESCs, these ELRIs are absent.  
The defining features of genomic loci that are involved in ELRIs are the presence of high levels 
of the H3K27me3 histone modification and the PRC2 and PRC1 complexes (Denholtz et al., 
123 
 
2013; Joshi et al., 2015; Schoenfelder et al., 2015b; Vieux-Rochas et al., 2015). To investigate 
the role of PRC2 we previously performed capture Hi-C on Eed knock-out mESCs grown in 
serum, and observed a complete loss of ELRIs. Similarly, Schoenfelder et al., 2015 showed 
abolishment of ELRI in Ring1A-Ring1B double knock-out mESCs. Taken together, these studies 
suggest important roles for PRC1 and PRC2 complexes in establishment/maintenance of ELRIs. 
However, the presence of H3K27me3 and PRC1/2 at many non-ELRI genomic loci at levels 
similar to that on ELRI loci suggests that the composition of factors binding to ELRI and non-ELRI 
loci is different. Furthermore, the basis and biological significance of ELRI is still elusive.  
PRCs play important roles in regulating expression of various genes including the Hox gene 
cluster, which control differentiation and body segmentation pattern (Morey et al., 2012, 
2015). PRCs are a complex group of protein with a high degree of modularity. PRC2 has three 
core components: Suz12, Eed and Ezh2/1 and can include 6 additional associated peptides 
depending on cell type and function (Cao and Zhang, 2004; Smits et al., 2013). PRC2 is recruited 
in a sequence specific manner to so-called PRE-elements and to? coding/non-coding RNA 
(Aranda et al., 2015; Morey et al., 2012, 2015; Simon and Kingston, 2009). Furthermore, PRC2 
recruitment to low DNA methylation sites and CpG islands has been established, yet the basis 
of PRC2 recruitment is not fully understood.  
PRC1 complexes contain two core component proteins: Ring1A/B and PCGF1-6 proteins. The 
PRC1 family can be divided into canonical PRC1 (cPRC1) and non-canonical PRC1 (ncPRC1) (Gao 
et al., 2012a, 2012b). cPRC1 are PRC1 complexes that contain one of five Cbx proteins as 
primary chromatin recruiters. These Cbx proteins have a chromo-domain responsible for 
recognition and binding to methylated lysine marks. The Cbx protein mediated recruitment of 
cPRC1 to the chromatin is often referred to as the ‘classical’ pathway of PRC recruitment. In this 
scenario, the recruitment of cPRC1 is conditional to H3K27me3 deposition by PRC2 complex 
(Gao et al., 2012b). In contrast, ncPRC1 recruitment is not PRC2 dependent but believed to be 
locus specific and dependent on PRC1 associated proteins (Tavares et al., 2012). In the absence 
of any Cbx protein, ncPRC1 recruitment is reported to be dependent on the YY1 or RYBP 
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proteins and independent of H3K27me3 (Aranda et al., 2015; Gao et al., 2012b; Wang et al., 
2010). 
 
 
Interestingly, in serum mESCs, ELRI loci as well as other bivalent loci have to a certain extent 
overlapping levels of PRC1/2 and H3K27me3 deposition. The question that arises is, ‘given a 
similar Suz12 and Ring1B composition and abundance at certain loci, what determines a locus 
as ELRI selective loci?’  
We have previously shown that ELRIs are maintained in WT serum mESCs and abolished in WT 
2i mESCs (Joshi et al., 2015). Several scenarios have been postulated for selective presence of 
ELRIs in serum mESCs compared to 2i mESCs. One scenario is that serum mESCs have a special 
protein composition and/or conformation of PRC1/2, capable of producing ELRIs. Another 
scenario is that a higher local  concentration of H3K27me3 and PRC1/2 factor at ELRI loci is 
responsible for ELRIs observed in serum mESCs (Joshi et al., 2015; Vieux-Rochas et al., 2015). 
We and others have previously shown the importance of the PRC complexes in ELRI regulation, 
as Knock-out (KO) of Eed -/- and double KO of Ring1A/B abolish ELRI in mESCs (Joshi et al., 
2015; Schoenfelder et al., 2015b).  
One possibility is that a specific PRC1/2 complex composition mediates ELRI versus non-ELRI 
interactions and/or that a certain level of H3K27me3 is required to detect/obtain ELRI. 
Therefore, we wanted to identify the factors, the mechanisms of establishment and 
maintenance of ELRI. To decipher the link between PRC1 recruitment and ELRIs we used 
CRISPR/Cas system to knock-out Cbx7, a potentially recruiter of cPRC1 to Hox and other ELRI 
loci, in mESCs. 
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RESULTS & DISCUSSION 
EFFECT OF DNA METHYLATION LOSS ON ELRI  
One of the most prominent differences in serum versus 2i mESCs is that 2i mESCs are highly 
hypo-methylated compared to serum mESCs (Habibi et al., 2013). It has been reported that loss 
of DNMT activity leads to loss of localized deposition of high levels of H3K27me3 and spreading 
of this mark (Brinkman et al., 2012; Hagarman et al., 2013; Reddington et al., 2013). We 
therefore investigate a ‘mimic’ of DNA hypo-methylated state of 2i mESCs, i.e. Dnmt triple 
knock-out mESCs (DnmtTKO or TKO mESCs) grown in serum condition, to assess a possible 
direct or indirect involvement of ‘DNA hypomethylation mediated dilution of H3K27me3’ 
(citation), in maintenance of ELRIs. We therefore assessed ELRIs in serum grown ‘DnmtTKO’ 
mESCs (Dnmt1, Dnmt3A, Dnmt3B triple knock-out).  
The H3K27me3 profiles of hypo-methylated DnmtTKO serum mESCs and 2i grown WT mESCs 
show similar trends. In both conditions, we find reduction of H3K27me3 deposition at ELRI and 
other bivalent genes, including the Hox cluster (Figures 1A and (Joshi et al., 2015)). Given the 
significant reduction of local deposition of H3K27me3, we investigated whether ELRIs are 
established in DnmtTKO serum mESCs and performed 4C experiment on the HoxD locus. Note 
that we do not actively alter the expression of components of the PRC1/2 complexes. As can be 
observed from the Figure 1C, loss of ELRIs interaction is evident in DnmtTKO serum mESCs 
mimicking the 4C interaction profile observed in WT 2i mESCs. Comparing the quantitated 
intensity of interactions strength for HoxD locus showed that the strength of interactions in 
DnmtTKO serum mESCs is almost completely abolished, compared to WT serum mESCs, to 
levels even lower than those observed for WT 2i mESCs (Figure 1D).  
Thus, we tentatively conclude that the loss of ELRIs in WT 2i mESCs and by extension in 
DnmtTKO serum mESCs is due to loss of H3K27me3. Thus, loss of DNA methylation causes a 
change in long-range interactions (ELRIs) and 3D chromatin structure in embryonic stem cells. 
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Role of H3K27me3 binding protein CBX7 in ELRI  
Knock-out (KO) of Eed -/-, the enzyme depositing H3K27me3 has clearly shown the importance 
of H3K27me3 and PRC2 in ELRI. This is further underpinned by the observation that in serum 
mESCs (DnmtTKO) causing DNA hypomethylation leads to reduction of localized high 
H3K27me3 deposition and loss of ELRI. Analysis of the Ring1a/b double knock out showed that 
PRC1 is essential in ELRI (Schoenfelder et al., 2015b). Interestingly, we observed that bivalent 
genes which do not display ELRIs also have occupancy of PRC1 and PRC2 similar to that of ELRI 
loci, yet do not display an ELRI structure (Joshi et al., 2015).   
The protein(s) and mechanisms involved in recruitment of PRC1 and formation of ELRI have not 
been studied in detail. Obvious candidates for recruitment of cPRC1 to the ELRI loci are the Cbx 
class of PRC1 associated proteins that contain a chromodomain capable of recognizing 
H3K27me3 histone modification and hence can recruit PRC1. The most robustly expressed Cbx 
protein in pluripotent mESCs grown in serum conditions is Cbx7 (Morey et al., 2012, 2013).  
Cbx7 is a repressor of the Cbx genes Cbx2/4/8, and the latter repress self-renewal and 
pluripotency genes during differentiation initiation. Cbx7 furthermore represses genes involved 
in lineage specification, which include many ELRI genes (Morey et al., 2012). Furthermore, the 
Morey et al 2011 study has shown recruitment of Cbx7 to the Hox clusters and complete loss of 
Cbx7 recruitment at the same loci in Eed -/- mESCs.  
To gain first insight into a role of Cbx7 in ELRI, we performed ChIP-seq experiments on serum-
to-2i transition using a Cbx7 antibody. Cbx7 occupancy at Hox clusters as well as at other ELRI 
loci is high in serum and strongly reduced in 2i ESCs (Figure 2A). This significant loss of Cbx7 at 
ELRI and non-ELRI loci is in line with loss of H3K27me3 and Ring1B in 2i ESCs (Marks, et al, 2012; 
Joshi et al., 2015). Next, we prepared a CRISPR-Cas knock-out (KO) for Cbx7 in E14 mESCs 
background by deleting exons 5 to 7 that are shared by all mRNA isoforms of Cbx7 (Figure 2C). 
Colonies were picked, sequenced and tested by western-blot using anti-Cbx7 antibody (Figure 
2D). To assess the occupancy of PRC1/2 complexes, we generated ChIP-seq profiles for Ring1B 
(core PRC1 component) and Suz12 (core PRC2 component). Comparison of normalized Ring1B 
profiles between serum mESCs, 2i mESCs and Cbx7KO mESCs on the Hox clusters shows a small 
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loss of the PRC1 component Ring1B in Cbx7KO mESCs (Figure 3A and B). Suz12 recruitment at 
the Hox cluster in Cbx7KO mESCs does not seem to be grossly affected compared to serum 
mESCs (Figure 3A and C).  
Quantification of the occupancy of the PRC2 component Suz12 at ELRI and at other H3K27me3 
decorated loci showed that the level is not significantly affected by Cbx7KO in mESCs grown in 
serum compared to WT serum mESCs (Figure 3C). These observations are in line with studies 
that show that Cbx7 does not play a significant role in the ‘canonical’ pathway of PRC2 
recruitment (Aranda et al., 2015). In contrast, the levels of Ring1B are slightly reduced in 
Cbx7KO mESCs at the ELRI loci in serum as compared to wild type mESCs (Figure 3A and 3B). 
However, Ring1B occupancy is also proportionally reduced at other bivalent, non-ELRI loci, 
implying a more general reduction in recruitment of PRC1. A loss in occupancy by Ring1B is 
expected, if Cbx7 is the ‘recruiter arm’ of the cPRC1. The occupancy of Ring1B in Cbx7KO serum 
suggests that other Cbx family members are able to recruit the PRC1 complex to H3K27me3 
loci. The possible alternative recruitment of Ring1B by other Cbx protein, other than Cbx7, must 
be confirmed and tested by further transcriptomic and proteomic studies.  
ELRI in CBX7KO SERUM ESC is largely maintained  
In an earlier study, we have described ELRI using capture Hi-C and validated the interactions by 
4C in serum ESCs between HoxD, HoxA and ELRI genes such as Bmi1, Lmx1b, Lhx2, Pax6, Meis2 
as well as Vax2, Dlx5/6 respectively. Visual inspection of the 4C analysis shows that ELRI is 
detectable in Cbx7KO mESCs grown in serum although the signal-strength of the 4C interaction 
was more variable being reduced at some interaction loci such as Lmx1B and Atoh1, and 
increased at others loci such as Pax6 (Figure 3D, 3E). Quantification of the signal intensity of 
interactions involving HoxD and HoxA loci corroborated and extended the notion that ELRI 
interactions are more variable in Cbx7KO.  The lower but appreciable level of ELRI suggests that 
Cbx7 plays only a minor role in maintenance of ELRIs.  
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PRC1/2 DYNAMICS AND ELRIs IN Cbx7KO CONTEXT DURING SERUM-2i-SERUM TRANSITION 
ChIP-seq profiling of PRC components showed only marginal differences between WT serum 
mESCs and Cbx7KO mESCs grown in serum conditions. 4C interaction experiments on Cbx7KO 
serum mESCs suggest that the chromo-domain containing PRC1 associated protein Cbx7 does 
not play an essential role in maintenance of ELRIs. However, our experiments do not rule out 
the possibility that Cbx7 might play a role in initiation of ELRIs. To investigate a potential role of 
Cbx7 during initiation/establishment of H3K27me3 and ELRIs, Cbx7KO mESCs were grown in 2i 
media condition for 14 days to abolish ELRIs and subsequently transferred back to serum 
conditions to assess the (re)gain of Ring1B (PRC1) and Suz12 (PRC2) by ChIP-seq and ELRIs by 
4C.  
Visual inspection of the occupancy of Ring1B and Sux12 on ELRI loci, from 2i (no or low 
H3K27me3) to serum (regain of H3K27me3) in Cbx7KO mESCs, showed significant gain of 
Ring1B and Suz12 at most ELRI loci (Figure 4A). The visual trends were confirmed by 
quantification, showing that the levels of Ring1B on ELRI loci, during this transition experiment 
returned to the approximate mean of original serum grown Cbx7KO mESCs, with a few loci 
showing higher variance (Figure 4B). Ring1B deposition on other bivalent genes (non-ELRI) did 
not fully recover to the levels observed in the original Cbx7KO mESCs grown in serum condition 
(Figure 4B). This suggests that levels of Ring1B show higher propensity to recover to original 
levels for ELRI loci upon transition from Serum-2i-Serum condition in Cbx7KO mESCs, unlike 
trend seen on non ELRI (other bivalent) loci. Quantitation of Suz12 during serum-2i-serum 
transition of Cbx7KO mESCs showed the expected initial loss of Suz12 at ELRI and bivalent loci 
during transition from serum to 2i. Unexpectedly, deposition of Suz12 during did not recover to 
the levels observed in the original Cbx7KO mESCs grown in serum condition upon return to 
serum conditions in ELRI or bivalent loci (Figures 4A, 4C). Also, the levels of Suz12 in Cbx7KO 
mESCs never dropped to levels observed in WT 2i mESCs. 
The dynamic of ELRIs upon return from 2i to serum condition was tested by 4C experiments 
(Figures 4D, 4E) targeting HoxA and HoxD clusters. The 4C interaction profiles during serum to 
2i showed a near complete abolishment of ELRIs. During the reverse transition of 2i grown 
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Cbx7KO mESCs back to serum, ELRI loci do not show significant interactions (Figures 4D,4E), for 
example, the 4C signal at Vax2 locus was severely reduced (Figure 4E). Similarly, interactions 
between HoxD locus and ELRI loci such as Bmi1, Lmx1B and Pax6 did not recover to the 
strengths observed in original Cbx7KO mESCs grown in serum condition (Figure 4D).  
This anomalous ELRI profiles during re-establishment of ELRIs in Cbx7KO context might be a 
reflection of the altered recruitment of Ring1B and Suz12. A serum-2i-serum transition of WT 
mESCs would be needed to confirm the significance of the observations with the Cbx7KO 
mESCs. Also, further research would be necessary to decipher the precise role of Cbx7 in 
recruitment of PRC1 and PRC2 complex as well as its complex relationship with ELRIs.   
 
DISCUSSION AND CONCLUSION  
In this study, we set out to decipher the role of H3K27me3’ as well as Cbx7 in ELRI. We showed 
that in DNA hypo-methylated conditions in DnmtTKO serum mESCs (mimicking WT 2i mESCs 
with respect to DNA methylation) ELRIs are not observed at intensity comparable to WT serum 
mESCs. This suggests that due to hypo-methylation of DNA, localized high H3K27me3 levels are 
diminished due to a general carpeting of the histone marks and consequently PRC2 and PRC1. 
This observation shows that without tampering with the polycomb machinery, 
dilution/redistribution of H3K27me3 is enough to abolish ELRIs in serum ESCs, showing the 
importance of high local occupancy of H3K27me3 and PRC1/2 components to establish ELRI. 
Cbx7KO serum mESCs showed a lower, but not abolished Ring1B occupancy (PRC1 component) 
at ELRI as well as bivalent loci. The data show that Cbx7 does not play an essential role in 
maintenance of ELRIs and that Cbx7 is not the only recruiter of cPRC1 to the ELRI loci; other Cbx 
proteins have likely taken over that role from Cbx7. As Cbx7 has been shown to repress 
Cbx2/4/8, loss of Cbx7 likely has led to increased expression and compensation of cPrc1 
recruitment, although RNA-seq experiments need to be performed to validate. Another 
explanation of the results could be that Ring1B recruitment and ELRI maintenance is partly 
driven by ncPRC1 that is independent of any Cbx recruitment proteins. 
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Interestingly, establishment/initiation of ELRIs in Cbx7KO mESCs upon return from 2i ESCs to 
serum showed that ELRIs are not established in Cbx7KO cells (or much slower?). Puzzling is the 
observation that Suz12 is not restored to serum levels. Comparison with WT mESCs going 
through the same culturing regime is required.  Whether Cbx7 indeed plays a role during 
initiation and establishment of ELRIs remains to be rigorously assessed.  
 
 
MATERIALS AND METHODS 
CELL CULTURE 
E14 Tg2a (E14) is a male ES cell line of 129 background. Serum (E14) mESCs were grown in 
DMEM containing 10% fetal-calf serum in presence of LIF, together called ‘serum medium’. 2i 
(E14) mESCs were grown in serum free NDiff 227 supplemented with MEK inhibitor PD0325901 
(1µM) and GSK3 inhibitor CHIR99021 (3µM) in presence of LIF, together called ‘2i medium’ 
(Ying et al., 2008). Cbx7KO mESCs were generated by deletion of 3 exons using CRISPR-cas 
strategy (Figure 1D) in serum (E14) mESCs. Detailed strategy for developing Cbx7KO mESCs is 
provided in section ‘Generating Cbx7KO mESCs using CRISPR-cas strategy’.  All cell-culture was 
conducted in feeder-free condition. Serum-to-2i transition was carried out by washing the 
mESCs in serum medium twice with PBS and then switching to 2i Medium. The generation and 
culture conditions for DnmtTKO mESCs (TKO mESCs) has been previously described in Tsumura 
et al., 2006. 
CHIP-SEQ AND DATA ANALYSIS 
All experiments were carried out with 6 million cells according to the protocol described (Marks 
et al., 2012). All ChIPs were carried out using 3µg or 5µg of antibody. For Ring-1B and Suz12 
ChIPs, 6 million cells per ChIP were used. For H3K27me3, H3K4me1 and H3K27ac ChIPs, 1 
million cells per ChIP were used. The antibodies used are as follows: Anti-Ring1B (D22F2) 
antibody from Cell Signaling and 5ul was used per ChIP; Anti-Suz12 (ab1207) antibody from 
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Abcam and 3ul was used per ChIP; Anti-H3K27me3 (07-449) antibody from Upstate (Millipore) 
and 3ul was used per ChIP; Anti-H3K27ac (C15410196-10) and Anti-H3K4me1 (CS-037-100) 
antibodies from Diagenode and 3ul was used per ChIP. 
Reads were mapped to the reference mouse genome (mm9) using BWA (Li, 2014) with default 
parameters and only uniquely mapped reads were kept. PCR duplicates were removed. MACS2 
(Zhang et al., 2008) was used to call peaks with parameters “--nomodel --broad”.  Peaks were 
filtered based on peak score. 
 
4C-SEQ AND DATA ANALYSIS 
4C assays were performed as described previously (Splinter et al., 2012; Van De Werken et al., 
2012)  with minor modifications. Briefly, 10 million cells were cross-linked for 10 minutes with 
2% paraformaldehyde, quenched with glycine and lysed in 50 ml lysis buffer (10mM Tris pH 7.5, 
10mM NaCl, 2% NP-40, 1X protease inhibitors) for 30 minutes. Nuclei were then digested with 
800U HindIII enzyme followed by 4 hours ‘in nuclei’ ligation at 16˚ C with 2000U T4 ligase (NEB) 
(Nagano et al., 2015). Reverse crosslinked and purified DNA was further digested with 50U 
DpnII enzyme, followed by circularization. 3200ng of 4C library was amplified with bait-specific 
inverse primers (Table S1), pooled and purified. Amplified library was adaptor ligated, PCR 
amplified (8 cycles) and sequenced paired-end on the Illumina NextSeq 500 to obtain 50bp long 
reads.   
To improve the mappability of the sequencing reads, we generated a reduced genome by 
extracting the sequences flanking the HindIII cutting sites (30bp on each strand from the HindIII 
cutting sites to downstream) based on the reference mouse genome (mm9). Then we evaluated 
the mappability of the extracted sequences (each strand separately) and only uniquely 
mappable HindIII cutting sites were considered for downstream analysis. 
All the reads from each library were parsed based on the bait-specific primer sequence and 
mapped to the reduced genome using BWA with the default parameters. 4C signals and 4C hits 
were calculated using a sliding window of a fixed number of HindIII fragments and normalized 
to the total number of uniquely mapped reads.  
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The primers used in the study were taken from Denholtz et al., 2013, and are as follows: 
HoxDFwP1 GAGACTGGTGGTCAGCTCTTG 
HoxDFwP2 GAGTCGTGGTTACAGAGTGCAg 
 
HoxAFwP1 CCTGAGTAGGCCCTTACaagc 
HoxAFwP2 TTGCTCAGCCAGTCTCAATG 
 
CRISPR-CAS KNOCK-OUT OF CBX7 TO GENERATE CBX7KO mESCs 
The strategy used for knock-out of Cbx7 has been illustrated in Figure 1D. sgRNAs were 
designed on different exons(exon 4, exon5  and and exon6) of Cbx7 according to 
http://crispr.mit.edu/ and referenced from GeCKO pool  to make sure all the Cbx7 isofroms 
would be ruined,  then ligated to the vector pSpCas9(BB)-2A-Puro (PX459) V2.0  (Addgene 
62988) from Feng Zhang’s lab and followed the published protocol (Cong et al., 2013). Totally, 
3ug constructed plasmids were co-transfected to 1 million E14 serum mESCs with 7.5ul 
Lipofectamine 3000 Reagent then selected by 1ug/ml puromycin 2 to 3 days. Single cell colonies 
were picked after recovering in normal medium for 2 days from puromycin treated population. 
To identify the CbxKO cell lines, we designed the PCR primers on genome which cover the 
whole targeted exons. The genome PCR from double allele KO cell lines will show a shorter 
band (around 400bp) without WT PCR bands(around 5kb) on agarose gel. Then the PCR 
products were gel purified and verified by sanger sequence. Finally, the candidate cell lines 
were verified by western blot. 
The oligos and primers used for the knock-out were: 
330-Cbx7-exon4-F1 CACCGcttggaccctcgccttgtca 
330-Cbx7-exon4-R1 AAACtgacaaggcgagggtccaagC 
330-Cbx7-exon4-F2 CACCGcgtaggccatgacaaggcga 
330-Cbx7-exon4-R2 AAACtcgccttgtcatggcctacgC 
330-Cbx7-exon5-F1 CACCGacctctcttcctataccccg 
330-Cbx7-exon5-R1 AAACcggggtataggaagagaggtC 
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330-Cbx7-exon6-F1 CACCgcctatggagcaagcccccg 
330-Cbx7-exon6-R1 AAACcgggggcttgctccataggc 
Cbx7-exon4-seqF1 tctgcagtaggagtcttgattgc 
Cbx7-exon4-seqR1 caatcaaatcaatccctcctcaca 
Cbx7-exon4-sanger-R tccttctttaatagggcaag 
Cbx7-exon5-seqF1 tatggacagtcttggttttctgaga 
Cbx7-exon5-seqR1 tttgcaagatcccttctattgaaatgt 
Cbx7-exon5-sanger-F actgacagaagttgaatgtc 
Cbx7-exon6-F aagggcaatgagaagctctgcttct 
Cbx7-exon6-sanger-R tagctatagcagaatgggcagg 
Cbx7-exon6-R acgcttgaagcaggatgctttagga 
 
PUBLIC DATASETS USED IN THIS STUDY 
Ring1B, Suz12 and H3K27me3 ChIP-seq profiles for WT serum mESCs, 2i mESCs, and transition 
stages were taken from Joshi et al., 2015. H3K27me3 ChIP-seq profiles were downloaded from 
Brinkman et al., 2012. 
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FIGURE LEGENDS 
Figure 1: Role played by DNA methylation in maintenance of ELRI. (A) A zoomed-in view of ELRI 
loci HoxA and HoxD showing dynamics of H3K27me3 deposition Brinkman et al., 2012 in WT 
serum mESCs and 2i mESCs compared to DnmtTKO serum mESCs (Brinkman et al., 2012). (B) A 
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boxplot comparing the intensity of H3K27me3 deposition on ELRI loci VS other bivalent genes. 
(C) A 4C interaction plot on Chromosome 2 showing interaction profile for HoxD locus, 
compared between conditions: WT serum mESCs, WT 2i mESCs and DnmtTKO serum mESCs. (D) 
A plot comparing quantified interaction strength for ELRI interaction between HoxD and its 
interactors for WT serum mESCs, WT 2i mESCs and DnmtTKO serum mESCs.  
Figure 2: Role of Cbx7 in ELRI loci in mESCs and its potential role. (A) A zoomed-in view of ELRI 
loci HoxB, HoxA, Bmi1 and non-ELRI loci Gad2 showing dynamics of Cbx7 deposition during 
Serum to 2i transition in mESCs. (B) A boxplot comparing the intensity of Cbx7 deposition on 
ELRI loci VS other bivalent genes. (C) A graphical representation of CRISPR-cas strategy used for 
knock-out of Cbx7 protein. (D) A western-blot validating knock-out of Cbx7 for clones 
numbered 2, 4 and 25 compared to Serum WT mESCs.  
Figure 3: Epigenetic effect of Cbx7KO on PRC1/PRC2 recruitment and ELRIs. (A)  A browser view 
of deposition of Ring1B and Suz12 on ELRI loci – HoxD, HoxA, Pax6 and Lhx2 in WT serum 
mESCs, WT 2i mESCs and Cbx7KO Serum mESCs. (B) A boxplot comparing the intensity of 
Ring1B deposition on ELRI loci VS other bivalent genes during WT serum to 2i transition in 
mESCs compared to Cbx7KO Serum mESCs. (C) A boxplot comparing the intensity of Suz12 
deposition on ELRI loci VS other bivalent loci during WT serum to 2i transition in mESCs 
compared to Cbx7KO Serum mESCs. (D) A 4C interaction plot on Chromosome 2 showing 
interaction profile for HoxD locus compared between conditions: WT Serum mESCs, WT 2i 
mESCs and Cbx7KO Serum mESCs. (E) A 4C interaction plot on Chromosome 6 showing 
interaction profile for HoxA locus compared between conditions: WT Serum mESCs, WT 2i 
mESCs and Cbx7KO Serum mESCs. (F) A plot comparing quantified interaction strength for ELRI 
interaction between HoxD/HoxA and their respective interactors for WT Serum mESCs, WT 2i 
mESCs and Cbx7KO Serum mESCs. 
Figure 4: Epigenetic effect of Cbx7KO on PRC1/PRC2 recruitment and ELRIs during 2i to Serum 
transition for mESCs. (A)  A browser view of deposition of Ring1B and Suz12 on ELRI loci – HoxD, 
HoxC, Dlx5/6 and Gata4 in WT serum mESCs, WT 2i mESCs, Cbx7KO Serum mESCs, Cbx7KO 2i 
mESCs and Cbx7KO 2i to Serum mESCs. (B) A boxplot comparing the intensity of Ring1B 
deposition on ELRI loci VS other bivalent genes in WT serum mESCs, WT 2i mESCs, Cbx7KO 
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Serum mESCs, Cbx7KO 2i mESCs and Cbx7KO 2i to Serum mESCs. (C) A boxplot comparing the 
intensity of Suz12 deposition on ELRI loci VS other bivalent loci in WT serum mESCs, WT 2i 
mESCs, Cbx7KO Serum mESCs, Cbx7KO 2i mESCs and Cbx7KO 2i to Serum mESCs. (D) A 4C 
interaction plot on Chromosome 2 showing interaction profile for HoxD locus compared 
between conditions: WT serum mESCs, WT 2i mESCs, Cbx7KO Serum mESCs, Cbx7KO 2i mESCs 
and Cbx7KO 2i to Serum mESCs. (E) A 4C interaction plot on Chromosome 6 showing interaction 
profile for HoxA locus compared between conditions: WT serum mESCs, WT 2i mESCs, Cbx7KO 
Serum mESCs, Cbx7KO 2i mESCs and Cbx7KO 2i to Serum mESCs.  (F) A plot comparing 
quantified interaction strength for ELRI interaction between HoxD and its interactors for WT 
serum mESCs, WT 2i mESCs, Cbx7KO Serum mESCs, Cbx7KO 2i mESCs and Cbx7KO 2i to Serum 
mESCs.  
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CHAPTER 5 
 
GENERAL DISCUSSION 
 
EPIGENETICS AND 3D CHROMATIN 
At the start of the thesis, I have talked about DNA and genetics as the ‘language of life’ as 
we know it on this planet Earth. Using the same analogy we can consider epigenetics as the 
grammar of this ‘language of life’ (Ameer, 2010). Hence, we can compare epigenetics to 
‘words in a sentence from a book’, giving a levels of meaning to the information contained. 
But the ‘words in a sentence’ and ‘sentences in a paragraph’ only make sense in a structured 
context. In a similar fashion, the folding of the chromatin thread is carried out to provide 
structure, accessibility, context and meaning to this ‘language/script of life - DNA’. Hence, it 
is of extreme importance to understand the phenomenon of packaging, folding and 
structuring of chromatin to gain momentum towards a complete understanding of 
epigenetics and the complex role it plays. 
Like a book is structured into units of information such as sentences, paragraphs and 
chapters; chromatin is similarly organized into increasingly complex higher-orders of 
structures. The lowest order starts with the local chromatin interactome, consisting of 
contacts between neighbouring genes and their regulatory elements. The next order of 
chromatin architecture is commonly accepted as topologically associated domains or TADs. 
Simply put, TADs are domains or fragments of linear genome that show statistically higher 
probability of interaction within the fragment as compared to a neighbouring genomic 
fragment (Dixon et al., 2012). Thus, the fragment of the genome inside a TAD is relatively 
isolated from the rest of the genome, and forms the basis for local chromatin and spatial 
regulation of genes. TADs form the basic structure for packaging of the genome into even 
higher order structure made up of several TADs, called A/B compartments (Bonev Boyan 
and Cavalli Giacomo, 2016; Dekker et al., 2013; Dixon et al., 2012; Gibcus and Dekker, 2013). 
The active domains are called the A compartment domains and are more open to facilitate 
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transcription, whereas inactive domains form B compartments which are relatively spatially 
restricted. Even higher order of chromatin architecture is maintained by restriction of 
chromosomes into spatially confined regions called chromosome territories (Cremer et al., 
1982; Hens et al., 1983; Visser et al., 2000). 
 
ROLE OF NEW AND EMERGING TECHNOLOGIES 
A wealth of information has been gathered over the past decades leading to our current 
level of understanding with regards to chromatin architecture. This knowledge could be 
gathered because of the continuous development and evolution of tools and methods to 
study 3D conformation of chromatin.  
This evolution of technology has moved from simple light microscopy to new generations of 
high-resolution, Nano-scale microscopes capable of looking deep into chromatin structure 
(Lakadamyali and Cosma, 2015). The limiting factor of microscopy is still its resolution and 
low-throughput nature looking at a few loci, in one nucleus at the time, although recent 
advances are being made using automation tools. With the advent of 3C technology, a new 
era of high-throughput tools to study chromatin was ushered in (Dekker et al., 2013). Over 
the years, we have moved from a gel-based 3C technology to next generation sequencing 
(NGS) based 3C-seq, 4C-seq, 5C, ChIA-PET and Hi-C like technologies. The advantages and 
disadvantages of each type of technology have been discussed in this thesis (Chapter 1). 
Each technology is serving its own purposes and furthers the knowledge of chromatin 
architecture. For example, 4C-seq is an excellent tool to investigate in detail the local level 
of chromatin contacts which probably impacts gene expression, one locus at the time. Tools 
such as Hi-C give researchers opportunity to investigate higher-order structure, in a 
genome-wide manner. The genome-wide nature of Hi-C comes at the cost of either 
compromising with the resolution or high cost of deep sequencing (Dekker et al., 2013; 
Maze et al., 2014).   
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ADVENT OF CAPTURE HI-C 
The technology gap between 4C and Hi-C has left an information gap, due to the lack of a 
tool to study large fractions of the genome at the required very high-resolution. This need 
was answered by the advent of Capture-C technology. Hughes et al., 2014 introduced the 
concept of an enrichment technique to pull-down and analyse hundreds of genomic loci of 
interest from a pool of all interaction. Capture-C combined the oligonucleotide capture 
technology (OCT) with 3C and NGS to study hundreds of distinct regions of interest in an 
single experiment (Hughes et al., 2014).  We and other labs developed a modification of an 
established technique to study the 3D conformation of chromatin at genome scale at 
significantly lower sequencing costs (Dryden et al., 2014; Joshi et al., 2015; McGovern et al., 
2016; Schoenfelder et al., 2015). This technique, called open chromatin focused Capture Hi-
C (Joshi et al., 2015) maximizes the resolution at which chromatin interactions are revealed, 
by focussing on interactions between loci with at least one end in the open chromatin. 
Capture Hi-C is a protocol developed by modifying and amalgamating a standard Hi-C 
protocol and protocols developed to pulldown specific DNA fragments using complementary 
oligos conjugated with biotin. 
Capture Hi-C is a technology that uses a double enrichment strategy to generate good 
quality data, efficiently and affordably (Dryden et al., 2014; Joshi et al., 2015; McGovern et 
al., 2016; Schoenfelder et al., 2015).  The first levels of enrichment is that of ‘interaction 
events’ and is an inherent quality of Hi-C. Interaction events are enriched by labelling the 
interaction junctions with biotin which can be enriched using streptavidin beads. The second 
level of enrichment is by capture of the fraction of genome of interest using complementary 
single-stranded DNA probes. These capture probes are also biotin labelled for easy beads-
based streptavidin enrichment. Using Capture Hi-C technology we, along with other labs, 
have been able to target a relatively large fraction of the genome and generate interactome 
with high-resolution (Dryden et al., 2014; Joshi et al., 2015; McGovern et al., 2016; 
Schoenfelder et al., 2015). We used Capture Hi-C technology to successfully target open 
chromatin in mESCs comprising the transcription regulatory regions to generate an 
interactome with high-resolution of ~1Kb. 
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With ever-decreasing requirement of starting material for protocols such as Capture Hi-C, 
we expect that analysis of limited biological samples such as early embryos and 
biopsy/patient materials can be tackled. This would enable generation of functionally 
important interactome to gain further insight into systems such as embryo development 
and disease models.     
 
DYNAMICS OF EXTREMELY LONG-RANGE INTERACTIONS BETWEEN TWO STATES OF 
PLURIPOTENCY 
Embryonic stem cells (ES cells) are in vitro cultured pluripotent stem cells derived from an 
early-stage preimplantation embryo, specifically from the inner cell mass of a blastocyst 
(Evans and Kaufman, 1981). The ability of ESCs to differentiate into any cells type from a 
body and their property of infinite self-renewal make these cells unique and provide a 
window to understand the fundamentals of pluripotency (Evans and Kaufman, 1981). mESCs 
are classically cultured in growth-media supplemented with fetal calf serum and leukaemia 
Inhibitory Factor (LIF) or, more recently, in serum-free 2i medium that contains LIF plus 2 
small-molecule kinase inhibitors: PD0325901 targeting mitogen-activated protein kinase 
(MEK) pathway and CHIR99021 targeting glycogen synthase kinase-3 (GSK3) pathway(Ying 
et al., 2008). The mESCs grown in serum media when compared to 2i are morphologically 
distinct.  
Studying the transition of mESCs from a ‘ground-state’ of pluripotency or ‘2i state’ to a 
relatively ‘primed state’ of pluripotency or ‘serum state’ is a fundamental model to studying 
very-early differentiation of the embryo. The added advantage to this ‘two state 
pluripotency model’ is the fact that with a simple change in growth media, mESCs can 
transition from one state to the other, in an interconvertible manner (Marks and 
Stunnenberg, 2014; Marks et al., 2012; Nichols and Smith, 2009).  A vast amount of 
epigenetic and transcriptomic data is available for the serum-2i system making it easy to 
correlate and compare new with existing data. The question arises ‘How do the differences 
in the epigenetic states of serum versus 2i mESCs translate into differences in the 
interactome, especially considering that both states are pluripotent and closely related but 
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markedly different in their respective epigenomes and infer the findings to early stages in 
mESCs development. 
The aim of the project discussed in CHAPTER 3 was to identify the differences in the 
interactome during reprogramming of mESCs during transition from serum-to-2i states of 
pluripotency. After applying ‘open chromatin’ based Capture Hi-C tool to this model we 
identified ~2 million contacts involving baits placed in genomic regions with open 
chromatin. We were able to show the existence of a special class of extremely long-range 
interactions (ELRIs) involving the Hox and other genomic loci only in serum mESCs, which 
are absent in 2i state of pluripotency. 
To further understand this dynamics in ELRIs between the two states of pluripotency, we 
explored the epigenetic features at these ELRI loci. H3K27me3, Suz12 and Ring1B showed 
strong localization at ELRI loci in serum condition compared to severely low occupancy in 2i 
condition. Upon looking at the loss of ELRI interaction during transition of mESCs from 
Serum to 2i condition (on DAY1 and Day3 of transition), we found that the rate at which ELRI 
was lost matched well with loss of PRC2 and PRC1 components at these loci. The synchrony 
between loss of ELRI and loss of PRC2 and PRC1 components suggested a significant role of 
these complexes in maintenance of ELRIs. We observed that bivalent genes that do not 
display ELRI also have occupancy of PRC1 (Ring1B) similar to that of ELRI loci. During the 
serum-to-2i transition, bivalent loci in general show the same kinetics as ELRI loci with 
respect to loss of Ring1B.  
Eed is one of the core components of PRC2 complex (Wang et al., 2002). To investigate the 
putative role of PRC2 and H3K27me3 deposition in ELRI, we performed Capture Hi-C on Eed-
/- mESCs cultured in serum media. Interestingly, we observed a complete abolishment of 
ELRIs in Eed-/- serum mESCs, mimicking lack of ELRIs observed in 2i mESCs. While our 
manuscript was in revision, Schoenfelder and coworkers using a promoter CHi-C approach 
identified extremely long-range interactions in serum mESCs, and pointed to a role of PRC1, 
in maintenance of ELRIs (Schoenfelder et al., 2015). 
Our observation on dynamics of ELRIs during serum-to-2i transition showed that these long 
range interactions are spatially restricted interactions, mediated by repressive chromatin 
markers (H3K27me3, PRC2 and PRC1). One would expect to observe an increase in 
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expression of ELRI genes when all the restrictive and repressive constrains on the chromatin 
are removed during transition of mESCs from serum-to-2i state. Converse to the 
expectation, we observed that only 18% of all ELRI genes significantly increased their 
expression in 2i condition. The increased expression coincided with gain of positive 
chromatin mark - H3K27ac in 2i mESCs. This suggested that lack of restrictive control on ELRI 
loci did not allow all ELRI genes to increase expression. We hypothesize that the absence of 
large-scale increase in transcriptional activity of ELRI genes might be due to absence of 
appropriate transcription factors (TFs) at the early ‘ground state’ pluripotency of mESCs.  
 
 
A POSSIBLE MODEL FOR ELRIs ESTABLISHMENT 
ELRIs are extremely long-range promoter-promoter interaction between genomic 
fragments, including all Hox loci, mediated by PRC2 and PRC1 complexes. High proportion of 
ELRI proteins have a homeobox domain and are master regulators of cell lineage 
determination. Considering all the observation with regards to ELRI, we propose the 
following model; ELRIs form a spatiotemporal network providing a repressive mechanism to 
control expression of Hox and other developmentally important genes during the transition 
of mESCs from 2i ‘ground-state’ to a serum ‘primed-state’ of pluripotency. The ELRI network 
is not present in 2i mESCs, as the ELRI genes do not require repression at ground-state, due 
to the lack of appropriate TFs. ELRIs may provide the embryonic differentiation program 
with an additional layer of spatiotemporal control. This spatiotemporal control could play an 
potential role in release of appropriate ELRI genes as regulators of specific direction of 
differentiation, subject to the correct stimulus provided. Further research would be needed, 
in vivo or on other differentiation models to completely understand role of ELRI network 
dynamics. 
Mechanistically, the following sequence of events seems likely to initiate establishment of 
ELRIs during transition of mESCs from a ‘ground’ to a ‘primed’ pluripotent state; 2i mESCs 
have low occupancy of H3K27me3, PRC2 (Suz12) and PRC1 (Ring1B) at ELRI loci. During 
transition to serum state, ELRI loci start recruiting PRC2 and H3K27me3 is deposited by the 
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EZH2 component. In response to high levels of H3K27me3, canonical PRC1 (cPRC1) is 
recruited to ELRI loci. Cbx proteins, with a chromo-domain capable of recognizing 
H3K27me3 mark, may recruit cPRC1 to ELRI loci. PRC2 and PRC1 synergistically form 
complexes to establish ELRIs in the serum state of pluripotency.  
It seems likely that ELRI requires a specific composition of the modular PRC1 or specific 
transcription factor co-binding and/or epigenetic context that act only on ELRI loci. Several 
studies have shown that PRC1 is a highly modular complex (Chen and Dent, 2014; Creppe et 
al., 2014; Gao et al., 2012; Mas and Di Croce, 2016; Senthilkumar and Mishra, 2009). The 
selective or discriminatory property of ELRIs to target a subset of PRC1-PRC2 positive 
bivalent genes while ignoring epigenetically similar genes, remains a mystery.  Why bivalent 
genes and ELRI loci lose their PRC markers in 2i condition has not yet been deciphered. 
Recent studies in Dnmt triple knock-out mESCs, with hypo-methylated DNA have shown loss 
of H3K27me3 deposition at bivalent loci including Hox, mimicking 2i mESCs (Hagarman et 
al., 2013; Reddington et al., 2013; Rose and Klose, 2014).    
POSSIBLE ROLE OF CBX7 AND DNA METHYLATION DURING ELRI MAINTENANCE AND 
ESTABLISHMENT 
In Chapter 3, we looked at extremely long-range interactions (ELRIs) that connected 108 
protein coding genes, including the Hox cluster, and 93 non-coding genes. One of the 
prominent features of the ELRIs was found to be a high level of H3K27me3 histone 
modification along with recruitment of PRC2 and PRC1 factors such as Suz12 and Ring1B to 
the ELRI loci. To investigate the role of PRC2, we performed Capture Hi-C on Eed knock-out 
serum mESCs, resulting in complete loss of ELRIs phenotype. Similarly, Schoenfelder et al., 
2015 showed abolishment of ELRI in Ring1A-Ring1B double knock-out mESCs. Hence, taken 
together the studies suggest important roles for both PRC1 and PRC2 complexes in 
establishment/maintenance of ELRIs. The synergistic nature of PRC2 and PRC1 is, in part, 
due to recruitment of canonical PRC1 (cPRC1) by Cbx proteins to genomic sites marked by 
H3K27me3 deposition (Morey et al., 2012, 2013). In Chapter 4, we took first steps to 
elucidate the method of recruitment of PRC proteins to the ELRI loci and to understand the 
initiation and establishment of ELRIs. To investigate recruitment of cPRC1 to ELRI loci, we 
generated a knock-out of the most abundant Cbx protein found in serum mESCs – Cbx7 
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(Morey et al., 2012, 2013; Tavares et al., 2012). The observation of loss of Cbx7 at ELRI loci 
as well as other bivalent loci, during transition of mESCs from a serum to 2i state of 
pluripotency, gave further credit to the potential importance of Cbx7 as the recruiter of 
cPRC1 to ELRI loci and establishment of ELRIs.  Deposition of Ring1B (PRC1 component) was 
reduced in Cbx7KO serum mESCs compared to WT serum mESCs but still maintained higher 
levels than WT 2i mESCs. Suz12 deposition did not change in Cbx7KO mESCs compared to 
WT serum mESCs as recruitment of PRC2 complex was not tampered with. The incomplete 
abolishment in recruitment of Ring1B to the ELRI loci suggest redundancy amongst Cbx 
proteins, or maintenance of PRC1 by a non-canonical pathway. Interestingly, although loss 
in Ring1B deposition was observed, interaction strength between ELRI loci did not change 
significantly. 
To address the hypothesis that Cbx7 might be involved only during initial recruitment of 
PRC1 and not during maintenance of PRC1 at ELRI loci, we tested initiation/re-establishment 
of PRC1 and ELRIs. The initiation/re-establishment of PRC1 and ELRIs was tested by 
converting Cbx7KO mESCs to 2i state, thereby severely lowering the levels of PRC1 and 
abolishing ELRIs; followed by reintroducing the Cbx7KO 2i mESCs to serum condition. We 
observed that upon forced initiation/re-establishment test, Ring1B deposition was diverse 
amongst distinct ELRI loci, although still lower than levels observed in WT serum mESCs. 
Interestingly, we did not observe recovery or reestablishment of ELRIs in response to 
initiation/re-establishment test. This suggests aberrant Ring1B deposition in absence of 
Cbx7 also leads to lack of reestablishment of ELRIs, although more validation experiments 
need to be performed. Hence, we can conclude subject to validation, that Cbx7 is not critical 
to maintenance of ELRIs but could be potentially important factor during initial 
establishment of ELRIs. 
We have shown in Chapter 3 that PRC2 and PRC1 are critical for maintenance of ELRIs in WT 
serum mESCs. In WT 2i mESCs, due to lower levels of PRC1 and PRC2 at ELRI loci, ELRIs are 
not established. An important question which had not been addressed was ‘why is there 
lower levels of PRC2 and PRC1 at other bivalent and ELRI loci?’. Studies in mouse embryonic 
stem cells have shown that DNA methylation and H3K27me3 are mutually exclusive 
(Brinkman et al., 2012; Hagarman et al., 2013; Kondo, 2014; Rose and Klose, 2014).   Recent 
studies have indicated role of DNA methylation in correct targeting of PRC2 linked 
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repression especially to Hox clusters (Reddington et al., 2013). The model suggested for 
Dnmt triple knock-out (DnmtTKO) mESCs condition is dilution of PRC2 from its cognate 
target genes, and spreading of PRC2 to inappropriate genomic loci, in DNA hypo-methylated 
conditions. This model fits well with observations made in WT 2i mESCs with respect to 
hypo-methylation of DNA and lack of H3K27me3 mark on bivalent genes. Hence, we 
investigated whether anomalous deposition of H3K27me3/PRC2 in DnmtTKO serum mESCs 
alters the ELRIs structure observed in serum mESCs.  We observed complete loss of ELRIs in 
DnmtTKO cells mimicking WT 2i mESCs and in contract with WT serum mESCs.  
Based on current evidence we can postulate that, there is a dilution of PRC2 from ELRI loci 
due to hypo-methylation of DNA in ‘2i state of pluripotency’, as genomic regions 
inaccessible in serum condition are now available for PRC2 binding. This dilution of PRC2 
from ELRI loci severely reduces recruitment of PRC1, hence ELRIs are not established in 
‘ground state’ of pluripotency (WT 2i mESCs). Hence we can argue, Dnmt triple knock-out 
phenotypically mimics 2i state mESCs. 
CAPTURE Hi-C DATA AS A RESOURCE FOR FUTURE STUDIES 
The aim of the doctoral project was to develop an approach to study the interactome of the 
open chromatin (consisting amongst others of promoters and enhancers) to study the 
dynamics between two states of pluripotency. Using Capture Hi-C technology we were 
successful in generating the interactome for open chromatin in Serum to 2i transition of 
mESCs at a high resolution of ~1kb. In this thesis, we discussed only a fraction of the 
interactions, used to identify highly differential long-range interaction called ELRIs. A large 
fraction of the interactome is still available for data mining to obtain useful biological 
information. Strategies available for further exploration of the data would be to identify 
qualitative and quantitative changes in the interactome during the transition. These 
differences if present, can then be correlated with differences in transcriptional activity of 
associated genes. Depending on whether the regulatory element is a repressor or enhancer, 
motif analysis can be performed to identify potentially important factors responsible for 
maintenance of either of the two states of pluripotency. Knock-out experiments on the 
identified factor can be used for validation. Inversely, any binding profiles of TFs or fragment 
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of DNA acting as a regulatory element can be investigated using Capture Hi-C data to find 
appropriate interaction partners.     
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APPENDIX 
SAMENVATTING - DUTCH 
Chromatine architectuur en zijn functionele rol zijn reeds decennia onderwerp van 
onderzoek. In dit thesis introduceerde ik algemene concepten met betrekking tot 
epigenetica, chromatine architectuur en methoden ontwikkeld om de 3D chromatine 
structuur te bestuderen. Tenslotte beschreef ik studies in welke wij deze methoden gebruikt 
hebben om de plasticiteit en dynamiek van de 3D architectuur van het genoom te 
bestuderen, met name gefocust op de vroege embryonale ontwikkeling. 
In Hoofdstuk 2 bediscussieerden we de noodzaak voor nieuwe technieken om het 
interactoom van het genoom omvangrijk in kaart te brengen. Ik introduceerde een nieuwe 
techniek in het lab om de 3D chromatine configuratie op hoge resolutie en tegen lagere 
kosten, genaamd Capture Hi-C, te bestuderen. We bediscussieerden de voordelen van 
Capture Hi-C ten opzichte van zogenaamde “high-throughput” technieken, alsmede het 
protocol ontwikkeld voor Capture Hi-C in samenwerking met Roche-NimbleGen. We 
vergeleken traditionele Hi-C met Capture Hi-C en belichten de verworven voordelen van 
deze aangepaste techniek. We bediscussieerden ook huidige en toekomstige toepassingen 
van Capture Hi-C. 
In Hoofdstuk 3 onderzochten we de dynamiek van 3D genoom organisatie tijdens de 
transitie van mESCs tussen twee verschillende staten van pluripotentie, namelijk die van 
‘naïeve’ 2i naar relatief op differentiatie ‘voorbereidde’ serum staat van pluripotentie. We 
bediscussiëren kort de nieuw ontwikkelde Capture Hi-C met target-sequentie verrijking van 
compleet open chromatine. We detecteerden extreem lange-afstands inter- en intra- 
chromosomale interacties tussen een kleine groep van H3K27me3 bivalente promoters het 
Hox cluster. Opmerkelijk, deze promoter-specifieke interacties zijn niet aanwezig in 2i 
ground-state pluripotente mESC maar verschijnen tijdens de ontwikkeling naar op 
differentiatie voorbereidde mESCs. Omgekeerde transitie van 2i naar serum leidt tot het 
omkeren van de promoter-promoter interacties in een tijdruimtelijke manier. H3K27me3, 
dat grotendeels afwezig is op bivalente promoters in 2i mESCs, is vereist, maar niet genoeg, 
om deze interacties tot stand te brengen, dat bevestigd werd door Capture Hi-C in Eed-/- 
serum mESCs. 
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In Hoofdstuk 4 bediscussieerden we de rol van Cbx7 en DNA methylatie in initiatie en 
onderhoud van de extreem lange-afstands Hox-gerelateerde interacties oftewel ELRIs. In dit 
hoofdstuk hebben we de mogelijke rekrutering van PRC1 en PRC2 naar de ELRI loci via de 
klassieke of niet-klassieke weg vastgesteld. We onderzochten het effect van de deletie van 
Cbx7 op de rekrutering van PRC1 en PRC2 naar de ELRIs en andere bivalente regio’s. We 
keken ook naar het effect op ELRI formatie en onderhoud. Tenslotte hebben we een 4C 
experiment op DNMT triple KO serum cellen uitgevoerd om de rol van DNA methylatie in 
ELRI formatie te bestuderen. In dit hoofdstuk lieten we zien dat in serum-gekweekte DNMT3 
KO mESCs het verlies van DNA methylatie en gelokaliseerde H3K27me3 resulteert in het 
verlies van ELRI, bevestigend de kritieke rol welke H4K27me3 heeft in ELRI formatie. Knock-
out van Cbx7, een component van het klassieke PRC1 complex betrokken bij verankering 
van PRC1 aan H3K27me3 loci door middel van zijn chromodomein, resulteerde in een 
vermindering van Ring1B rekrutering (een kern component van PRC1) naar ELRI en andere 
bivalente loci, het beïnvloedt de ELRIs echter slechts marginaal. Cbx7 draagt desalniettemin 
bij aan ELRI formatie tijdens het verwerven van H3K27me3 wanneer zijn van 2i-naar-serum 
staat switchen. We observeerden dat het niveau van PRC2 aan de hand van Suz12, niet 
herstelt naar het niveau gelijk aan geobserveerd in mESCs gevestigd en onderhouden in 
serum condities. De experimenten tonen aan dat Cbx7 wellicht een belangrijke rol speelt in 
het tot stand brengen en onderhouden van ELRIs in op differentiatie voorbereidde 
pluripotente stamcellen. 
Hoofdstuk 5 vat de bevindingen en verkregen inzichten beschreven in deze thesis samen. 
We bediscussiëren de belangrijkste bevindingen van elk hoofdstuk om te riching van 
toekomstig onderzoek te bepalen. 
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SUMMARY - ENGLISH 
Chromatin architecture and its functional role have been a subject of research for decades. 
In this thesis I introduced general concepts of epigenetics, chromatin architecture and tools 
developed to study 3D chromatin structure. Finally I described studies in which we used 
these techniques to answer plasticity and dynamics of 3D chromatin architecture, with 
special emphasis on very early embryonic differentiation.  
In Chapter 2, we discussed the need for new technology to comprehensively map the 
interactome of the functional genome. I introduced the establishment of new technique 
developed in the lab to study 3D chromatin conformation at high resolution and at lower 
cost, called Capture Hi-C. We discussed the advantages of Capture Hi-C over other high-
throughput techniques. We discuss in detail the protocol developed for Capture Hi-C in 
collaboration with Roche-NimbleGen. We compared traditional Hi-C with Capture Hi-C 
highlighting the advantages gained using this adapted technology. We also discussed the 
current applications and future applications of Capture Hi-C. 
In Chapter 3, we investigated the dynamics of 3D genomic organization during the transition 
of mESCs between two states of pluripotency, namely ‘Naïve’ 2i state to a relatively ‘primed’ 
Serum state of pluripotency. We briefly discuss the newly developed Capture Hi-C with 
target-sequence enrichment of all open chromatin. We detected extremely long-range 
intra- and inter-chromosomal interactions between a small subset of H3K27me3 marked 
bivalent promoters involving the Hox clusters. Markedly, these promoter-confined 
interactions are not present in 2i ground-state pluripotent mESCs but appear upon further 
development into primed like serum mESCs. Reversing serum mESCs to ground-state 2i 
mESCs reverses the promoter-promoter interaction in a spatiotemporal manner. 
H3K27me3, that is largely absent at bivalent promoters in ground-state 2i mESCs is 
necessary but not sufficient to establish these interactions, which is confirmed by Capture 
Hi-C on Eed-/- serum mESCs.  
In Chapter 4, we discussed the role of Cbx7 and DNA methylation on initiation and 
maintenance of Extremely Long-Range Hox-related Interactions or ELRIs. In this Chapter we 
assessed possible recruitment of PRC1 and PRC2 to the ELRI loci via the canonical or non-
canonical pathways. Concentrating on Cbx7, we investigated the effect of Cbx7 knock-out 
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on recruitment of PRC1 and PRC2 components to the ELRI and other bivalent loci. We also 
looked into the effect of Cbx7 KO on ELRI formation and maintenance. Finally, we 
performed 4C experiment on DNMT triple KO cells grown in serum condition to investigate 
role of DNA methylation on ELRIs. In this chapter, we showed that in serum-cultured 
Dnmt3KO mESCs the loss of DNA methylation and consequent loss of localized H3K27me3 
accumulation results in loss of ELRI corroborating the critical role of H3K27me3 in ELRI. 
Knock-out of Cbx7, a component of canonical PRC1 involved in anchoring of PRC1 to 
H3K27me3 loci via its chromodomain, resulted in reduction of Ring1B recruitment (a core 
component of PRC1) to ELRI and other bivalent loci but, only marginally affects ELRI. Cbx7 
however contributes to establishment of ELRI during acquisition of H3K27me3 when moving 
from the 2i-to-serum state mESCs. We observed that the level of PRC2 monitored by Suz12, 
does not recover to levels observed in mESCs that are established and long-term cultured in 
serum. The experiments show that Cbx7 may play an important role in establishment or 
maintenance of ELRIs in primed pluripotent stem cells. 
Chapter 5 summarizes the findings and insights gained in the thesis. We discuss the main 
messages from each chapter to understand the direction future research should take. 
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